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INHIBITORY IMPACT OF SELECTED ANTIBIOTICS ON 
BIODEGRADATION CHARACTERISTICS AND MICROBIAL 
POPULATION UNDER AEROBIC CONDITIONS 
SUMMARY 
The study evaluated the inhibitory impact of antibiotics on the biodegradation of 
peptone mixture by an acclimated microbial culture under aerobic conditions, 
together with their effects on the microbial population and the resistance profile of 
the biomass. Two fill and draw reactors fed with the peptone mixture defined in the 
ISO 8192 procedure and sustained at steady state at a sludge age of 10 days and 2 
days were used as the biomass pool with a well-defined culture history.  
Acute inhibition experiments involved running a total of six and five parallel batch 
reactors, for each sludge age of 10 and 2 days, respectively, seeded with biomass 
from control reactors (SRT 10d and 2 d) and the same peptone mixture together with 
pulse feeding of 50 mg/L and 200 mg/L of Sulfamethoxazole, Tetracycline and 
Erythromycin.  
Moreover, the effects of chronic exposure of the antibiotics were evaluated, for 
which a total number of six chronic reactors were set and investigated on different 
days throughout the study. Substrate utilization was evaluated by observing the 
respective oxygen uptake rate profiles and compared with both control reactors, 
which were started without antibiotic addition.  
All the data obtained were simulated using Activated Sludge Model No.3. Results 
showed that while all available external substrate was removed from solution, 
addition of antibiotics induced a significant decrease in the amount of oxygen 
consumed, indicating that a varying fraction of peptone mixture was blocked by the 
antibiotic and did not participate to the on-going microbial growth mechanism. This 
observation was also compatible with the concept of the uncompetitive inhibition 
mechanism, which defines a similar substrate blockage through formation of an 
enzyme-inhibitor complex.  
Additionally, resistance genes profiles and the microbial population characteristics of 
chronically inhibited systems were investigated. Moreover, microbial population 
dynamics studies by pyrosequencing revealed that the microbial population structure 
alters significantly under constant exposure to antibiotic substances. Results of both 
investigations revealed that organisms harboring resistance genes against antibiotics 
were able to survive under constant exposure to the inhibitory substances at both 
sludge ages.  
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SEÇİLMİŞ ANTİBİYOTİKLERİN AEROBİK KOŞULLAR ALTINDA 
BİYOLOJİK AYRIŞABİLİRLİK VE MİKROBİYAL POPÜLASYON 
ÜZERİNE ETKİLERİNİN BELİRLENMESİ 
ÖZET 
Teknoloji, endüstri ve tarımsal aktivitelerdeki gelişmeler neticesinde sentetik ve 
genellikle toksik organik maddeler atıksulara girmeye başlamıştır. Çeşitli endüstriyel 
proseslerde ortaya çıkan kalıcı organik maddelerin ve mikrokirleticilerin varlığı, bu 
maddelerin gideriminin ve arıtma sistemlerine etkilerinin belirlenmesinin önemini 
arttırmıştır. Bu kalıcı organik maddelerden olan ve son yıllarda çevre için büyük 
tehlike arz etmeye başlayan zenobiyotikler, genellikle sentetik olarak üretilen ve 
organizmaya yabancı olan maddeler olarak tanımlanmaktadır.  
Antibiyotikler de doğada ayrışmadan kalabilen ve besin zincirinde biyoakümüle olan 
zenobiyotiklerden biridir. Günümüzde başta tıp alanında olmak üzere veterinerlik ve 
tarımda yaygın olarak uygulanan antibiyotiklerin, bilinçsiz kullanımı ile sularda ve 
toprakta miktarları her geçen gün artmaktadır. Günümüzde bu kontrolsüz kullanım 
sonucu birçok bakteri türünün, özellikle patojen türlerin, antibiyotik direnci 
kazanması söz konusudur. Antibiyotik direnci kazanan mikroorganizmaların doğal 
ekosistemlerde yaygın olarak bulunması, başta insanlar olmak üzere hayvanlar ve 
bitkiler açısından büyük bir risk oluşturmaktadır.  
Literatürde antibiyotiklerin atıksu arıtma tesislerinin giriş ve çıkışlarındaki 
konsantrasyon değerleri ve alıcı ortamlardaki konsantrasyonları ile ilgili birçok 
çalışma bulunmaktadır. Buna karşın bu maddelerin arıtma tesislerindeki ayrışma 
mekanizmaları ve sistemdeki mikrobiyal popülasyon üzerine olan etkilerin ayrıntılı 
olarak araştırılmadığı görülmüştür. Yapılan araştırmalarda ise sistemde ya sadece 
kollektif parametrelerin ölçüldüğü ya da sadece antibiyotik konsantrasyonlarının 
izlendiği görülmektedir. Mikrobiyal popülasyonun antibiyotiklere verdikleri tepkiler 
ve popülasyon dinamiği de incelenmemiştir. Ayrıca, literatürde antibiyotiklerin 
biyolojik ayrışmaları ile ilgili yapılan çalışmalarda birbirinden çok farklı sonuçlara 
ulaşılmış olduğu da görülmektedir.  
Sulfonamidler insanlarda toplam antibiyotik kullanımının % 16-21 kadarını 
kapsamaktadır, kullanım sonrasında genellikle metabolitleri ve bir kısmı da orijinal 
aktif madde olmak üzere idrar ile dışarı atılmaktadır. Bu grubu temsilen seçilen 
sulfametoksazol en yaygın görülen sulfonamid grubu antibiyotiktir. Literatürde 
yapılan çalışmalarda sulfametoksazolün giderimi ile ilgili olarak kesin bir bilgi 
bulunmamaktadır.  
Seçilen ikinci antibiyotik olan tetrasiklin ve türevi antibiyotikler, hayvancılık ve 
tarımda en yaygın kullanılan antibiyotiklerdendir. Tetrasiklin grubu 
antibiyotiklerinin %80’i fotokatalitik reaksiyonlar ile ayrışma özelliğine sahiptir. 
Tetrasiklin antibiyotiğinin, aktif çamur sistemlerinde çamura tutunma yolu ile 
xxviii 
 
giderildiği ve bunun tetrasiklinin kalsiyum ve benzeri iyonlar ile, çözünürlüğü çok 
düşük bileşikler oluşturma eğiliminin bir sonucu olabileceği belirtilmiştir. 
Makrolidler ise insanlarda toplam antibiyotik kullanımının % 9-12 kadarını kapsayan 
en önemli antibiyotik gruplarından biridir ve penisilinlere alternatif olarak 
kullanılmaktadırlar. Makrolidler genellikle metabolize edilememekte ve değişmeden 
dışkı ile atılmaktadır.  
Gerçekleştirilmiş olan çalışma, antibiyotik maddelerin pepton karışımına aklime 
edilmiş bir aerobik mikrobiyal kültürün substrat ayrıştırması üzerine olan etkilerini, 
mikrobiyal popülasyon üzerine olan etkilerini ve aynı zamanda sistemin direnç 
profilini incelemiştir. İki adet doldur-boşalt tipi reaktör ISO8192 prosedüründe 
belirlenmiş olan pepton karışımı ile beslenmiş ve iki farklı çamur yaşında (çamur 
yaşı 10 gün ve 2 gün) kararlı halde devam ettirilerek, çalışma boyunca biyokütle 
kaynağı olarak kullanılmıştır.  
Akut inhibisyon çalışmaları için, kontrol reaktörlerinden alınan kaynak çamur 
kullanılarak kurulan paralel kesikli reaktörlerde, toplamda her iki çamur yaşı için 
onbir set deneysel çalışma gerçekleştirilmiştir. 50 mg/L ve 200 mg/L olmak üzere ani 
Sulfamethoksazol, Tetrasiklin ve Eritromisin ilavesi yapılmıştır.  
Ayrıca, aktif çamur sistemlerinin antibiyotiklere kronik maruz kalmalarının 
etkilerinin incelenmesi amacıyla toplamda altı adet reaktör işletilmiş ve farklı 
günlerde deneysel çalışmalar gerçekleştirilmiştir. Substrat tüketimi, ilgili oksijen 
tüketim profillerinin gözlemlenmesi ile incelenmiş ve antibiyotik etkisi altında 
olmayan ilgili kontrol reaktörünün oksijen tüketim profili ile karşılaştırılmıştır.  
Serbest substratın temel stokiyometrisi ve kütle dengesi, inhibitörlerin etkisinin 
açıklanması açısından çok önemlidir, bunun nedeni ise substratın bloke edilmesinin 
göz ardı edilmesi ile elde edilen kinetik değerlendirmenin yanlış yönlerdici özelliğe 
sahip olmasıdır. Literatürdeki birçok çalışma substrat bağlanmasını göz ardı etmiştir 
ve sadece substrat profillerine dayalı incelemelerde bulunmuşlardır. Bu çalışmalarda 
biyokimyasal reaksiyonlara katılmayan bağlı substrat ayrıdedilmemiştir. Oksijen 
tüketim hızı (OTH) profillerinin inhibisyon etkisi incelemelerinde kullanılmaları bu 
çalışmanın orijinalliğini oluşturmaktadır. Bu kapsamda seçilmiş olan antibiyotiklerin 
substrat bağlayıcı özellikleri unkompetitif inhibisyon yaklaşımı ile belirlenebilmiştir.  
Seçilmiş olan antibiyotik maddelerin pepton karışımının biyolojik olarak ayrışması 
üzerindeki akut ve kronik inhibisyon etkilerinin belirlenmesi amacıyla, bütün OTH 
profilleri temin eden respirometrik testler çalışmanın temelini oluşturmuşlardır. 
İnhibisyon etkisi, antibiyotik ilavesinin olmadığı kontrol testinde elde edilen orijinal 
OTH profilinin şeklindeki değişiklikler ile ortaya konmuştur.  
Antibiyotiklerin, peptonun piyolojik ayrışmasına en önemli etkisi, OTH testlerinde 
tüketilen oksijen miktarının azalmasıdır. Bu etki, maksimum büyüme hızını (μH) 
azaltarak ve/veya yarı doygunluk sabitini (KS) arttırarak biyolojik ayrışmayı 
etkileyen geleneksel inhibisyon kavramı ile açıklanamamaktadır. Bu iki etki de 
kinetik olarak substrat kullanımını yavaşlatma özelliğine sahiptir. Bu tür bir 
inhibisyon OTH eğrilerinin endojen solunum aşamasına ulaşma süresini uzatacak 
ancak OTH eğrisi altındaki alana tekbül eden oksijen tüketim miktarının sabit 
kalmasına neden olacaktır. 
Ancak, bu çalışmada elde edilen OTH profilleri farklı özelliklere sahiptir. 
Antibiyotik ilavesi ardından, biyolojik ayrışma süresi sabit kalmakta, buna karşın 
tüketilen oksijen miktarı kullanılan antibiyotik türü ve dozajına bağlı olarak 
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azalmaktadır. Bu kapsamda, farklı oranlarda pepton karışımının antibiyotik 
tarafından bloke edildiği ve devam eden mikrobiyal büyüme reaksiyonlarına 
katılamadığı sonucu ortaya çıkmaktadır. Bu gözlem sadece unkompetitif inhibisyon 
mekanizması ile açıklanabilmektedir. Bu kapsamda, bütün gözlemler unkompetitif 
inhibisyon kavramı ile açıklanmıştır ancak inhibisyon etkisinin antibiyotik dozu ve 
türüne bağlı olarak değiştiği gözlemlenmiştir. 
Elde edilen deneysel data Aktif Çamur Model No.3 kullanılarak simüle edilmiştir. 
Sonuçlar, bütün dışsal substrat giderilirken, antibiyotik ilavesi ile oksijen tüketiminde 
önemli bir düşüş yaşandığını ortaya koymuştur. Bu durum, pepton karışımının 
değişken fraksiyonlarının antibiyotik madde tarafından bloke edildiğini ve biyolojik 
ayrışmaya girmediğini göstemiştir. Bu gözlem, enzim-inhibitör kompleksi oluşumu 
ile benzer bir substrat blokajına neden olan unkompetitif inhibisyon mekanizması ile 
örtüşmektedir.  
Ayrıca, kronik reaktörlerinde görülen direnç profili ve pirosekanslama yöntemi 
kullanılarak kronik sistemlerin mikrobiyal popülasyon dinamikleri incelenmiştir. Bu 
çalışmalardan elde edilen sonuçlar sistemlerin dominant türlerinde kayma 
gerçekleştiğini ve sistemlerde antibiyotik etkisi altında canlılığını sürdürebilen 
organizmaların antibiyotik maddelere dirençli olma özelliklerini ortaya koymuştur.  
Çalışmalardan elde edilen sonuçlar çamur yaşının mikrobiyal popülasyona olan 
etkilerini de açığa çıkarmıştır. Elde edilen sonuçlara gore, yavaş büyüme özelliği 
olan Actinobacteria türlerinin hızlı büyüyen SRT2d sistemini domine etme 
özelliklerinin olmadığını göstermiştir. Buna karşın SRT2d sistemini Proteobacteria 
türlerinin domine ettiği görülmüştür. Ancak, çamur yaşı 10 gün sisteminde 
Actinobacteria yıkanmamış ve sistemi domine edebilmişlerdir. ERY etkisi altında ise 
SRT 10gün sisteminde popülasyonda bir kayma geçeklemiş ve dominantlik 
Actinobacteria’dan Proteobacteria‘ya geçmiştir. Bunun nedeni dirençli 
Proteobacteria’nın sistemde yaşamını sürdürebilmesidir. Sistemde Comamonas sp 
OTU#293 en baskın canlılardan olmuştur. SRT2gün sisteminde ise ERY etkisi yok 
iken Proteobacteria baskın olmasına ragmen ERY etkisi altında kültüre alınamamış 
aday phylum olan TM7 türü (OTU#83) baskın hale gelmiştir. Ancak TET ve SMX’in 
etkilerinin popülasyonda bir kaymaya neden olmadığı görülmüştür. Buna karşın, 
TET SRT2d sisteminde Deinococcus-Thermus phylumu yok olurken, SMX SRT2d 
sisteminde OTU#1, Deinococcus-Thermus phylumu türünün en baskın 
organizmalardan biri haline geldiği görülmektedir. SMX SRT2d sisteminde 
Proteobacteria önemli derecede azalmiş ve Deinococcus-Thermus phylumu 
artmıştır. Ancak SRT0d sisteminde Bacteroidetes önemli derece azalmıştır. Bütün 
SMX ve TET sistemlerinde Arthrobacter türlerinin baskın oldukları belirlenmiştir 
(OTU#2, OTU#55 ve OTU#4). 
Antibiyotik çalışmalarının devam ettirilmesi halinde, bu maddelerin giderilmesi ile 
ilgili çalışmaların gerçekleştirilmesi ve antibiyotikleri ayrıştırabilen organizmaların 
belirlenmesi üzerinde çalışılmasının faydalı olacağı düşünülmüştür. Ayrıca bu tür 
çalışmalarda da mutlaka modelleme simülasyon çalışmalarının devam ettirilmesi 
gerekmektedir. Böylece sistemin verdiği tepkinin doğru şekilde belirlenmesi 
mümkün olacaktır. 
  
 
 
xxx 
 
 
 
1 
 
 
1. INTRODUCTION 
Due to developments in technology, industry and agriculture, synthetic and generally 
toxic organic substances started to occur in wastewaters. The occurrence of persistent 
organic substances and micropollutants produced in various industrial processes 
increased the need to determine effects of such substances on wastewater treatment 
systems. Xenobiotics, among these persistent organic substances, are defined as 
substances foreign the organisms that are generally produced synthetically (Van der 
Meer et al., 1992).  
Antibiotics are among the xenobiotic compounds that are persistent to 
biodegradation and have the tendency to accumulate in the environment (Chrencik et 
al., 2005). They are extensively used in human and veterinary medicine. Possible 
irresponsible usage of these substances leads to resistant pathogenic microorganisms 
living in the surface waters and soil, which causes a large threat to human and 
environmental health (Boxall et al., 2003, Martinez et al., 2008, Li and Zhang, 2010). 
Antibiotics enter the sewerage with wastewater and reach the wastewater treatment 
plants. In wastewater treatment plants activated sludge systems are one of the most 
applied treatment technologies, and they date back to the beginning of the 20
th
 
century (Orhon and Artan, 1994). Due to their biological nature, activated sludge 
systems are one of the most susceptible parts of the treatment pipeline to antibiotics. 
In the literature there are many studies that have measured the concentrations in the 
influent and the effluent of the wastewater treatment plants and also in the receiving 
water media (Giger et al., 2003; Hirsch et al., 1999; Alexy et al., 2006). On the other 
hand, there is not enough information on their effects on treatment plant microbial 
population. Moreover, in the conducted studies it can be seen that either only 
collective parameters or antibiotic concentrations were measured, but the responses 
of the microbial population to the antibiotics and population dynamics were not 
analyzed thoroughly. Additionally in the studies conducted on the biodegradability 
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characteristics of the chosen antibiotics it can be seen that each study has given 
different results.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
2. AIM OF THE STUDY 
The scope of the current study was to conduct a detailed analysis of the effect of 
antibiotics on the activated sludge systems. For this purpose it aimed to determine 
the acute and chronic inhibition effects of three model antibiotics on non-acclimated 
and acclimated aerobic activated sludge cultures and their effects on the degradation 
mechanisms of the substrate using activated sludge modeling tools. Moreover it is 
aimed to determine the microbial species and antibiotic resistance genes in the 
system to enlighten the chronic effects of antibiotics on microbial diversity.  
Three model antibiotics, sulfamethoxazole, tetracycline and erythromycin, were 
chosen to determine their effects on the aerobic activated sludge systems and the 
removal mechanism of the substrate, peptone-meat extract mixture. In the current 
study, different concentrations of these three antibiotics were applied individually to 
determine their acute and chronic effects on the activated sludge systems.  
Respirometric methods and activated sludge modeling tools were implemented for 
the characterization of the response of the biomass to the antibiotic considered as an 
inhibitor substance. Moreover the antibiotic resistance genes were monitored 
qualitatively, showing the response of the biomass to chronic exposure to the model 
antibiotics, and this data was supported with microbial population analysis using 
ultrafast 454-pyrosequencing technology. 
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3. LITERATURE REVIEW 
3.1 Xenobiotics 
Nowadays, concentrations of synthetic and generally toxic compounds in 
wastewaters increase drastically due to developments in technology, industry and 
agricultural activities (Dogruel et al., 2004; Oktem et al., 2006). Occurrence of 
persistent organic substances and micropollutants in various industrial processes 
increased the importance of determining the effects of these substances on the 
treatment systems. 
These compounds are generally synthetically produced and cover many groups of 
chemicals including persistent compounds (van der Meer et al., 1992). 
Pharmaceuticals (antibiotics, antidepressants, and many other chemicals) are 
examples of such xenobiotic compounds which have the potential to accumulate in 
the food chain and threaten human health (van der Meer et al., 1992).  In spite of the 
fact that in the literature there are studies on bio-reclamation of natural ecosystems 
polluted with these compounds (O’Neill et al, 2000; Dou et al, 2008), there is not 
enough knowledge about the treatability of xenobiotic rich wastewaters and their 
effects on active species in the treatment systems. 
3.2 Antibiotics 
According to Kümmerer (2009), the classical definition of antibiotics is “a 
compound produced by a microorganism (such as Streptomyces spp.) which inhibits 
the growth of another microorganism”. However the meaning of antibiotic has 
changed over the years, leading to the current meaning of “substances with 
antibacterial, anti-fungal, or anti-parasitical activity”, which include synthetic and 
semi-synthetic products that have killing or inhibiting effect on bacteria, fungi or 
viruses (Kümmerer, 2009). Antibiotics are among the xenobiotic compounds (Alonso 
et al., 2001) that are persistent to biodegradation and have the tendency to 
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accumulate in the environment (Chrencik et al., 2005), and are widely used in human 
and veterinary medicine, aquaculture for preventing or treating microbial infections. 
Several hundred different antibiotic and antimycotic substances are used in human 
and veterinary medicine (Kümmerer and Henninger, 2003). Possible irresponsible 
usage of these substances leads to resistant pathogenic microorganisms living in the 
surface waters and soil, which causes a large threat to human and environmental 
health.  
There are different classes of antibiotics; an overview of main classes of antibiotics is 
given in Table 3.1. However in order to investigate the elimination mechanism of 
antibiotic substances in activated sludge systems and their effects on these systems 
three model substances were chosen. These substances were chosen to represent 
major groups of antibiotics and are among the abundantly used antibiotic substances 
in the world and in Turkey. Sulfamethoxazole was chosen to represent sulfonamides 
group, tetracycline to represent tetracyclines and erythromycin for macrolide group 
of antibiotics. 
Table 3.1: Major classes of antibiotics (taken from Kümmerer, 2009). 
Class Group Subgroup Example 
ß-lactams 
Penicillins 
Benzyl-penicillins Phenoxypenicillin 
Isoxazolylpenicillins Oxacillin 
Aminopenicillins Amoxicillin 
Carboxypenicillins Carbenicillin 
Acylaminopenicillins Piperacillin 
Cephalosporins 
Cefazolin group Cefazolin 
Cefuroxim group Cefuroxim 
Cefotaxim group Cefotaxim 
Cefalexin group Cefprozil 
Carbpenems – Meropenem 
Tetracyclines – – Doxycycline 
Aminoglycosides – – Gentamicin 1c 
Macrolides   Erythromycin A 
Glycopeptides   Vancomycin 
Sulfonamides   Sulfamethoxazole 
Quinolones   Ciprofloxacin 
3.2.1 Sulfamethoxazole 
Sulfamethoxazole is a member of the sulfonamide family and 16-21% of the 
antibiotic drugs used for human needs are from the sulfonamide group (Göbel et al., 
2005). The mode of action of the bacteriostatic agent Sulfamethoxazole is preventing 
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the dihydrofolic acid formation in bacteria (Drilla et al., 2005; Masters et al., 2003, 
Sköld, 2001), which is essential in the pathway of producing purines and 
pyrimidines. Due to development of bacterial resistance against Sulfamethoxazole, it 
is nowadays being used in combination with Trimethoprim (Drilla et al., 2005).  
3.2.2 Tetracycline 
Tetracyclines, discovered in the 1940’s, are broad-spectrum antibiotics that work 
against a large number of gram-negative and –positive bacteria, chlamydiae, 
mycoplasmas, rickettsiae and protozoa (Chopra and Roberts, 2001), and are one of 
the majorly used antimicrobials. Tetracycline as Sulfamethoxazole is a bacteriostatic 
agent (Le-Minh et al., 2010). Tetracycline group of antibiotics are strong chelating 
agents, which supports their antimicrobial properties (Blackwood, 1985, Chopra et 
al., 1992, Chopra and Roberts, 2001). They inhibit the protein synthesis by hindering 
the binding of amiacyl-tRNA with the ribosome (Chopra et al.,1992; Schnappinger 
and Hillen, 1996; Chopra and Roberts, 2001). 
3.2.3 Erythromycin 
Macrolides are among most widely used antibiotics for treatment of human diseases 
by 9-12% of the total use of antibiotics and they are used as an alternative to 
penicillin. They bind to the large subunit of the ribosome. Eryhromycin, especially, 
blocks the entrance to the tunnel of the large ribosomal subunit, hindering the exit of 
the peptide chains. This blockage causes creations of short uncompleted polypeptide 
chains (Tenson et al., 2003). Even though Erythromycin is a bacteriostatic agent 
(Louvet et al., 2010), in larger concentrations it can be cidial. 
3.3 Treatment of Antibiotics  
3.3.1 Antibiotics in the environment 
Residences, hospitals, poultry farms and pharmaceutical industries can be given as 
main sources of antibiotics that are among specific pollutants. Antibiotics used for 
animal breeding can pass into soil and receiving waters by animal manure. It has 
been reported that only 60-80% of used antibiotics is by prescription and that the 
main source of antibiotics in the receiving media is human usage (Göbel et al., 2005). 
Antibiotics are adsorbed in tissues and undergo metabolic changes in the receiving 
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body; however the unmetabolized parent product is also excreted together with the 
biotransformation products (Boxall et al., 2004; Perez et al., 2005).  
The hydrophilic structure of antibiotics enables their travel through water and makes 
it easier to reach the water reservoirs. Studies showed that elimination of antibiotics 
in wastewater treatment systems is not complete (Göbel et al., 2005; Xu et al., 2007, 
Golet et al., 2002; Li and Zhang, 2010). In this case, they are discharged into the 
surface waters and therefore able to reach the drinking water reservoirs.  
Antibiotic concentrations detected in wastewaters can be classified as high and low 
concentrations. Wastewaters contaminated with antibiotics during the production 
level are classified high concentration antibiotic containing wastewaters, whereas 
wastewaters contaminated with antibiotics after usage are classified as low 
concentration antibiotic containing wastewaters.  
In the literature there are studies that measured concentrations of antibiotics in the 
influent and the effluent of treatment plants and reported that the values are at ng/L 
to µg/L level (Drilla et al., 2005; Watkinson et al., 2007; Li and Zhang, 2010), µg/kg 
to mg/kg level in soil and sludge (Hamscher et al., 2002; Golet et al., 2003; Li and 
Zhang, 2010). Antibiotics that enter the wastewater treatment plants have the 
potential to affect the biomass in sewage systems. The inhibition of wastewater 
bacteria may seriously affect organic matter degradation; therefore, effects of 
antibiotics on the microbial population are of great interest (Kümmerer, 2009).  
 Other than the usage of antibiotics, pharmaceutical industries are also important 
sources of antibiotics in the environment. Pharmaceutical wastewaters contain high 
suspended solids concentrations and inert soluble organic matter. Moreover, 
pharmaceutical wastewaters having high chemical oxygen demand (COD) are either 
very alkaline or very acidic depending on the production at the industry and it is 
known that the substances in the wastewater have toxic effects on the biological 
community in the receiving media (Raj and Anjaneyulu, 2005). 
Typical pharmaceutical wastewater has the COD, sulfate and total suspended solids 
(TSS) concentrations of 12.500 mg/L, 9.000 mg/L and 36.000 mg/L, respectively. 
Moreover the antibiotic concentrations in some point sources like hospital 
wastewaters and pharmaceutical wastewaters have been reported to be as high as 10 
to 600 mg/L (Sponza and Celebi, 2012). Coagulation, chemical precipitation and 
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biological treatment by activated sludge systems can be given among the classical 
treatment methods of pharmaceutical wastewaters. Two stage chemical and 
biochemical treatment can be counted among the treatment strategies for the 
pharmaceutical wastewater (Raj and Anjaneyulu, 2005). 
Bernard and Gray (2000) reported that compared to domestic wastewater treatment 
plant sludge, with a dense and strong flocculation characteristic; the floc structure in 
activated sludge systems treating pharmaceutical wastewater was weak and 
dispersed.  
Elimination of pharmaceuticals in wastewater treatment plants is depended on many 
parameters like the sludge age, hydraulic retention time, temperature, pH, biomass 
concentration, polarity and biodegradability of the substance. It has been reported 
that there are different removal mechanisms of antibiotics in activated sludge 
systems. Among these abiotic and biotic processes can be given. Antibiotics bound 
to the activated sludge can be removed by adsorption (attachment to the surface) and 
absorption (diffusion into the solid phase) (Press-Kristensen, 2007). 
3.3.2 Sulfamethoxazole 
15% of Sulfamethoxazole is reported to be excreted from the body unmetabolized 
(Hirsch et al.,1999; Perez et al., 2005). Sulfamethoxazole concentration in German 
surface waters was measured between 30 and 85 ng/L (Hartig et al., 1999). It is one 
of the most commonly detected sulfonamides in wastewater ( Göbel et al., 2007; 
Choi et al., 2008; Le-Minh et al., 2010). Sulfamethoxazole has the property to bind to 
soil organic matter by different mechanisms like cation bridging and cation exchange 
(Xu et al., 2011). In the literature there is no definitive information on the elimination 
of Sulfamethoxazole (Baran et al., 2011). 
In biodegradability tests it has been determined that sulfamethoxazole was stable 
during the test period of 28 days (Gartiser et al., 2007; Alexy et al., 2004) and seen to 
be resistant to biodegradation (Garcia-Galan et al., 2008). On the other hand when 
sulfamethoxazole was fed to an activated sludge system operated as a sequencing 
batch reactor, the acclimated microbial culture was able to use the substance as the 
carbon and/or nitrogen source (Drillia et al., 2005). Drillia et al. (2005) investigated 
the removal of sulfamethoxazole simulating a common situation in wastewater 
treatment plants, i.e. presence of excess ammonium and readily biodegradable carbon 
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source. It has been found out that under these conditions the enzymes responsible for 
the removal of the antibiotic were inactive, and that if enough time was given for the 
synthesis of these enzymes, degradation of sulfamethoxazole was also possible under 
ammonium poor conditions. According to the results obtained from the study, it has 
been concluded that sulfamethoxazole can be removed in systems like extended 
aeration systems, where there is an absence of a readily biodegradable substrate. 
Moreover, according to Xu et al (2011), higher temperatures and higher humic acid 
content induced Sulfamethoxazole biodegradation, and they have also confirmed 
abiotic removal of the substance. Additionally, the study suggested that 
Sulfamethoxazole resistant bacteria Bacillus firmus and Bacillus cereus have the 
capacity to degrade Sulfamethoxazole in natural waters by high rates. 
3.3.3 Tetracycline 
Tetracycline antibiotics are known to be susceptible against light, therefore have the 
property to be degraded by photocatalytic reactions (Kümmerer, 2009). They were 
proved to be more stable in sediments. Moreover, the knowledge suggests that they 
remain in sediments for longer time periods, given that are is no known degradation 
mechanism of tetracyclines (Oka et al., 1989; Lunestad and Goksøyr, 1990, 
Kümmerer 2009). According to the study by Smith (2002), the tetracycline 
concentration in the Lee River near London was reported as 9.5 µg/L and 1 µg/L.  
It has been determined that in activated sludge systems tetracycline is removed by 
sorption onto sludge (Gartiser et al., 2007, Kim et al., 2005) and that this removal 
mechanism may be the result of tetracycline’s tendency to form very low solubility 
complexes by binding with divalent cations like calcium, magnesium, cadmium, 
cobalt and magnesium (Yamaguchi et al., 1990a; Alexy et al., 2004) and of their 
strong chelating capability (Chopra and Roberts, 2001). Alexy et al (2004) studied 
the biodegradability characteristics of antibiotics by Closed Bottle Biodegradability 
Test (OECD 301D). The obtained results showed tetracycline removal up to 75%.  
Shi et al (2011) investigated removal of tetracycline in nitrifying granular systems by 
short term exposure to the substance and also for sorption and biodegradation of the 
substance. In order to determine short term effects the authors treated the biomass 
with 20 mg/L tetracycline and measured the specific oxygen utilization rates of 
heterotrophic, ammonia oxidizing bacteria and nitrite oxidizing bacteria using 
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glucose, sodium acetate and NH4
+
-N as carbon and nitrogen sources, respectively. 
They characterized the removal process by quick sorption and slow biodegradation 
of the compound. At initial tetracycline concentrations of 10, 20 and 30 mg/L, the 
system was shown to present high tetracycline removal rates. Additionally, they 
determined that presence COD and ammonia nitrogen (< 150 mg/L) enhanced the 
removal process. However, they determined that the short term effect of the 
substance is to inhibit the respirometric activities of the biomass. 
3.3.4 Erythromycin 
Erythromycin was reported to be resistant to biodegradation by Richardson and 
Bowron (1985) and to be excreted from the body unaltered (Göbel et al., 2005). On 
the other hand high removal efficiencies of erythromycin in activated sludge systems 
operated with high sludge ages were reported, which shows that different reactor 
configurations have effects on the removal of erythromycin. Studies on the biological 
removal of erythromycin showed that in membrane bioreactors erythromycin was 
removed with 67% of removal efficiency (Radjenovic et al., 2007), whereas in 
completely mixed reactors efficiencies this high were not obtainable (Radjenovic et 
al., 2007; Göbel et al., 2007). 
Giger et al (2003), reported that in wastewater treatment plants complete removal of 
macrolide antibiotics was not possible and therefore residual antibiotics accumulate 
in the receiving water bodies. In order to minimize the antibiotic concentrations in 
the receiving media, the wastewater treatment plant effluent antibiotic concentrations 
have to be minimized. According to Giger et al (2003) another method to lower the 
antibiotic concentrations in the receiving media was to minimize the amount of 
antibiotic containing wastewater at the source.  
Louvet et al (2010) studied the effect of erythromycin on activated sludge biomass 
flock structure. They monitored the reactors for 24 hours and fed the system with 10 
mg/L erythromycin. Obtained results showed that the substance was toxic to the 
biomass and that it destroyed the flock structure. 
3.4 Enzyme Inhibition 
Chemical reactions in biological systems are mediated by enzymes, catalysts that 
lower the activation energy of a reaction. Enzymes are highly specific for particular 
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reactions and they carry out different reactions like hydrolysis, polymerization, 
oxidation-reduction, isomerization etc. However substances, called inhibitors, have 
the ability to bind with the enzyme influencing the binding of the substrate to the 
enzyme and reduce the enzymes activity, and there are different mechanisms that 
inhibitor substances can act (Voet and Voet, 1990). 
3.4.1 Competitive inhibition 
In this type of inhibition, the inhibitor substance acts as the substrate and competes 
with the substrate for the enzymatic-binding site. These types of inhibitors are called 
competitive inhibitors and they resemble the substrate. When bound to the enzyme 
active site the enzyme becomes unreactive. The model for competitive inhibition is 
given in the following reaction scheme: 
    
  
↔    
  
→        (3.1) 
    
  
↔          (3.2) 
     →                 (3.3) 
By competitive inhibition it is assumed that the competitive inhibitor reversibly binds 
to the enzyme active site and the enzyme-inhibitor complex is catalytically inactive 
(Voet and Voet, 1990). The competitive inhibitor reduces the active enzyme 
concentration available for substrate binding, leading to increased half saturation 
constants in the system. The dissociation constant (KI) is defined by:  
   
[ ][ ]
[  ]
      (3.4) 
The competitive inhibition can however be overcome by increasing the substrate 
concentration, therefore lowering the chances of the inhibitor to compete with the 
substrate for the enzyme active site. The effect of competitive inhibition on enzyme 
reaction is given in Figure 3.1. 
3.4.2 Non-competitive inhibition 
In contrary to competitive inhibition, by non-competitive inhibition the effects of 
inhibition cannot be reversed by increasing the substrate concentration (Orhon and 
Artan, 1994).  
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Figure 3.1 gives the effect of non-competitive inhibition on the enzyme reaction. In 
non-competitive inhibition a portion of the enzyme concentration is blocked by the 
inhibitor that binds to a site other than the active site of the enzyme. It results in a 
decreased maximum growth rate of the system, where the dissociation constant (KI) 
is defined by: 
   
[  
 ][ ]
[  ]
      (3.5) 
 
 
 
Figure 3.1: Effect of competitive and non-competitive inhibitors on the enzyme 
kinetics (Conn et al., 1987). 
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3.4.3 Un-competitive inhibition 
In un-competitive inhibition the inhibitor substance binds to the enzyme-substrate 
complex, and not to the free enzyme. Moreover the uncompetitive inhibitor like the 
noncompetitive inhibitor binds to a separate site than the active site. The kinetic 
scheme for uncompetitive inhibition is given in the following reaction scheme: 
    
  
↔    
  
→         (3.6) 
     
  
↔              (3.7) 
             →                           (3.8) 
, where the dissociation constant (KI) is defined by: 
   
[  ][ ]
[   ]
         (3.9) 
Since the uncompetitive inhibitor does not need to resemble the substrate while 
binding with the enzyme, it causes structural damage to the enzyme active site and 
increases the apparent affinity of the enzyme to the substrate, therefore lowering the 
KS (Boyer, 2006). Moreover the maximum growth rate of the system decreases, since 
it takes longer time for the product to leave the enzyme active site. 
Uncompetitive inhibition affects the enzymes catalytic function; however it does not 
have an effect on its substrate binding properties. This type of inhibition is especially 
important for multi-substrate enzymes (Voet and Voet, 1990). 
The effects of un-competitive inhibition cannot be reversed by increasing the 
substrate concentration, however at low substrate concentrations, where [ ]    , 
the effect of uncompetitive inhibition becomes negligible (Voet and Voet, 1990). 
Figure 3.2 gives the effect of un-competitive inhibition on the enzyme reaction. 
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Figure 3.2: Effect of un-competitive inhibitors on the enzyme kinetics (Conn et al., 
1987). 
3.4.4 Mixed inhibition 
Mixed inhibition is a type of inhibition where the inhibitor binds to both free enzyme 
and the enzyme-substrate complex. It is a combination of competitive and un-
competitive inhibition. The model for mixed inhibition is given in the following 
reaction scheme: 
    
  
↔    
  
→         (3.10) 
               
  
↔               (3.11) 
  →                          (3.12) 
     
  
 
↔                (3.13) 
                          →                  (3.14) 
The effect of mixed inhibition on the system is that both maximum growth rate and 
the half saturation constants are affected, so that whereas the maximum growth rate 
decreases, the half saturation constant increases (Storrey, 2004).  
3.5 Respirometry 
Two main research points in toxicity/inhibition works can be found in the literature. 
One of which is the determination of specific pollutant concentrations and the other 
one is the determination of the concentrations and their biodegradability in biological 
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treatment systems. In these studies, either only the substance or collective parameters 
were measured. Especially in biological treatment systems, this approach leads to 
characterization of the response of the biomass only on substrate removal.  
Nowadays, in the studies on activated sludge systems respirometric methods are 
preferred instead of characterizing the system over substrate removal. The reason for 
this is that the change in the oxygen utilization rates (OUR) gives a better insight to 
the response of the biomass than substrate removal efficiency, because oxygen 
consumption is directly related to both substrate utilization and biomass production 
(Vanrolleghem, 2002). 
Wastewaters flowing into activated sludge systems are complex substrates that are 
combinations of various compounds and different metabolic processes are required 
for their breakdown. However, evaluating all the kinetic processes in the system is 
made possible with respirometry. Respirometry is measuring and interpreting 
biological oxygen consumption under defined conditions (Vanrolleghem, 2002). The 
results obtained from respirometry are being compared with substrate removal 
efficiencies and the all the data is evaluated with a multicomponent point of view. 
Finally, obtained oxygen utilization rate (OUR) profiles are evaluated with 
mathematical models. By comparing the change in model parameters it is also 
possible to determine the level of inhibition.  
Respirometry may be specifically designed for the differentiation of different 
chemical oxygen demand (COD) fractions in the substrate (Ekama et al., 1986; 
Orhon et al., 2002) or for the assessment of specific kinetic and stoichiometric 
coefficients such as the maximum heterotrophic specific growth rate (Kappeler and 
Gujer, 1992), the endogenous decay rate (Avcioglu et al., 1998) or the storage yield 
(Karahan-Gul et al., 2002). The OUR profile may also be conveniently calibrated 
using a suitable activated sludge model to yield the most appropriate values for the 
kinetic and stoichiometric coefficients associated with different biochemical 
processes defined in the selected model. 
Ekama et al. (1986) pioneered the usage of OUR profiles for the determination of 
biodegradable COD fractions and model parameters. Later OUR profiles were started 
to be used in many areas and especially for the experimental determination of 
process kinetics (Sollfrank and Gujer, 1991; Kappeler and Gujer, 1992; Spanjers and 
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Vanrolleghem, 1995; Avcıoglu et al., 1998; Cokgor et al., 1998; Sozen et al., 1998; 
Karahan-Gul et al., 2002; Insel et al., 2003). Nowadays, respirometric techniques are 
used commonly for the determination of activated sludge behavior. The response of 
the biomass to any inhibitory substance is observed by the change in substrate 
utilization and/or in maximum growth conditions. This observation is obtained by 
OUR profiles from batch experiments (Ellis et al., 1996; Guissesola et al., 2003). 
OUR profile sets an appropriate basis for the evaluation of inhibition for activated 
sludge (Insel et al., 2006). 
In this context, using OUR profiles obtained by adding antibiotics on the biomass at 
high concentrations, characterizing pharmaceutical wastewater, the acute and chronic 
effects of antibiotics on the activated sludge culture were investigated.  
In order to determine the applicable concentrations a concentration screening test has 
been applied. ISO8192 Respiration inhibition has been implemented for this purpose. 
However inhibition tests like ISO 8192 were shown to be misleading since the 
comparison of inhibited and control OUR’s are reported at certain specific time 
points during the test (Insel et al., 2006), and these tests do not provide detailed 
information like complete OUR profiles. For this reason ISO 8192 has not been used 
for the characterization of the response of the activated sludge culture. Antibiotic 
concentrations obtained from ISO8192 experiments have only been used as an 
indicator.   
3.6 Activated Sludge Modeling  
The purpose of using dynamic models is to design treatment plants, to optimize and 
control plant operation. Generally the models in use today are deterministic, which 
give a realistic approach to the treatment process (Henze, 2005). The elements of a 
model contain biological and chemical processes, like growth and decay of 
heterotrophic biomass, together with hydraulics, components, like the biomass (XH) 
or soluble readily biodegradable COD (SS) and transport processes, which is only 
about the transportation of water inside the plant. (Henze, 2005). 
Model evaluation of activated sludge systems enables to (i) identify all the microbial 
processes involved for the biodegradation of the selected substrate; (ii) visualize the 
impact of inhibition on each process; and (iii) quantify numerical terms the impact of 
18 
 
inhibition by assessing the change in the values of relevant model coefficients after 
addition of the selected inhibitor. It also helps to visualize the overall impact of the 
inhibitory compound on every stage of substrate biodegradation, through inspection 
and evaluation of the entire OUR profile (Insel et al., 2002). 
In 1987, The International Association on Water Quality task group released the 
IAWQ Activated Sludge Model No.1, which ended up being the base of all the 
subsequent models (Henze, 2005). ASM1 is a very simple model, which can be 
expanded according to the systems requirements. Therefore in order to solve a 
system, complex kinetic equations and different components can be added to the 
ASM1 in order to increase the degree of complexity (Henze, 2005). 
3.6.1 Wastewater characterization in activated sludge modeling 
The wastewater carbon content characterization is done according to the 
biodegradability characteristics of the carbon fragments in the wastewater. The total 
influent COD (CT) having two major components represents the total substrate for 
the activated sludge biomass. A schematic distribution is given in Figure 3.3. 
Figure 3.3: Distribution of COD fractions in wastewater (Orhon and Artan, 1994). 
The two components of CT are the total biodegradable COD (CS) and the total non-
biodegradable COD (CI) fractions. One of which, the non-biodegradable COD 
fraction leaves the system without being processes in any biochemical reaction. 
However whereas the soluble part of the inert COD fraction (SI) stays in the soluble 
fragment and py-passes the system, the particulate inert COD fraction (XI) leaves the 
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system via waste sludge accumulating in the activated sludge biomass (Orhon and 
Artan, 1994). 
The biodegradable fraction of the total COD (CS), is further divided into three major 
fractions, readily biodegradable COD (SS), rapidly hydrolysable COD (SH) and 
slowly biodegradable COD (XS) (Orhon and Artan, 1994). 
The readily biodegradable COD (SS) is assumed to be soluble and consistent of 
simple compounds that can be directly used by the organism for synthesis reactions. 
However both the rapidly hydrolysable COD (SH) and the slowly biodegradable 
COD (XS) consist of larger and more complex organic particles that need to be 
hydrolyzed prior to absorption by the bacteria (Orhon and Artan, 1994).  
3.6.2 Activated sludge model no. 1 
ASM1 includes both nitrification and denitrification and is basically designed for 
domestic and municipal wastewater. However it is used for industrial wastewaters by 
careful calibration of the model parameters (Henze, 2005). Schematic view of the 
biological processes taking place in an activated sludge system according to ASM1 is 
can be seen in Figure 3.4. 
 
Figure 3.4: Process for heterotrophic and nitrifying bacteria in ASM1 (Gujer et al., 
1999). 
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3.6.2.1 Process kinetics for carbon removal 
IWAQ ASM1 has different processes to explain the behavior of an activated sludge 
system. Since the model includes nitrification and denitrification along with carbon 
removal the processes include microbial growth and decay of autotrophic and 
denitrifying organisms, as well as aerobic metabolic activities of heterotrophic 
bacteria. 
In the model there are two processes associated with carbon removing heterotrophic 
bacteria; aerobic growth and decay of heterotrophic bacteria. For the aerobic growth 
process the bacteria can only utilize the readily biodegradable substrate (SS) as the 
carbon source for growth, during which the bacteria utilize oxygen (SO) as the final 
electron acceptor. The reaction is modeled according to the Monod Kinetics, where 
KS and KOH are the half saturation constants of SS and SO, respectively:  
   
  
   
 (
  
     
) (
  
      
)      (3.15) 
Only the readily biodegradable substrate (SS) is utilized by the bacteria for growth, 
which decreases its concentration. However rapidly hydrolysable (SH) and slowly 
biodegradable substrates (XS), contained in the wastewater, need to be hydrolyzed in 
order for them to be utilized by the bacteria in the growth process. Hydrolysis of 
these COD fractions increases the concentration of SS. Therefore the transformation 
of SH and XS into SS takes place as the hydrolysis of rapidly hydrolysable and slowly 
biodegradable substrates (Orhon and Artan, 1994). Equations 3.16, 3.17 and 3.18 
represent the removal of SH, XS and SS, respectively: 
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, where YH is the yield coefficient, which represent the amount of COD used for 
biosynthesis. 
Decay of heterotrophic bacteria can be defined as the loss of microbial biomass, 
which mathematically can be explained in a first order differential equation (Orhon 
and Artan, 1994):  
   
  
           (3.19) 
Therefore the general equation for the net amount of aerobic growth of heterotrophic 
bacteria is: 
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)    ]       (3.20) 
During endogenous decay a fraction of the decayed biomass cannot be degraded 
completely and accumulates in the sludge, which forms the particulate inert organic 
products (XP) (Orhon and Artan, 1994): 
   
  
     
   
  
            (3.21) 
 Moreover the endogenous decay of microorganisms also results in formation of 
soluble inert products (SP) that cannot be further oxidized (Orhon and Artan, 1994): 
   
  
     
   
  
            (3.22) 
               (3.23) 
The final electron acceptor, oxygen (SO), in activated sludge systems, is utilized 
throughout the whole process. Oxygen is used for growth and decay processes. 
   
  
 [ 
    
  
  
 (
  
     
)]  (    )       (3.24) 
Finally the ammonia nitrogen (SNH) is incorporated into the biomass by iXB during 
growth, which can be considered as the potential nitrogen removal of carbon removal 
(Orhon and Artan, 1994). Moreover the nitrogen in the biomass is being released into 
the wastewater as the biomass is being decayed. Utilization of SNH is also in expense 
of some alkalinity. 
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The matrix representation of ASM No.1can be found in Table 3.2.  
3.6.3 Activated sludge model no. 3 
10 years after the release of ASM1 the IWAQ Task Group on Mathematical 
Modeling for Design and Operation of Biological Wastewater Treatment Processes 
introduced a new model, which overcame the weaknesses of ASM1. The ASM3, 
included a storage process, which has been seen in some aerobic and anoxic 
conditions in activated sludge plants (Gujer et al., 1999). 
Internal storage compounds like polyhydroxyalkanoates (PHA) and glycogen (GLY) 
were present in aerobic and anoxic processes. Therefore the in ASM1 absent storage 
process it was added to ASM3 (Gujer et al., 1999). Schematic view of the biological 
processes taking place in an activated sludge system according to ASM3 is can be 
seen in Figure 3.5. 
 
Figure 3.5: Process for heterotrophic and nitrifying bacteria in ASM3 (Gujer et al., 
1999). 
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Table 3.2: Matrix representation of activated sludge model no.1. 
Components→ 
Processes↓ 
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The metabolism of storage suggests that it occurs under two different conditions, one 
of which includes cases where electron donors and acceptors are separately available, 
like in polyphosphate accumulating organisms (PAOs) and glycogen accumulating 
organisms (GAOs). The other is when the microorganisms are not subjected to a 
continuous substrate flow, which is a more general reason of internal storage 
concerning non-steady state conditions (Reis et al., 2003).  
Dawes (1990), states that ceasing of protein synthesis results in high concentrations 
of NADH, which inhibits the enzyme citrate synthase. The enzyme citrate synthase is 
a key enzyme in the tricarboxylic acid (TCA) cycle. According to Doi (1990), acetyl-
CoA cannot enter the TCA cycle under unbalanced conditions. Therefore the 
inhibition of the enzyme citrate synthase causes acetyl-CoA’s inability to enter the 
TCA cycle. Finally the excess acetyl-CoA in the cell is used as substrate for PHA 
synthesis, a substance, which serves as a carbon or energy source during starvation 
periods (Punrattanasin, 2001).  
Another storage product glycogen is a branched polymer consisting of glucose 
monomers and its granules are smaller than of PHA, straight-chain polymer (Prescott 
et al., 1990). It is formed if the primary substrate is glucose or a compound that can 
be converted to pyruvate are present in the wastewater, where glucose is taken into 
the cell and converted into glycogen (van Loosdrecht et al., 1997). Glycogen storage 
mechanism is used to balance the growth process under dynamic conditions (Dircks 
et al., 2001).  The stored glycogen then serves as an energy source in the famine 
conditions. 
3.6.3.1 Process kinetics for carbon removal 
ASM3 incorporated the internal storage of heterotrophic bacteria into the model, in 
which the internal storage product (PHA or GLY) are associated with XH, however 
they are not included into the mass of XH. They are considered separately as XSTO 
(mgCOD/L). 
The assumption of ASM3 is that the readily biodegradable substrate (SS) is first 
stored as internal storage product and then utilized as substrate for biosynthesis. The 
storage process describes the storage of SS as XSTO, and the energy required for this 
process is gained from aerobic respiration, utilizing oxygen (SO) (Gujer et al., 1999). 
Moreover the internal storage products are assumed to be decayed together with the 
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biomass during endogenous respiration phase. Finally, the storage yield coefficient 
(YSTO) gives the amount of substrate converted into storage products under aerobic 
conditions. 
As described in ASM3, the readily biodegradable substrate is directly being stored by 
the microorganisms as XSTO (Gujer et al., 1999), with a maximum storage rate of 
kSTO and storage yield of YSTO, 
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Growth of heterotrophic biomass under aerobic conditions is depended on the XSTO 
concentration since the biomass will use the stored polymers as substrate for 
biosynthesis (Gujer et al., 1999). 
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Finally, degradation of the storage compounds is depended on the heterotrophic yield 
coefficient (YH): 
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The matrix representation of ASM No.3 can be found in Table 3.3.  
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Table 3.3: Matrix representation of activated sludge model no.3. 
Components→ 
Processes↓ 
SO SS SH XS XH XP SP XSTO SNH SAlk Rate Equations 
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3.7 Effect of Inhibition Types on Respirometric Profiles 
3.7.1 Competitive inhibition 
In the situation, where competitive inhibition is present the mass balance for enzyme 
components is given as, where the amount of ES complex is the amount left from 
unbound enzyme and the EI complex (Orhon and Artan, 1994): 
                (3.30) 
Using both equations the ES complex can be defines as (Orhon and Artan, 1994): 
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, which changes the basic rate equation for substrate utilization to (Orhon and Artan, 
1994): 
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, which means that the maximum growth rate of the system is left unchanged. 
However competitive inhibition effects the half saturation constant of the system and 
increases it by (   
 
  
). This leads to the concept of apparent KS (   
  ) (Orhon and 
Artan, 1994):  
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The effect of competitive inhibition on the OUR curve is given in Figure 3.6. It can 
be seen that the system reaches endogenous decay level after the uninhibited system, 
however in this case the area under the curve stays however unchanged. In recent 
biochemical models incorporating dissolved oxygen (SO) as the main model 
parameter, the corresponding oxygen uptake rate (OUR) expression becomes: 
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Figure 3.6: Effect of competitive inhibition on the OUR profile (Özkök et al., 2011). 
3.7.2 Non-competitive inhibition 
A portion of the initial enzyme concentration is blocked by the inhibitor substance: 
  
                (3.35) 
, which leads to the definition of the dissociation constant KI (Orhon and Artan, 
1994): 
   
[  
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     (3.36) 
In non-competitive inhibition the half saturation constant stays unchanged; however 
the maximum growth rate decreases. 
Using both equations the ES complex can be defined as (Orhon and Artan, 1994): 
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, which changes the basic rate equation for substrate utilization to (Orhon and Artan, 
1994): 
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, which means that in non-competitive inhibition the half saturation constant is left 
unaltered. However the maximum growth rate of the system decreases by (
  
    
) 
(  ̂):  
  ̂   ̂ (
  
    
)    (3.39) 
The effect of non-competitive inhibition on the OUR curve is given in Figure 3.7. 
Like in competitive inhibition it can be seen that under the effect of non-competitive 
inhibition the system reaches endogenous decay level later than that of the 
uninhibited system, in which case the area under the curve stays unchanged. The 
following rate expression defines the resulting OUR: 
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     (3.40) 
Figure 3.7: Effect of non-competitive inhibition (growth inhibition) on the OUR 
profile (Özkök et al., 2011). 
3.7.3 Un-competitive inhibition 
Figure 3.8 shows the effect of uncompetitive inhibition on the OUR profile. It can be 
seen that the inhibited profile clearly shows that with increasing inhibition the area 
under the curve is getting smaller; meaning amount of oxygen is consumed in each 
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degree of uncompetitive inhibition. Additionally, all the curves reach the endogenous 
decay level same time as the control system. Moreover,  
Figure 3.8 also shows the effect of lower substrate additions on the OUR profile. 
Since in uncompetitive inhibition, the inhibitor (I) attacks the enzyme substrate sites, 
[ES], and forms an [ESI] complex, which does not undergo further biochemical 
reactions and this way, it blocks a part of the available substrate for biodegradation, 
as indicated by the following kinetic expression: 
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Figure 3.8: Effect of un-competitive inhibition on the OUR profile. 
3.7.4 Mixed inhibition 
The effect of mixed inhibition on the OUR curve is given in  
Figure 3.9. It can be seen that the system reaches the endogenous decay level later 
than that of the non-inhibited system, however the area under the OUR curve is kept 
unchanged. The kinetic effect of mixed inhibition on the OUR expression is as in the 
following equation: 
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Figure 3.9: Effect of mixed inhibition on the OUR curve (Özkök et al., 2011). 
3.8 Microbial Community Analysis 
3.8.1 Antibiotic resistance gene analysis 
3.8.1.1 Resistance to antibiotics 
Prescription of high doses of antibiotics by doctors and unperscribed usage of these 
substances increases the inflow of antibiotics to natural habitats. Antibiotic 
substances, causing pollution in receiving waters are resistant to biodegradation and 
therefore they tend to persist in the environment, which increases the probability of 
environmental organisms to become resistant to these substances. Finally, today in 
most of the tested water bodies and soil samples antibiotic resistance genes are being 
detected (Zhang et al., 2009; Kemper, 2008), proving the effect of antibiotics in 
natural habitats.  
Besides the environmental concerns, increasing clinical resistance leads to inability 
of treating illnesses by taking antibiotics. In addition resistant bacteria in 
subterranean water bodies may reach surface waters, which are used as drinking 
water supplies, and cause illnesses (Feuerpfeil et al., 1999). Therefore, antibiotic 
resistance constitutes a major problem for human and animal and therefore for World 
health (Kemper, 2008).  
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According to Kemper (2008), veterinary antibiotics cause selection of resistant 
bacteria, which leads to being exposed to resistant bacteria via food chain in addition 
to direct contact. Keeping in mind that the bacteria isolated from humans are proved 
to be environmentally originated, the author also states that even though antibiotics 
are not directly used, presence of antibiotic resistance shows the importance of the 
problem.  Since genetic molecules are coded on mobile elements in the bacteria, they 
can easily be transmitted from one to another, which causes the resistance to be 
spread even from non-pathogenic organisms to pathogenic organisms (Ma et al., 
2011).  
Wastewater treatment plants are like reservoirs of human and animal bacteria, and 
antibiotic resistance genes are leaving these reservoirs through effluent reaching the 
receiving waters (Zhang et al., 2009; Tennstedt et al., 2003; Ma et al., 2011). 
Activated sludge systems, one of the biological treatment systems, are diverse and 
dynamic ecosystems and have large potential for exchange of genetic information 
(Parsley et al., 2010). This has been proved by different studies on activated sludge 
systems, showing that activated sludge systems contains high amounts and wide 
diversities of antibiotic resistance genes (Auerbach et al., 2007; Tennstedt et al., 
2003; Ma et al., 2011).  
In most of the studies, culture dependent methods have been applied to 
environmental samples prior to detection of antibiotic resistance genes for screening 
purposes. These studies depend on the capability of bacteria to grow on media 
containing antibiotic substances. These have also showed the increasing trends of 
resistance genes (Harwood et al., 2000; Reinthaler et al., 2003; McKeon et al., 1995; 
Auerbach et al., 2007). However, due to the fact that most of the environmental 
bacteria are not cultivable, it is not an appropriate method to determine the resistance 
of complicated biological systems (like activated sludge) depending on cultivable 
bacteria, which only reflects 1% of total community (Auerbach et al., 2007). 
Therefore methods based on polymerase chain reaction (PCR) give more reliable 
results, which in this study were used to determine the resistance genes in complex 
activated sludge samples.  
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3.8.1.2 Antibiotic resistance mechanisms 
There are four different resistance mechanisms against antibiotic substances (Zhang 
et al., 2009): 
1. Efflux Pumps: Due to structural changes in the cell membrane 
intracellular antibiotic concentration is kept low, causing the ribosomes to 
function normally.  
2. Target Modification: The target cellular component is modified by 
different mechanisms, so that the antibiotic cannot affect the component.  
3. Target By-Pass: Due to mutations on the target enzyme or deletion 
mutations on the gene sequence coding the enzyme, it is prevented for the 
enzyme to be affected by the antibiotic.   
4. Inactivation of Antibiotic Substance: This mechanism directly inactivates 
the antibiotic substance.  
3.8.1.3 Resistance to sulfonamides 
The effect mechanism of sulfonamide antibiotics is to inhibit the formation of 
dihydrofolic acid, which catalyzes the condensation reaction of p-aminobenzoic acid 
(PABA) and 7,8-dihydro-6-hydroximethylptesin-pyrophosphate (DHPPP) that 
results in formation of dihydropteroic acid.  For this to happen the antibiotic inhibits 
the dihydropteroate syntase (DHPS) enzyme (Sköld, 2000). 
Sulfonamide resistance gene is generally coded by the mutations in the highly 
conserved regions of DHPS gene (sul) (Sköld, 2000). Different sulfonamide resistant 
mechanisms have been detected, which occur due to mutations on the sul gene and 
spread through mobile genetic elements (Antunes et al., 2007; Houvinen, 2001). 
In environment bacteria four different sulfonamide resistance genes have been 
defined (sulI, II, III, ve A). sulI and sulII were detected in stool samples taken from 
cattle farms (Srinivasan et al. 2005), in sediments of wetlands (Akinbowale et al. 
2007; Agersø and Petersen 2007), and also in polluted river and sea waters (Lin and 
Biyela 2005; Hu et al. 2008; Mohapatra et al. 2008). sulI is a part of class 1 integrone 
and it can be transferred from one to another bacterial specie in water media like 
river and sea (Tennstedt et al. 2003, Mukherjee and Chakraborty 2006, Taviani et al. 
2008). sulA is the chromosomal gene in S.Pneumoniae, which codes DHPS and it 
has been mutated by 3-6bp insertion leading to sulfonamide resistance (Maskell et 
34 
 
al., 1997). Sulfonamide resistance genes, their biological and environmental sources 
are given in Table 3.4. In this study activated sludge samples chronically inhibited 
with Sulfamethoxazole were examined for the presence of sulI sulII and sulIII genes. 
Table 3.4: Sulfonamide resistance genes in water environments (Zhang et al., 2009). 
Gene Biological Source Environmental Source 
1
 
sulI 
Aeromonas, Escherichia, Listeria; pB2, pB3, 
pB8, pB10 Plasmids; Microbial Community 
AS, DW, NW, SD, SW 
sulII 
Acinetobacter, Escherichies, Salmonella, 
Vibrio; Microbial Community 
DW, NW, SD, SW 
sulIII Escherichia; Microbial Community NW, SD 
sulA Microbial Community SD 
1) SW: Special wastewaters like hospital, animal farms and agricultural areas, AS: Activated sludge from 
treatment plants, NW: Natural waters, SD: Sediments, DW: Drinking waters 
3.8.1.4 Resistance to tetracyclines 
Resistance to tetracyclines can be explained by different mechanisms, such as efflux 
pumps, ribosomal protection proteins and enzymatic mechanisms. In the literature, 
43 tet and otr genes have been defined coding resistance against tetracyclines, among 
which 27 are coding efflux pumps, while 12 are coding ribosomal protection 
proteins. In addition to these, there are 3 genes for enzymatic resistance and 1 gene 
for an unknown mechanism (http://faculty.washington.edu/marilynr/). The number of 
tet genes that can be found in water environments is less. However the tet genes 
found in activated sludge systems are even more limited. Moreover tet genes that can 
be detected in gram-positive and gram-negative bacteria are also different 
(http://www.antibioresistance.be/).  
Table 3.5 and Table 3.6 show the tetracycline resistance genes found in activated 
sludge and the distinction between genes found in gram-positive and –negative 
bacteria, respectively.  
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Table 3.5: Tetracycline resistance genes detected in activated sludge systems (taken 
from Zhang et al. 2009). 
Function Gene Reference 
Efflux Proteins 
tetA, tetB,  
tetC, tetD,  
tetE, tetG 
otrB 
Szczepanowski et al., 2004; 
Tennstedt et al., 2005;  
Agersø and Sandvang, 2005;  
Auerbach et al., 2007;  
Schmidt et al., 2001; 
Nikolakopoulou et al., 2005 
Ribosomal Protection 
Proteins 
tetM, tetO,  
tetQ, tetS 
otrA 
Auerbach et al., 2007;  
Nikolakopoulou et al., 2005 
Table 3.6: Tetracycline resistance genes detected in gram-positive and -negative 
bacteria (http://www.antibioresistance.be/). 
Function Gram-Positive Gram-Negative 
Efflux Proteins 
tetK, tetL,  
tetP, tetV,  
tetZ, 
otrB 
tetA, tetB,  
tetC, tetD,  
tetE, tetG, tetH 
Ribosomal Protection 
Proteins 
tetM, tetO,  
tetQ, tetS 
tetM, tetO,  
tetQ 
Sludge samples taken from an activated sludge system chronically fed with 
tetracycline were qualitatively analyzed for the presence of tet A, B, C, D, E, G, K, 
L, otrB and tet M, O genes, covering both efflux protein and ribosomal protection 
genes, respectively.   
3.8.1.5 Resistance to macrolides 
Over time bacteria developed different resistance mechanisms against erythromycin 
as well, one of macrolide antibiotics that was chosen as the model antibiotic to 
represent macrolides. (Figure 3.10)  
 
Figure 3.10: Different macrolide resistance mechanisms (Wright, 2011). 
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The first mechanism is the rRNA methylase (erm) group, which change the binding 
point of macrolides on the 23S rRNA (Leclercq and Courvalin, 1991; Martineau et 
al., 2000; Sutcliffe et al., 1996; Weisblum, 1995). Among them erm(A), (B), (C), (E), 
(F), (T), (V), (X) have been detected in farm and poultry wastes, lagoon and 
treatment systems (Hayes et al., 2005; Chen et al., 2007; Patterson et al., 2007; 
Zhang et al., 2009). Since erm genes are found on mobile genetic elements like 
plasmids and transposons they are easily transferred to another microorganism 
(Roberts, 2003; Liu et al., 2007; Okitsu et al., 2005; Zhang et al., 2009).  
Another resistance mechanism is the enzymatic inactivation of the antibiotic 
substance. Esterases, lyases, transferses and phosphorylases are the enzymes 
responsible for this action. Among macrolide resistance genes, only mph(A), 
macrolide-2’-phosphotransferase, has been detected in activated sludge biomass 
(Szczepanowski et al., 2004; Zhang et al., 2009). Moreover, efflux mechanism could 
not be defined in activated sludge systems, but it has been detected in 
Staphylococcus spp. (Martineau et al., 2000). Resistance mechanisms and genes 
against macrolide antibiotics are given in Table 3.7.  
Table 3.7: Macrolide resistance mechanisms and genes (Roberts, 2008). 
rRNA-
methylases 
Efflux 
Proteins 
Inactivation Enzymes 
Esterases Lyases Transferases Phosphorylases 
erm(A), (B), (C), 
(D), (E), (F), (G), 
(I), (H), (N), (O), 
(R), (S), (T), (U), 
(V), (W), (X), (Y), 
(Z), (30), (31), 
(32), (33), (34), 
(35), (36), (37), 
(38), (39), (40), 
(41) 
nef(A), 
mef(B), 
msr(A), (C), 
(D) 
car(A), 
lmr(A), 
ole(B), (C) 
srm(B), 
tlc(C) 
lsa(A), (B), 
(C), vga(A), 
(B), (C) 
ere(A), 
(B) 
vgb(A), 
(B) 
lnu(A), (B), 
(C), (D), (F) 
vat(A), (B), 
(C), (D), (E), 
(F) 
mph(A), (B), 
(C), (D) 
In the current study, presence of erm(A), (B) and (C) from erm class genes were 
examined, which were frequently determined in microbial communities, treatment 
plant effluents and in hospital wastewaters, even though they have not yet been 
detected in activated sludge biomass. In the literature it has been stated that the 
amounts and distribution of erm genes in total microbial communities, of which the 
most important source is the animal wastes, should be determined (Chen et al., 
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2007). Moreover, the presence of mph(A) that has been detected in activated sludge 
systems (Szczepanowski et al, 2004) and msr(A) were examined. msr(A) was not 
previously found in activated sludge biomass but this gene codes ATP dependent 
efflux mechanism and causes resistance against the antibiotic erythromycin both in 
gram-positive and –negative bacteria (Martineau et al., 2000; Roberts 2008). 
According to Roberts (2008) the erm(B) gene can frequently be found in gram-
positive and –negative bacteria and aerobic and anaerobic bacteria and in many 
different ecosystems. Moreover it has the widest host range with 33 genera due to its 
association with mobile genetic elements (Roberts, 2008). erm(F), the second most 
detected macrolide resistance gene (24 genera) has been eliminated due to its 
appearance mostly in anaerobic genera, which are in aerobic activated sludge 
systems not to be seen. Whereas erm(A) gene can be found in 7 genera and erm(C) in 
16. Moreover, it has been repoted that in S.pyrogenes, S. Aureus and S. Epidermidis 
bacteria erm(B) and erm(A) are frequently present (Roberts, 2008). In addition in 
different studies it has been stated, that erm(A) and erm(C) are responsible genes for 
macrolide resistance in Staphylococcus species (Weisblum, 1995; Leclercq, 2002; 
Fiebelkorn et al., 2003; Aktaş et al., 2007 ). 
3.8.2 454-pyrosequencing 
Classification of organisms started with traditional methods like culture depended 
techniques, which depends on organism’s ability to survive on different growth 
media, and phenotypic differences and similarities with one and other. These 
methods included gram staining and biochemical tests, which take growth 
characteristics and culture requirements into account. However it has been stated that 
objective taxonomic classification would not be sufficient with traditional methods 
due to variations in phenotypic characteristics (Woo et al., 2008). Moreover 
traditional methods cannot be used for uncultivable bacteria, a group in which the 
environmental bacteria are also a part of, since most of the environmental bacteria 
are not cultivable. 
By the use of 16S rDNA genes of bacteria for analyzing organisms draw backs 
caused by cultivation based techniques have been overcome. Moreover invention and 
use of polymerase chain reaction (PCR), together with sequencing has started a new 
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era, in which uncultivable bacteria were classified and phylogenic relationships were 
determined. Moreover new bacteria were discovered (Woo et al., 2008). 
PCR based techniques have widely been used for determining the community 
structure of activated sludge systems. Microbial community structures of laboratory 
and full scale engineered activated sludge systems and natural systems have been 
analyzed by the use of different methods, including PCR-DGGE (polymerase chain 
reaction-denaturing gradient gel electrophoresis), t-RFLP (terminal restriction 
fragment length polymorphism), FISH (fluorescence in situ hybridization), RISA 
(ribosomal spacer analysis), and analysis of 16S rRNA clone libraries (Ye et al., 
2011). However due to the exceptionally rich microbial diversity of activated sludge 
biomass these methods fail to characterize the total community. According to Ye et 
al (2011) the diversity of the activated sludge exceeds the sensitivity range of 
aforementioned methods. Moreover Xia et al (2010) states that the knowledge on 
microbial communities in activated sludge systems is incomplete due to limitation of  
traditional methods, as they cannot capture the whole complexity of these 
communities. 
The aforementioned methods although effective determining the microbial 
community their effectiveness tends to decrease with increasing complexity of the 
community. For example, 16S rRNA clone libraries with even more than 1000 
clones still have moderate sensitivity, which result in missing rare taxa (Xia et al, 
2010; DeSantis et al, 2007; Fuhrman, 2009). Muyzer et al (1998) states that DGGE 
and TGGE detect groups that are larger than 1% of the bacterial population, however 
single bands do not coincide with single bacterial species (Xia et al, 2010). Lastly t-
RFLP is also inadequate to determine the microbial characteristics of a very complex 
community, since its sensitivity is limited to only approximately fifty most abundant 
organisms in the community (Sakano and Kerkhof, 1998; Dunbar et al., 2000; Xia et 
al., 2010).  
On the other hand the development of methods like 454-pyrosequencing and 
microarrays have been used for characterizing complex ecosystems and, have shown 
to have significantly higher throughput then the traditional methods. The next-
generation sequencing methods, even though more expensive, produce large amounts 
of DNA reads, giving more accurate results. There are commercially available  
Genome sequencers operated on pyrosequencing based chemistries: GS-FLX 
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Genome sequencer from Roche/454 Life Sciences, 1G Analyzer from 
Illumina/Solexa and SOLID System from Applied Biosystems (Desai at al., 2010). 
The Roche (454) Genome Sequencer technology depends on detection of 
pyrophosphate release upon nucleotide incorporation, and it generates massive 
amounts of parallel DNA sequence reads from amplified PCR products with a 
sequencing-by-synthesis approach (Margulies et al., 2005, Ye et al., 2011) . It 
provides 300,000 sequences at once (Desai et al., 2010). With the 454-
pyrosequencing method 400-600 bp can be sequenced in one reaction, which cannot 
be obtained by any other technology. The platform operates as a high-throughput 
sequencing tool (Roh et al., 2010). Moreover, prior cloning steps for DNA 
sequencing are not required for performing this very fast method, 454-
pyrosequencing, and therefore it has been accepted as one of the ideal tools to 
analyze complex microbial communities (Edwards et al., 2006, Krause et al., 2006, 
Szczepanowski et al., 2008). 
High-throughput pyrosequencing technology is being used in the different microbial 
ecology branches, such as microbial diversity and functional genes diversity (Roh et 
al., 2010). It has also been used for analyzing environmental samples including soil, 
marine water and wastewater treatment plant influent (Roesch et al., 2007, Qian et 
al., 2011, McLellan et al., 2010, Ye et al., 2011). However, in the literature only few 
studies can be found conducted on activated sludge applying this technology. Zhang 
et al (2011) and Ye et al (2011) applied 454-pyrosequencing in their full-scale and 
laboratory-scale wastewater treatment plants, respectively to determine the diversity 
and abundance of nitrifying bacteria in their systems. Park et al (2011) investigated 
the microbial community structure of a laboratory-scale Bardenpho Process using 
pyrosequencing. Microbial diversity of a full scale fixed-film activated sludge 
systems has been investigated by the use of 454-pyrosequencing by Kwon et al. 
(2010). Sanapareddy et al (2009) successfully determined the microbial community 
structure of a domestic wastewater treatment plant in North Carolina, USA. 
Moreover the plasmid metagenome of a wastewater treatment plant showing reduced 
susceptibility to antimicrobials has been analyzed by the same technique. Activated 
sludge samples grown on antibiotic supplemented growth media and their plasmids 
were extracted. The sequencing results revealed that the wastewater bacteria were 
important reservoirs for clinically important resistance determinants and they may 
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contribute to rapid dissemination of antibiotic resistances (Szczepanowski et al., 
2008). Moreover the authors stated that the ultrafast 454-pyrosequencing was proven 
to be a powerful tool for analyzing plasmid metagenome of wastewater bacteria 
(Szczepanowski et al., 2008). In another study Schlüter et al. (2008) investigated the 
genetic diversity of a plasmid metagenome of a wastewater treatment plant using the 
same methodology as Szczepanowski et al. (2008) and stated that wastewater 
treatment plants play an important role as hot-spots for circulation of antibiotic 
resistance determinants, as they serve as interfaces between different environmental 
compartments. Szczepanowski et al. (2011) also conducted a study on the IncP-1α 
plasmids. Three important antibiotic resistance plasmids of IncP-1α group 
originating from two different wastewater treatment plants were analyzed by 454-
pyrosequencing and the obtained results revealed that these plasmids were effective 
tools for antibiotic and heavy metal resistance dissemination (Szczepanowski et al., 
2011). 
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4. MATERIALS AND METHODS 
4.1 Reactor Setup and Operation 
4.1.1 Control reactors 
A 14 L and an 8 L (VT) fill and draw control reactors, with the sludge age of 10 and 
2 days, respectively, were set using the seed sludge taken from the aeration tank of a 
domestic wastewater treatment plant. The sludge age 10 days control reactor was fed 
with 600 mgCOD/L concentration of peptone-meat extract mixture and the sludge 
age 2 days control reactor was fed with peptone-meat extract mixture of 720 mg 
COD/L concentration. 1 L of the peptone-meat extract mixture (ISO 8192) consisted 
of 16 g of peptone, 11 g of meat extract, 3 g of urea, 0.7 g of NaCl, 0.4 g of 
CaCl2.2H2O, 0.2 g of  MgSO4.7H2O and 2.8 g of K2HPO4. Besides carbon source 
(peptone-meat extract mixture), macro (K2HPO4: 320 g/L, and KH2PO4: 160 g/L) 
and micro (MgSO4.7H2O: 15 g/L, FeSO4.7H2O: 0.5 g/L, ZnSO4.7H2O: 0.5 g/L, 
MnSO4.H2O: 0.41 g/L, CaCl2.2H2O: 2.65 g/L) nutrients were added to the reactors. 
pH in the reactor was kept at neutral levels. Reactors were fed once a day (HRT: 1 
d). During each feeding period, reactors were settled for 1 h (ts) and decanted until 2 
L (V0). Reactors were aerated continuously and the oxygen concentration in the 
reactor was kept above 3 mg/L to maintain aerobic conditions. pH of the reactor was 
kept around 7 to maintain neutral pH levels. After the reactor reached steady state, 
the acclimated biomass was used for respirometric experiments. 
4.1.2 Chronic reactors 
Seed sludge of the chronic reactors was taken from both control reactors depending 
on the sludge age and operated until all systems reached steady state. The chronic 
reactors were fed with peptone – meat extract mixture (720 mgCOD/L) and the 
antibiotic substance together. In the case of SMX (SRT:2d) the antibiotic 
concentration was 100 mg/L for SMX (SRT:10d), and 50 mg/L for TET (SRT: 2 and 
10d) and ERY (SRT: 2 and 10d). 
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4.2 Experimental Procedures 
Chemical Oxygen Demand (COD) was measured using the procedure defined by 
ISO 6060. For soluble COD determination, samples were subjected to filtration by 
means of Millipore membrane filters with a pore size of 0.45 μm. The Millipore 
AP40 glass fiber filters were used for SS and VSS measurements that were 
performed as defined in Standard Methods (2005). During the experiments Orion 
520 A pH meter was used for pH measurements and before each usage of the device 
the pH meter was calibrated. For TOC measurements a Shimatsu VPCN model 
Carbon Analyzer has been used. A PerkinElmer Lambda 25 model UV/VIS 
Spectrophotometer has been used for UV scan of antibiotics. Finally IC 
measurements were done on a Dionex ICS-1500 model Ion Chromatograph. 
4.2.1 EC50 inhibition experiments (ISO 8192) 
The inhibitory effects of antibiotics on activated sludge were determined with ISO 
8192 method. ISO 8192 method determines EC50 value as the inhibitor 
concentration, which causes 50% decrease in the respiration rate of the bacterial 
culture.  
During the test a Manotherm RA-1000 respirometry was used for measuring the 
oxygen concentrations at different times. Oxygen Uptake Rate (OUR) of activated 
sludge with and without the addition of inhibitors was calculated.  
The method determines OUR of control system without inhibitors (OURcontrol). 
Additionally, it defines effective concentration (EC50) of inhibitor giving an OUR 
(OURinhibited) in the system.  The obtained OUR corresponds to the 50 % of OUR of 
control system without inhibitors (OURcontrol). EC50 is calculated as given below:     
     
                       
          
           (4.1) 
4.2.2 Respirometry 
Respirometric tests were conducted with relevant acclimated biomass seeding alone 
to obtain endogenous oxygen uptake rate (OUR) level of biomass. Samples with 
desired F/M ratios are added to the reactor and the OUR data was monitored. Control 
analysis without antibiotic addition was conducted before inhibition analysis for each 
study. OUR measurements were performed with an Applitek RA-Combo-1000 
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continuous respirometer with PC connection. During each test a nitrification inhibitor 
(Formula 2533, Hach Company) was added to the OUR reactors to prevent any 
possible interference induced by nitrification. 
4.2.3 Polyhydroxy butyric acid (PHB) measurements 
PHB samples were taken into 2x10 ml centrifuge tubes containing 2 drops 
formaldehyde to prevent the biological activity. The PHB content of the washed (K-P 
buffer solution) and freeze-dried biomass were subjected to extraction, hydrolization, 
and esterification in a mixture of hydrochloric acid, 1-propanol, and dichloroethane 
at 100°C (Beun et al., 2000). The resulting organic phase was extracted with water to 
remove free acids. The propylesters were analyzed by a gas chromatograph and 
benzoic acid was used as an internal standard throughout the procedure. 
4.2.4 Sulfamethoxazole measurements 
SMX was analyzed by high-performance liquid chromatography (Agilent) with a 
Novapac C18 column. A 30:70 v/v methanol-water mixture was used as a mobile 
phase at a constant flow rate of 0.6 ml/min (Beltran et al., 2008). The mobile phase 
was acidified at pH 2.5 with phosphoric acid (0.1 % concentration). Detection was 
made with a Diode Array Detector at 280 nm. Injection volume and flow were 40 µl 
and 1 ml/min, respectively. Figure 4.1 shows the SMX calibration curve. Moreover 
according to the results obtained from the measurements in the liquid phase the SMX 
measurements in the activated sludge have been cancelled. 
 
Figure 4.1: SMX calibration curve. 
y = 1x
R² = 0,9994
0
50
100
150
200
250
0 50 100 150 200 250
S
M
X
 (
m
g/
L
)
SMX (mg/L)
SMX Calibration Curve
SMX
Linear (SMX)
44 
 
4.2.5 Microbial community analysis  
4.2.5.1 Determination of antibiotic resistance genes 
For the determination of resistance genes present in activated sludge samples the 
genomic DNA was extracted from each sample, and after determining the obtained 
DNA concentration, using appropriate primers designed to target the specific regions 
the regions coding the antibiotic resistance genes were amplified. The PCR products 
were visualized by gel electrophoresis and ethidium bromide staining.  
DNA Extraction from Activated Sludge 
Activated sludge biomasses are complex microbial communities. Therefore for 
extracting the entire DNA, effective methods have to be used to destroy the cellular 
membranes and isolate the DNAs from different members of the community. In 
addition to the complexity of the community, since these samples are environmental 
the sample may contain PCR inhibitors such as KCl, NaCl, urea and/or iron. 
Therefore these inhibitors have to be eliminated during DNA extraction procedure. 
In this context in order to determine the most effective DNA extraction procedure 
different methods were applied and the results were compared to each other. Among 
these methods, most effective and high yield method has been chosen and DNA from 
the activated sludge samples was extracted using the chosen method. 
In order to determine the most efficient DNA extraction method 3 different methods 
were run with same amount of sludge, and the results were compared. The method 
was expected to yield the highest DNA concentration and lyse gram-positive 
bacteria. Among 3 different extraction methods Macherey-Nagel NucleoSpin Soil 
DNA extraction kit has been chosen, due to its performance depending on the 
previous criteria.  
The Macherey-Nagel NucleoSpin Soil DNA extraction kit was executed according to 
the procedure of the manufacturer. 25 mg of precentrifuged activated sludge biomass 
from each sample has been used for DNA extraction. The DNA extraction procedure 
applied on the activated sludge samples is given in Table 4.1. In addition to the DNA 
extraction procedure, in order to eliminate the RNA in the sample, RNAse treatment 
was added to the procedure.  
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Determination of DNA Concentration 
The amount of DNA obtained was measured by a NanoDrop DNA/RNA-
Concentration Measurement Spectrometer (ND-1000). The device measures the 
highest absorbance emitted by nucleic acids at 260nm and calculates the DNA 
concentration in [ng/µl]. 
Table 4.1: Macherey-Nagel (MN) NucleoSpin Soil DNA extraction manual. 
1. Sample Preparation 
Load the sample into NucleoSpin Soil Bead Tubes 
Add 700 µl SL2 
2. Adjusting the Lysis 
Conditions 
Add 150 µl Enhancer SX (not applied) 
3. Sample Lysis Horizontally vortex for 5min at RT 
4. Precipitation of 
Contaminants 
Centrifuge at 11.000 x g for 2min 
Add 150 µl SL3 
Vortex for 5sec 
Incubate at 0 – 4 oC for 5min 
Centrifuge at 11.000 x g for 1min 
5. Inhibitor Removal 
Load supernatant on NucleoSpin Inhibitor Removal 
Column 
Centrifuge at 11.000 x g for 1min 
6. Adjusting Binding 
Conditions 
Add 250 µl Binding Solution (SB) 
Vortex for 5sec 
7. Binding the DNA 
Load 550 µl sample on NucleoSpin Soil Column 
Centrifuge at 11.000 x g for 1min 
8. Washing the Silica 
Membrane 
1 – Add 500 µl SB –  
      Centrifuge at 11.000 x g for 30sec 
2 – Add 550 µl Washing Solution1 (SW1) –  
      Centrifuge at 11.000 x g for 30sec 
3 – Add 700 µl Washing Solution2 (SW2) –           
Vortex 2sec – Centrifuge at 11.000 x g for 30sec 
4 – Add 700 µl SW2 – Vortex 2sec –  
      Centrifuge at 11.000 x g for 30sec 
9. Drying the Silica Membrane Centrifuge at 11.000 x g for 2min 
10. Eluting the DNA 
Add 50 µl Elution Buffer (SE) 
Incubate 1 min at RT 
Centrifuge at 11.000 x g for 1min 
Polymerase Chain Reaction (PCR) 
Polymerase Chain Reaction (PCR) is an enzymatic method to amplify a region 
between two segments of known sequence on the DNA.  There are three main steps 
of PCR, each having different temperature conditions: denaturation, annealing, and 
elongation, which constitute a cycle. A schematic representation of PCR is given in 
Figure 4.2. 
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Figure 4.2: Schematic representation of polymerase chain reaction. 
In the denaturation step the double stranded DNA is being denatured and the strands 
are separated from each other. In the annealing step the forward and reverse primers 
are being bound to continuous and noncontinuous strands of the DNA, respectively. 
The last step, elongation, is when the enzymatic reaction takes place, in which the 
Taq-polymerase makes a copy of the wanted DNA segment, in which it uses the 
dNTP’s present in the reaction mixtures. In PCR the product of each cycle is being 
used as the template for the next cycle. With each cycle the amount of DNA 
increases exponentially. For an effective DNA amplification, 20-30 cycles have to be 
run. Using this method, the amount of DNA fragment of interest is being amplified 
and millions of copies are being obtained (Alberts et al., 2002).  
PCR mixture consists of template DNA, forward and reverse primer pairs, DNA-
polymerase, deoxynucleosid trifosfates (dNTPs), PCR buffer solution, and a divalent 
cation solution like MgCl2. For controlling the accuracy of the PCR system, each set 
of experiments includes a positive and a negative control. Negative control is a 
sample that contains no DNA, therefore is not supposed to yield any DNA 
amplification products. It verifies that there is no contamination in the reaction 
mixture. However a positive control is a sample, which certainly contains the DNA 
to be amplified. Therefore it is expected to yield amplified DNA. Positive control 
verifies that the DNA fragments amplified are the correctly amplified. 
Control of DNA Extraction Method  
In activated sludge systems gram-positive and –negative bacteria exist together. 
Gram-positive bacteria, because of the thick peptidoglycan layer in their cell wall are 
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more resistant to outside effects. Therefore in order to ensure the destruction of cell 
walls of gram-positive bacteria the factors applied during DNA extraction should be 
made more drastic. DNA extraction procedures for gram-positive bacteria therefore 
include enzymatic extraction methods in addition to physical and chemical extraction 
methods.  
During the study different methods were applied to activated sludge samples, and the 
method showing good extraction performance has been chosen for application. In 
order to determine the effectiveness of the methods on gram-positive bacteria, a 
special PCR method has been applied.  
In the literature, it has been stated that a 100bp stable insertion to the DomainIII 
(helix 54a) of 23S ribosomal DNA has used to distinguish the high GC-Gram-
positive bacteria (Roller et al., 1992; Yu et al., 2002). For this purpose 23InsV (5’-
MADGCGTAGNCGAWGG-3’) and 23InsR (5’-GTGWCGGTTTNBGGTA-3’) 
primers have been used to determine the gram-positive bacteria. Each PCR tube 
contained 2.5µl of 10X PCR Buffer solution (Applied Biosystems, Roche), 1µl of 
2.5mM dNTP mixture, 2µl of MgCl2 (25mM) solution (Applied Biosystems, Roche), 
1µl of each 100µm 23InsV and 23InsR primers and 0.2µl of 5U/µl Taq DNA 
Polymerase. 1µl genomic DNA was added to the PCR tubes and filled with H2O 
until the final volume of 25 µl. The conditions of the Thermal Cycler were; 9min of 
pre-denaturation at 95
o
C, followed by 33 cycles of 30sec denaturation at 94
o
C, 45sec 
annealing at 63
o
C and 1min elongation at 72
o
C, and later 5min of final incubation at 
72
o
C. Obtained PCR products were visualized on a 1% agarose gel by gel 
electrophoresis. It has been stated that this PCR amplifies the 270 and/or 380 bp 
fragment of the III.Domain of the 23S rDNA. Therefore it is expected to visualize 
270 and/or 380 bp bands on the agarose gel.  
Agarose Gel Electrophoresis 
Agarose gel electrophoresis is an analytical technique, which is generally used to 
separate the amplified DNA fragments according to their size and to control the PCR 
procedure.  Following this procedure the bands forming on the gel can be cut off and 
after cleaning up the DNA can be used for quantification purposes.  
In this procedure gel provides a viscous medium, where the nucleic acids can travel. 
When electricity is applied; DNA molecule, an acid, being negatively charged moves 
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though the gel from the anode to the cathode. The length of distance traveled by the 
amplified PCR product is reversely proportional to its size. Therefore shorter DNA 
fragments can move farther along the gel than the longer DNA fragments, since 
longer fragments encounter more resistance.  
During gel electrophoresis, a marker is used to determine the size of the DNA 
fragments on the gel. Marker consists of a mixture of different DNA fragments of 
different sizes, and it also serves as a positive control, showing that the gel 
electrophoresis procedure has been run correctly. 
Qualitative Determination of Antibiotic Resistance Genes 
PCR based techniques have been applied for qualitative analysis of antibiotic 
resistance. Appropriate primers were chosen to amplify the gene sequence coding the 
resistance gene. Moreover strains that contain these genes have also been collected, 
which served as positive control during PCR experiments, showing that the correct 
fragment has been amplified. For resistance genes, for which no positive controls 
were available, the PCR product was sequenced and BLASTed to verify that the 
correct region was amplified. Due to changing annealing temperatures of chosen 
primers, different cycling conditions have been applied according to the information 
given for each specific primer in the literature.   
4.2.5.2 Resistance to sulfonamides 
Qualitative analysis of sul genes coding resistance to sulfamethoxazole has been 
completed using primers, of which the information is given in Table 4.2.  Each PCR 
mixture consisted of 2.5µl 10X PCR Buffer solution (Applied Biosystems, Roche), 
1µl of 2.5mM dNTP mixture, 2µl of MgCl2 (25mM) solution (Applied Biosystems, 
Roche), 1µl of each 25µM sul forward and reverse primers, 0.2µl 5U/µl Taq DNA 
Polymerase (Applied Biosystems, Roche), and 1µl genomic DNA. Finally required 
amount of sterile water was added to reach the final volume of 25µl. Moreover, 
Thermal Cycler conditions were as follows: 9min pre-denaturation at 95
o
C, 40 cycles 
of 15sec denaturation at 95
o
C, 30sec annealing (annealing temperatures are given in 
Table 4.2) and 1min elongation at 72
o
C, and then 5min final incubation at 72
o
C.   
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Table 4.2: Primers used for the determination of sulfonamide resistance genes. 
Gene Primers Sequence 
Annealing 
Temperature 
Amplicon 
Size 
Reference 
sulI 
sulI-FW cgcaccggaaacatcgctgcac 
55.9 163 
(Pei et al., 
2006) 
sulI-RV tgaagttccgccgcaaggctcg 
sulII 
sulII-FW tccggtggaggccggtatctgg 
60.8 191 
sulII-RV cgggaatgccatctgccttgag 
sulIII 
sulIII-FW tccgttcagcgaattggtgcag 
60.0 128 
sulIII-RV ttcgttcacgccttacaccagc 
4.2.5.3 Resistance to tetracyclines 
In order to determine the presence of tetracycline resistance genes and the 
tetracycline resistance profile in activated sludge samples several tet genes covering 
efflux (tet A, B, C, D, E, G, K, L and otrB) and ribosomal protection proteins (tet M, 
O) have been chosen, which have previously been detected in wastewater and 
activated sludge systems. Information on primers used in PCR experiments is given 
in Table 4.3.  
Each PCR mixture consisted of 2.5µl 10X PCR Buffer solution (Applied 
Biosystems, Roche), 1µl of 2.5mM dNTP mixture, 2µl of MgCl2 (25mM) solution 
(Applied Biosystems, Roche), 1µl of each 25µM tet forward and reverse primers, 
0.2µl 5U/µl Taq DNA Polymerase (Applied Biosystems, Roche), and 1µl genomic 
DNA. However, for tetC and tetB different Taq polymerase and PCR buffer has been 
used. Therefore the PCR mixture for determination of these genes consisted of 2.5µl 
10X PCR Buffer solution (Applied Biosystems, Roche), 1µl of 2.5mM dNTP 
mixture, 1µl of each 25µM tet forward and reverse primers, 0.2µl 5U/µl Taq DNA 
Polymerase (Applied Biosystems, Roche), and 1µl genomic DNA Finally required 
amount of sterile water was added to reach the final volume of 25µl. Moreover all 
the PCR mixtures contained 1µl Dimethyl sulfoxide (DMSO) to inhibit the 
secondary structures minimizing interfering reactions. The thermal cycler conditions 
for tet genes are given in Table 4.4. 
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Table 4.3: Primers used for the determination of tetracycline resistance genes. 
Gene Primers Sequence 
Amplicon 
Size 
Reference 
tetA 
tetA-FW gctacatcctgcttgccttc 
210 
(Ng et al., 2001) 
tetA-RV catagatcgccgtgaagagg 
tetB 
tetB-FW ttggttaggggcaagttttg 
659 
tetB-RV gtaatgggccaataacaccg 
tetC 
tetC-FW cttgagagccttcaacccag 
418 
tetC-RV atggtcgtcatctacctgcc 
tetD 
tetD-FW aaaccattacggcattctgc 
787 
tetD-RV gaccggatacaccatccatc 
tetE 
tetE-FW aaaccacatcctccatacgc 
278 
tetE-RV aaataggccacaaccgtcag 
tetG 
tetG-FW gctcggtggtatctctgctc 
468 
tetG-RV agcaacagaatcgggaacac 
tetK 
tetK-FW tcg ata gga aca gca gta 
169 
tetK-RV cag cag atc cta ctc ctt 
tetL 
tetL-FW tcg tta gcg tgc tgt cat tc 
267 
tetL-RV gta tcc cac caa tgt agc cg 
tetM 
tetM-FW gtggacaaaggtacaacgag 
406 
tetM-RV cggtaaagttcgtcacacac 
tetO 
tetO-FW aacttaggcattctggctcac 
515 
tetO-RV tcccactgttccatatcgtca 
otrB 
otrB-FW ccgacatctacgggcgcaagc 
947 
(Nikolakopoulou 
et al., 2005) otrB-RV ggtgatgacggtctgggacag 
Table 4.4: Thermal cycler conditions for determination of tetracycline resistance 
genes. 
Gene Thermal Cycler Conditions 
tetA 
Pre-denaturation: 9min at 95
o
C,  
40 cycles: 45sec at 95
o
C, 45sec at 55
o
C, 90sec at 72
o
C. 
Final incubation: 7min at 72
 o
C. 
tetB Pre-denaturation: 2min at 95
o
C,  
30 cycles: 30sec at 95
o
C, 30sec at 57
o
C, 50sec at 72
o
C. tetC 
tetD 
Pre-denaturation: 9min at 95
o
C,  
30 cycles: 45sec at 95
o
C, 45sec at 57
o
C, 90sec at 72
o
C. 
Final incubation: 7min at 72
 o
C. 
tetE 
Pre-denaturation: 9min at 95
o
C,  
35 cycles: 30sec at 95
o
C, 30sec at 55
o
C, 50sec at 72
o
C. 
Final incubation: 7min at 72
 o
C. 
tetG 
Pre-denaturation: 9min at 95
o
C,  
30 cycles: 30sec at 95
o
C, 30sec at 57
o
C, 50sec at 72
o
C. 
tetK 
tetL 
tetM 
tetO Pre-denaturation: 9min at 95
o
C,  
35 cycles: 30sec at 95
o
C, 30sec at 55
o
C, 50sec at 72
o
C. 
Final incubation: 7min at 72
 o
C. otrB 
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4.2.5.4 Resistance to macrolides 
For qualitative determination of resistance to erythromycin the method reported by 
Martineau et al (2000) has been applied. Presence of erm(A), erm(B), erm(C) and 
msr(A) genes were determined by multiplex PCR. These PCR’s, besides primers to 
amplify the specific resistance gene, contained an internal control which amplifies 
the 16S rRNA gene (universal bacterial amplification) resulting in a 241bp PCR 
product, showing that the PCR system has worked properly. However, in order to 
determine the presence of mph(A) in activated sludge samples the method reported 
by Sutcliffe et al (1996) has been applied. Moreover, positive controls were used to 
ensure that the correct region has been amplified, and negative controls to ensure that 
there were no contaminations. Information on primers is given on Table 4.5. 
Table 4.5: Primers used for the determination of macrolide resistance genes. 
Gene Primers Sequence 
Amplicon 
Size 
Reference 
erm(A) 
ermA-FW tatcttatcgttgagaagggatt 
139 
(Martineau 
et al., 
2000) 
ermA-RV ctacacttggcttaggatgaaa 
erm(B) 
ermB-FW ctatctgattgttgaagaaggatt 
142 
ermB-RV gtttactcttggtttaggatgaaa 
erm(C) 
ermC-FW cttgttgatcacgataatttcc 
190 
ermC-RV atcttttagcaaacccgtatt 
msr(A) 
msrA-FW tccaatcattgcacaaaatc 
163 
msrA-RV aattccctctatttggtggt 
Internal 
control 
(16S rRNA) 
FW ggaggaaggtggggatgacg 
241 
RV atggtgtgacgggcggtgtg 
mph(A) 
mphA-FW aactgtacgcacttgc 
837 
(Sutcliffe 
et al., 
1996) 
mphA-RV ggtactcttcgttacc 
For the determination of erm and msr genes, each PCR tube contained 2.5µl of 10X 
PCR Buffer solution (Applied Biosystems, Roche), 2µl of 2.5mM dNTP mixture, 2µl 
of MgCl2 (25mM) solution (Applied Biosystems, Roche), 1µl of each 25µM genes 
specific forward and reverse primers, 0.4µl of 5U/µl Taq DNA Polymerase (Applied 
Biosystems, Roche), and 1µl genomic DNA. Finally appropriate amount of sterile 
water has been added to reach the final volume of 25 µl. Additionally each tube 
contained 16S rRNA universal primers with 1/10 concentration of gene specific 
primers to eliminate competition.  Finally, the Thermal Cycler conditions for erm 
genes and msr(A) were: 9min at 95
o
C pre-denaturation, 30 cycles of 30sec at 95
o
C 
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denaturation, 30sec at 55
o
C annealing and 30sec at 72
o
C elongation.  The thermal 
cycler conditions for mph(A) were: : 9min at 95
o
C pre-denaturation, 35 cycles of 
15sec at 95
o
C denaturation, 30sec at 52
o
C annealing and 60sec at 72
o
C elongation, 
and 5min final incubation at 72
 o
C. 
4.2.5.5 454-pyrosequencing 
454 technology amplified using the “emulsion PCR” method. At the beginning small 
DNA fragments (400-600 bp) are ligated to adapters and separated into single 
strands. Later favorable conditions are created so that one fragment is bound to one 
DNA capture bead. These fragments are then amplified by “emulsion PCR” 
technique, in which each DNA capture bead is isolated within a oil emulsion, droplet 
of a PCR reaction mixture. The amplification results in beads each bead carries 
several million copies of a unique DNA fragment. In the next steps the emulsion is 
broken, the DNA is denatured and the beads are deposited in the PicoTiterPlate, of 
which the wells are designed to fit only one bead. (Delseny  et al., 2010) 
The PicoTiterPlate contains millions of wells, which serve as individual reactors for 
the sequencing reactions. In 454-pyrosequencing, the sequencing reactions are 
catalysed by the Bacillus stearothermophilus (Bst) DNA-polymerase. (Delseny et al., 
2010) 
PicoTiterPlate is placed in a flow cell, into which reagents are injected. During 
sequencing at the end of each addition of a nucleotide by the DNA-polymerase a 
pyrophosphate molecule is released, which is then converted into ATP by a 
sulfurylase. Finally, luciferase reaction produces a chemiluminescent signal using the 
produced ATP molecule. The chemiluminescent signal released by the ATP 
molecule is recorded by a camera, indicating in which well the nucleotide has been 
incorporated. The unincorporated nucleotides are washed away and replaced by other 
nucleotides. (Delseny et al., 2010) 
The sequencing cycle, consisting of incorporation, recording and washing steps, is 
repeated with the all four nucleotides until sufficient length of the primer is achieved. 
The intensity of the signal recorded by the camera is proportional to the number of 
nucleotides that have been incorporated by the DNA-polymerase. (Delseny et al., 
2010) 
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Prior to applying 454-pyrosequencing of activated sludge genomic DNA for 
community analysis the V1-V2 hypervariable regions of the 16S rRNA gene of the 
genomic DNA were amplified, during which a special Multiplex Identifier (MID) 
was attached to every sample (Hamady et al., 2008). Barcodes (MIDs) that allow 
sample multiplexing during pyrosequencing were incorporated between the 454 
adapter and the reverse primer. MID’s were attached to the reverse primer used for 
16S rDNA amplification. The primers used for amplification were 27F (5’-
GCCTTGCCAGCCCGCTCAGTCAGAGTTTGATCCTGGCTCAG-3’) and 338R 
(5’GCCTCCCTCGCGCCATCAGNNNNNNNNCATGCTGCCTCCCGTAGGA
GT-3’), where the bold sequences stand for the universal primers amplifying the V1-
V2 hypervariable regions of the 16S rRNA gene (Baker et al., 2003). Moreover the 
underlined sequences represent the 454 Life Sciences FLX sequencing primers 
incorporated in universal primers, that are Adapter B and A in 27F and 338R, 
respectively. The 8Ns in 338R primer represent the MID within the primer. The PCR 
mixture consisted of 2.5µl of 10X PCR Buffer solution (Applied Biosystems, 
Roche), 2µl of 2.5mM dNTP mixture, 2µl of MgCl2 (25mM) solution (Applied 
Biosystems, Roche), 0.5µl of each primers, 0.2µl of 5U/µl Taq DNA Polymerase 
(Applied Biosystems, Roche), 1µl of dimethylsulfoxid (DMSO) and  1µl genomic 
DNA. Finally appropriate amount of sterile water has been added to reach the final 
volume of 25 µl. Thermal cycler conditions were as follows: 9min at 95oC pre-
denaturation, 30 cycles of 10sec at 95
o
C denaturation, 30sec at 55
o
C annealing and 
30sec at 72
o
C elongation, and 10min final incubation at 72
 o
C. The PCR products 
were visualized by gel electrophoresis in a 2% agarose gel and staining by ethidium 
bromide. 
Following gel electrophoresis, the bands on the gel were cut and purified by Qiagen 
MinElute Gel Extraction Kit Qiagen, CA, USA). The Gel extraction protocol is given 
in Table 4.6.  
Pyrosequencing on purified amplicon mixtures was performed by Institute of 
Clinical Molecular Biology at University of Kiel (Kiel, Germany) using Roche 
Genome Sequencer 454 FLX (Roche, NJ, USA). 
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Table 4.6: Qiagen MinElute gel extraction protocol (MinElute Handbook 03/2006). 
1. Excision of DNA Fragment 
DNA Fragment was excised from the gel by a 
clean scalpel. Extra gel was removed and the size 
was minimized.  
2. Solubilization of the Agarose 
Gel 
3 volumes of Buffer QG was added to 1 volume of 
gel 
The mixture was incubated at 50
o
C for 10 min. 
Tube was subjected to vortexing every 2-3 min to 
help dissolving. 
3. Adjusting the pH 
The mixture obtained after solubilization of the 
agarose gel should have a yellow color, indicating 
the pH value of ≤7.5. 
For orange of violet colors of the mixture, 10 µl of 
3M sodium acetate was added to adjust the pH. 
4. Adjusting Binding 
Conditions 
1 volume of isopropanol was added to 1 volume of 
gel slice and the tube was inverted several times 
(no centrifugation). – Especially applied for DNA 
fragments <500bp and >4kb. 
5. Binding the DNA 
Mixture is applied to a MinElute column and 
centrifuged for 1 min. (flow-through was 
discarded) 
500 µl Buffer QG was added to the spin column 
and centrifuged for 1 min to remove the traces of 
agarose left in the mixture. 
6. Washing the Column 
750 µl of Buffer PE was added to the MinElute 
Column and incubated for 2-5 min at room 
temperature. Tube was centrifuged for 1 min. 
7. Drying the Column Centrifuge at 13,000 x g for 1min 
8. Eluting the DNA 
10 µl of Buffer EB was added on the center of the 
membrane and incubated for 1 min at room 
temperature. Then centrifuged for 1 min.  
The eluted DNA was stored at -20
o
C. 
16S rRNA Gene Sequence Community Composition Analysis 
DNA extracted from activated sludge samples collected at different days of antibiotic 
treatments were amplified using barcoded universal primers and a DNA pool has 
been prepared for pyrosequencing. Obtained sequencing products were cleaned up 
prior to analysis. After removing primer sequences, sequences with more than six 
homopolymers, ambiguous bases and chimera, each sample resulted with different 
amount of sequences. Following the primary clean-up of sequences groups were 
formed and the data has been compared amongst each other.  
During the analysis all the sequences were used, and no subsampling has been done. 
However evaluation has been done by normalization against the total number of 
sequences of each sample and obtaining percentages. For clean-up PANGEA 
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program (Giongo et al., 2010) and for analysis of sequences MOTHUR software was 
utilized (Schloss et al., 2009). Taxonomic classification has been done using the RDP 
Classifier and alignment has been done using the SILVA bacterial reference files 
obtained from MOTHUR webpage (www.mothur.org). 80% confidence threshold 
has been used for classification. Moreover, for each group significant changes on 
phylum level were determined using RDP library comparison program. 
To evaluate the change in richness in between samples in each group, rarefaction 
curves were established. Rarefaction curves were obtained by plotting the number of 
OTUs observed against the number of sequences sampled. The rarefaction curves for 
all samples gave a trend how the curve progresses as the number of samples 
increases, however most curves did not reach a plateau, and more number of 
sequences might have been needed. Theoretically, species richness was estimated by 
using Chao1 and ACE calculations.  
To determine the estimated richness of the activated sludge samples non-parametric 
richness estimators, abundance-based coverage estimator (ACE) and Chao1 were 
calculated. All samples amongst each group were compared to each other at 3% 
(species) and 20% (phylum) levels.   
Shannon’s index was used to measure diversity of all three samples at both distances. 
Additionally, evenness has been calculated with E=H/lnS, where H is the Shannon’s 
index and S is the total number of observed OTUs. Good’s estimator of coverage has 
been calculated by the formula (1-(n/N)), where n is the number of singletons and N 
is the total number of observed OTUs. Shannon’s index of diversity is commonly 
used to characterize the diversity of a community and it considers both abundance 
and evenness of species present. Shannon’s equitability (Evenness) is a measure of 
the equality or distribution of individuals. It results in a number between 0 and 1, 
with 1 being complete even. A community in which each species present is equally 
abundant has high evenness; a community in which the species differ widely in 
abundance has low evenness (Smith and Wilson, 1996), meaning lower evenness 
shows increasing dominance in a population. Moreover Venn diagrams were 
established, using the MOTHUR program that shows the shared and unshared OTUs 
on species (3%) and phylum (20%) levels.   
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In order to determine the change in population the number of sequences of observed 
OTUs has been normalized to the total number of sequences in each sample, and 
occurrence percentages of OTUs have been obtained. Moreover to determine if the 
changes in the abundances are significant p-values have been calculated using 
MOTHUR’s “metastats” command based on the Metastats program (White et al., 
2009), which compares all samples to each other. In this study the significance 
threshold level has been selected as 0.05. Therefore for changes in OTUs, if the p-
value that is the individual measure for false positive rate, is smaller than 0.05 the 
changes in the OTU abundances are accepted significant. For calculations of p-
values the null distribution has been estimated using the permutation method (White 
et al., 2009). Moreover using the same method, q-values have been calculated using 
the “metastats” command of MOTHUR, which is an adjusted p-value using an 
optimized False Discovery Rate approach. Both p and q values were taken into 
consideration during evaluation. Statistical evaluations and classification of OTUs 
were done on the species level. 
Due to the fact that minimum amount of unclassified operational taxonomic units 
(OTUs) occur on the phyla level, results were evaluated starting at the phylum level 
(20% difference). Significant changes observed at this level required deeper 
evaluation of activated sludge populations at the species level (3% difference). 
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5. RESULTS AND DICUSSIONS 
5.1 Characterization of Antibiotics 
In order to determine the basic characteristics of the antibiotic substances to be 
studies chemical oxygen demand (COD), total organic carbon (TOC) and ion 
chromatography (IC) measurements were conducted. Moreover in order to determine 
the wavelength in which the compounds give a peak a UV scan of the compounds 
has been done. Table 5.1 gives some basic information on the chosen antibiotics. 
Table 5.1: Basic properties of the selected antibiotics. 
Compound Molecular Formula CAS No Structure 
Sulfamethoxazole  C10H11N3O3S 723-46-6 
 
Tetracycline C22H24N2O8 . xH2O 60-54-8 
 
Erythromycin C37H67NO13 114-07-8 
 
The results of characterization studies showed that TOC measurements were in 
accordance with the theoretical TOC (ThTOC). On the other hand, although the 
measured total COD concentrations were different than the theoretical COD 
(ThCOD) values, the soluble COD concentrations both filtered through 0.45 µm and 
0.22 µm filters showed that the substances were solved in distilled water with high 
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efficiency. Table 5.2 and Figure 5.1 give the results for the TOC and COD 
measurements. 
Table 5.2: COD and TOC characterization of antibiotics. 
 
Concentration 
(mg/L) 
ThCOD 
(mg/L) 
Total COD 
(mg/L) 
ThTOC 
(mg/L) 
TOC 
(mg/L) 
Sulfamethoxazole 200 253 236 94.8 95.9 
Tetracycline 200 318 232 119 109 
Erythromycin 200 406 299 121.2 114.5 
 
Figure 5.1: Total and soluble COD concentrations of antibiotics. 
In order to determine at which wavelength these antibiotics are giving a peak, a UV 
scan was conducted. Results showed that erythromycin does not yield a peak 
between wavelengths of 400 and 700 nm. On the other hand sulfamethoxazole and 
tetracycline showed peaks at 262.75 nm and between 357-276 nm, respectively. For 
the purpose of characterization an anion scan of antibiotic solutions was conducted 
using an IC device. The analysis results are given in Table 5.3.  
Table 5.3: UV and IC characterization of antibiotics. 
 
UV Absorbance 
(nm) 
Anion Concentrations 
Floride 
(mg/L) 
Chloride 
(mg/L) 
Nitrate 
(mg/L) 
Phosphate 
(mg/L) 
Sulphate  
(mg/L) 
SMX 262.75 0.0206 3.16 7.0938 1.0337 4.5239 
TET 357 - 276 - 2.0106 9.2641 1.1128 3.6442 
ERY - - 2.3107 5.8882 0.814 2.0292 
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5.2 Reactor Operation 
The control reactors were operated throughout the study period. The SS, VSS and 
effluent COD concentrations together with removal efficiencies and pH were 
monitored. The reactors were operated with a sludge age of 10d and 2 days. Influent 
COD concentrations were 720 mg/L. At steady state conditions the biomass 
concentrations for the reactors were 2000 mgVSS/L and 570 mgVSS/L, yielding the 
F/M ratios of 0.36 mgCOD/mgVSS and 1.26 mgCOD/mgVSS, for SRT 10d and 
SRT 2d reactors, respectively.  
5.3 EC50 Inhibition Experiments (ISO 8192) 
ISO8192 Respiration inhibition test was conducted in order to determine the EC50 
values of the antibiotic substances. The results of the test did not show any accurate 
results; therefore it has been decided to choose high antibiotic concentrations, which 
would characterize wastewaters with high antibiotic contents. Using the selected 
concentrations OUR profiles were obtained by respirometry (Section 5.5.) and 30 
min and 180 min OUR values were compared with 30 min and 180 min of the 
ISO8192 test. 
The comparison showed that both tests yielded very different results. Table 5.4 and 
Figure 5.2 shows the differences of the measured OUR values. Moreover in the 
literature it has been stated that inhibition tests like ISO 8192 might be misleading 
since the comparison of OUR with inhibition and the control are reported at only 
specified times during the test and correct information about the inhibition cannot be 
obtained without additional information on the stoichiometry and kinetics applicable 
to the specific experimental conditions (Insel et al., 2006). 
Table 5.4: The comparison of EC50 results with respirometric studies. 
Inhibition Test Control SMX, 50 mg/L TET, 50 mg/L ERY, 50 mg/L 
EC50-30 min  57 80 75 
OUR-30 min 98 83 52 40 
EC50-180 min  17 29 24 
OUR-180 min 28 34 20 18 
 
 
60 
 
 
Figure 5.2: Differences between EC50 and OUR measurements. 
5.4 Respirometric Studies 
The study involves assessment of acute effects of antibiotics, to which the microbial 
system is exposed for the first time. The evaluation assumes that antibiotics remain 
non-biodegradable for the short term tests as indicated in the literature. On the other 
hand as a further study, chronic inhibition effects of antibiotics were also 
investigated involving continuous exposure of peptone-meat extract acclimated 
biomass. For the investigation of the acute effect of antibiotics 50 mg/L and 200 
mg/L antibiotic concentrations were chosen. Moreover, 50 mg/L concentration was 
chosen for determination of chronic effects, except for SMX SRT 2d chronic reactor, 
to which 100 mg/L SMX was fed.  
5.4.1 Acute inhibition studies SRT: 10 d 
The reactors were operated with a sludge age of 10d and influent COD 
concentrations were 600 mg/L. At steady state conditions the biomass concentrations 
for the reactors were for the Peptone reactor 2000 mg/L, yielding the F/M ratios of 
0.3 mgCOD/mgVSS. In order to avoid oxygen limitation during the experiments the 
F/M ratio of batch systems were selected as 0.42 mgCOD/mgVSS. 
Using the acclimated biomass, batch reactors were set to investigate the inhibitory 
effects of selected antibiotics and operated under parallel conditions with the control 
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reactor. In this context, 7 runs of experiments were conducted; detailed information 
related to the batch experiments is given in Table 5.5. 
Table 5.5: Characteristics of acute experiments. 
Runs 
Antibiotic 
Conc. 
Peptone 
COD 
F/M 
Antibiotic 
COD 
Total 
COD 
Remaining 
Total COD 
(mg/L) (mg/L) 
(mgCOD/
mgVSS) 
(mg/L) (mg/L) (mg/L) 
Control - 600 0.42 0 600 36 
SMX 
50 600 0.45 70 670 182 
200 650 0.42 280 930 343 
TET 
50 600 0.43 66 666 52 
200 600 0.41 264 864 143 
ERY  
50 600 0.42 84 684 109 
200 600 0.42 336 939 329 
During the acute inhibition experiments the biomass was exposed to the substances 
for the first time. The evaluation assumes that antibiotics remain non-biodegradable 
for the short term tests as indicated in the literature. In order to overcome oxygen 
limitation the F/M ratio of the batch tests was chosen as 0.42 mgCOD/mgVSS. 
The OUR curve obtained from biodegradation of peptone-meat extract mixture is 
shown in  
Figure 5.3. The maximum oxygen uptake rate of the biomass gives the first peak 
around 160 mg/L.h, which is due to readily biodegradable COD components in the 
peptone-meat extract mixture. The profile continues to drop with different rates 
corresponding to degradation of different COD fractions present in the peptone-meat 
extract mixture. The area under the OUR curve gives the total oxygen consumption, 
which is calculated as 211 mg/L. The COD removal of the biomass was 94%.  
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Figure 5.3: OUR curve of peptone-meat extract mixture degradation (SRT 10d). 
 
Figure 5.4: Effect of 50 mg/L SMX addition (SRT 10d). 
Acute effects of 50 mg/L
 
antibiotic addition on peptone-meat extract mixture 
acclimated biomass were investigated and each compound yielded different OUR 
profiles. SMX caused it to drop to around 106 mg/L.h ( Figure 5.4). However, in the 
case of TET and ERY additions, the maximum oxygen uptake rate of the biomass 
has dropped from 160 mg/L.h to 120 mg/L.h, as shown in Figure 5.5 and Figure 5.6. 
The amount of oxygen consumed for the growth of microorganisms for additions of 
SMX, TET and ERY are calculated as 206, 171 and 112 mg/L, respectively.  
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Figure 5.5: Effect of 50 mg/L TET addition (SRT 10d). 
 
Figure 5.6: Effect of 50 mg/L ERY addition (SRT 10d). 
The inhibition effects of increasing antibiotic concentrations on the biomass were 
investigated. In this context, antibiotic solutions of 200 mg/L concentrations were 
applied and the maximum oxygen uptake rate has dropped from 160 mg/L.h to 150 
and 100 mg/L.h in the cases of SMX and ERY additions (Figure 5.7 and Figure 5.9). 
Addition of TET however did not cause a significant drop in the maximum oxygen 
uptake rate (Figure 5.8).  
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Figure 5.7: Effect of 200 mg/L of SMX addition (SRT 10d). 
 
Figure 5.8: Effect of 200 mg/L of TET addition (SRT 10d). 
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Figure 5.9: Effect of 200 mg/L of ERY additions (SRT 10d). 
The system performance is better observed in terms of the total oxygen consumed 
during the OUR test, which were evaluated as 251 mg O2 for SMX for 650 mg/L 
peptone-meat extract mixture addition, 174 mg O2 for TET and 56 mg O2 for ERY for 
600 mg/L peptone-meat extract additions during 200 mg/L antibiotic acute inhibition 
experiments.  
Addition of antibiotics has also affected the COD removal efficiency of the sludge. 
The peptone-meat extract mixture COD removal efficiency was calculated by 
assuming that in short amounts of time the antibiotic substance is not degraded. 
Therefore the effluent peptone-meat extract mixture COD concentration was 
obtained by subtracting the antibiotic COD equivalent from the total amount of 
effluent COD concentration, which can be called the “traditional method”. However 
the traditional calculation is given for informational purposes, the COD removal 
properties of all systems will be evaluated differently in the following sections.  
According to this calculation for SMX additions of 50 and 200 mg/L the peptone-
meat extract removal efficiency dropped from 94% to 81% and 90%, respectively. 50 
mg/L ERY addition however resulted in peptone- meat extract removal efficiencies 
of 96%. However the property of ERY to bind with the biomass, suggests that these 
values do not reflect the real response of the system. The peptone-meat extract 
mixture COD removal efficiencies of 50 and 200 mg/L TET added systems could not 
be calculated, since it is known that TET has the tendency to adsorb onto the sludge 
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and also bind and settle with the divalent ions in the system like calcium and 
magnesium that can also be found in the feeding solutions of the reactor. COD 
removal trend of all batch experiments can be seen in Figure 5.10. 
 
Figure 5.10: Effect of acute antibiotic addition on COD removal performance. 
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5.4.2 Acute inhibition studies SRT: 2 d 
Using the acclimated biomass from the control reactor (SRT: 2d), batch reactors 
were set to investigate the inhibitory effects of selected pharmaceuticals and operated 
under parallel conditions with the control reactor. The sludge age 2d control reactor 
was fed with 720mgCOD/L.  At steady state conditions the biomass concentrations 
for the reactors were for the Peptone reactor 570 mg/L, yielding the F/M ratios of 
1.26 mgCOD/mgVSS. Sludge taken from the control reactor was used to determine 
the acute inhibition impact of antibiotics on the sludge age 2d biomass. In this 
context, 6 runs of experiments were conducted; detailed information related to the 
batch experiments is given in Table 5.6. 
Table 5.6: Characteristics of batch experiments SRT: 2d. 
Runs 
Antibiotic 
Conc. 
Peptone 
COD 
F/M 
Antibiotic 
COD 
Total 
COD 
Remaining 
Total COD 
(mg/L) (mg/L) 
(mgCOD/
mgVSS) 
(mg/L) (mg/L) (mg/L) 
Control - 760 1.33 0 760 71 
SMX 
50 720 1.14 70 770 189 
200 720 1.28 280 1000 326 
TET 
50 720 1.03 66 786 75 
200 720 1.14 264 984 267 
ERY  50 720 1.27 84 804 379 
The OUR curve obtained from peptone-meat extract mixture of the sludge age 2 d 
system gives the first peak around 80 mg/L.h, which is due to readily biodegradable 
COD components in the peptone-meat extract mixture, and coincides with the 
maximum oxygen uptake rate of the biomass. The area under the OUR curve giving 
the total oxygen consumption for the degradation of the substrate by a fast growing 
biomass consortia was calculated as 284 mg/L. The COD removal efficiency of the 
sludge age 2d control reactor was 91%. 
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Figure 5.11: Acute inhibition effects of antibiotics on peptone-meat extract mixture 
degradation SRT: 2d. 
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Addition of 50 mg/L of SMX, TET and ERY had different effects on the substrate 
removal of the system. The maximum oxygen uptake rate of the control system 
dropped to 53 mg/L.h for SMX addition, whereas TET addition caused it to drop to 
43 mg/L.h. The maximum oxygen uptake rate for ERY50 acute inhibition system 
was 67 mg/L.h (Figure 5.11). Moreover the total amount of oxygen consumptions of 
inhibited systems has also lowered, showing that the COD removal capacity of the 
system has been altered. The total area under the OUR curves are 266 mg/L, 229 
mg/L and 124 mg/L for SMX, TET and ERY, respectively. Maximum oxygen uptake 
rates of SMX200 and TET200 acute systems were 71 mg/L.h and 95 m/L.h, 
respectively. Total amount of oxygen consumptions were 260 mg/L, 187 mg/L for 
SMX and TET, respectively. The degree of inhibition caused by the antibiotic 
substance can be seen by the amount of decrease of the oxygen consumption. 
The experiments showed that antibiotic substances have different effects on the COD 
removal efficiencies of batch systems, which were calculated using the traditional 
method. The peptone-meat extract mixture COD removal efficiency was calculated 
for SRT 2d acute experiments as well. The peptone-meat extract mixture COD 
removal efficiency for 50 and 200 mg/L SMX additions were calculated as 84% and 
94%, respectively. Addition of 50 mg/L ERY retarded the COD removal at most and 
made it to drop until 59%. On the other hand the tendency of TET to bind with ions 
and settle may have caused peptone to be unavailable for biodegradation and also in 
the effluent liquid phase, since the removal efficiencies were calculated as 99% for 
both 50 and 200 mg/L addition of TET. Figure 5.12 shows the COD removal trends 
of all SRT 2d acute inhibition experiments.  
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Figure 5.12: COD removal trends of batch experiments. 
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5.4.3 Chronic inhibition studies  
Total number of six chronic inhibition tests has been run. During SRT 2d 
experiments, respirometric tests were conducted together with a parallel reactor on 0, 
2
nd
, 4
th
, 6
th
 and 7
th
 days, of which for the last two days only antibiotic and only 
peptone-meat extract mixture were given as substrates. On the other hand during 
SRT 10 d experiments, respirometric tests were conducted on 0, 5
th
, 10
th
, 20
th
 and 
30
th
 days. On the 30
th
 day a parallel system was set to determine only the effect of the 
antibiotic substance on the system. Table 5.7 gives the characteristics of chronic 
experiments. 
Table 5.7: Characteristics of chronic experiments. 
Runs 
Sludge Age 
Antibiotic 
Concentration 
Peptone 
COD 
Antibiotic 
COD 
Total 
COD 
(days) (mg/L) (mg/L) (mg/L) (mg/L) 
Control 
2 - 760 0 760 
10 - 600 0 600 
SMX 
2 100 720 140 860 
10 50 720 70 790 
TET 
2 50 720 66 786 
10 50 720 66 786 
ERY  
2 50 720 84 804 
10 50 720 84 804 
Moreover in the last day of all chronic sets, degradation of each antibiotic compound 
was analyzed, which showed that the amount of oxygen consumed was not due to 
degradation of the antibiotic compounds. The areas under the OUR curves could not 
be calculated, due to the fact that the biomass did not consume oxygen. The only 
effect was that the addition of antibiotics increased the endogenous decay level of the 
biomass. In the case of SMX all the added SMX was measured in the effluent liquid 
phase, showing that it was not degraded by microorganisms.  
S100 SRT 2d chronic reactor was fed with a combination of 720 mgCOD/L of 
peptone-meat extract mixture and 100mg/L of SMX, which in total resulted in 860 
mgCOD/L. Each day the SMX concentration was measured and all the substance 
was found in the effluent liquid. Moreover SMX altered peptone removal of the 
system, as well, which can be seen looking at the amount of oxygen consumed on the 
7
th
 day, where only peptone was fed to the system. System was fed with only 
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peptone-meat extract mixture it only consumed 217 mg/L oxygen. Additionally, the 
change in the total amount of oxygen consumed and also the OUR curve profile 
during the course of 7 days also suggest that chronic exposure to SMX alters the 
behavior of the biomass. The amount of oxygen consumed decreased as well; 181 
mg/L and 255 mg/L in 2
nd
 and 4
th
 days of exposure, respectively, whereas the control 
system utilized 284 mg/L oxygen without the interference of the antibiotic substance. 
The OUR profiles and COD removal trends of S100 SRT 2d chronic reactor can be 
seen in Figure 5.13 and Figure 5.16, respectively. 
Table 5.8: Amount of oxygen consumed during chronic experiments. 
Day/Run 
S100 
SRT:2d 
[mg/L] 
T50 
SRT:2d 
[mg/L] 
E50 
SRT:2d 
[mg/L] 
S50 
SRT:10d 
[mg/L] 
T50 
SRT:10d 
[mg/L] 
E50 
SRT:10d 
[mg/L] 
0 284 284 284 211 211 211 
2 181 278 - - - - 
4 255 - 218 (D3) - - - 
5 - - - - 207 110 
6 - - - - - - 
7 217 271 - - - - 
10 - - 274 275 206 - 
20 - - - 277 (D24) - - 
30 - - - 278 243 238 (D31) 
50 - - - 275 - 216 
 
 
Figure 5.13: Chronic effect of SMX on activated sludge system (SRT: 2d, 100 
mg/L). 
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T50 SRT 2d chronic reactor was fed with a combination of 720 mgCOD/L of 
peptone-meat extract mixture and 50mg/L of TET, which in total resulted in 786 
mgCOD/L. In the 6
th
 day, where only TET was fed, the obtained OUR curve 
suggests that TET was not degraded by the biomass. Moreover peptone-meat extract 
mixture removal efficiency of the biomass seems only slightly to be affected, since 
on the 7
th
 day the amount of oxygen consumed for the degradation of peptone-meat 
extract addition was close to the control system, as well as the COD removal 
efficiency. However in the case of TET, as in the former COD efficiency 
calculations, the calculated removal efficiency may not reflect the truth due to the 
binding properties of the antibiotic substance with divalent ions. Moreover, even 
though the area under the OUR curves are the same, showing that the same amount 
of oxygen is utilized, it can be seen that the profile has altered. More insight in the 
change of degradation kinetics will be revealed in the activated sludge modeling 
section. The OUR profiles and COD removal trends of T50 SRT 2d chronic reactor 
can be seen in Figure 5.14 and Figure 5.16, respectively. 
E50 SRT 2d chronic reactor was fed with a combination of 720 mgCOD/L of 
peptone-meat extract mixture and 50mg/L of ERY, which in total resulted in 804 
mgCOD/L. The chronic test of ERY 50 mg/L of SRT 2d showed lower oxygen 
consumption of 218 mg/L in the 3
rd
 day of exposure. The obtained OUR curve 
during only ERY feeding on the 7
th
 day, suggests that ERY was not degraded by the 
biomass. Chronic exposure of ERY has changed the OUR profile and the oxygen 
consumption decreased slightly. On the 10
th
 day, where only peptone was fed to the 
system, the biomass consumed 274 mg/L oxygen for growth, whereas the control 
reactor required 284 mg/L oxygen for growth. The OUR profiles and COD removal 
trends of E50 SRT 2d chronic reactor can be seen in Figure 5.15 and Figure 5.16, 
respectively. 
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Figure 5.14: Chronic effect of TET on activated sludge system (SRT: 2d, 50 mg/L). 
 
Figure 5.15: Chronic effect of ERY on activated sludge system (SRT: 2d, 50 mg/L). 
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Figure 5.16: COD removal trends of chronic feeding reactors (SRT: 2d). 
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S50 SRT 10d chronic reactor was fed with a combination of 720 mgCOD/L of 
peptone-meat extract mixture and 50mg/L of SMX, which in total resulted in 
790 mgCOD/L. SMX measurements and the obtained OUR curve on the day of only 
SMX-feeding showed that SMX was not degraded by the biomass. The change in the 
OUR curve profile during the course of 30 days suggest that chronic exposure to 
SMX alters the behavior of the biomass. The OUR profiles and COD removal trends 
of S50 SRT 10d chronic reactor can be seen in Figure 5.17 and Figure 5.20, 
respectively. 
 
Figure 5.17: Chronic effect of SMX on activated sludge system (SRT: 10d, 50 
mg/L). 
T50 SRT 10d chronic reactor was fed with a combination of 720 mgCOD/L of 
peptone-meat extract mixture and 50mg/L of TET, which in total resulted in 786 
mgCOD/L. The amount of oxygen consumed when only TET was fed, suggests that 
TET was not degraded by the biomass. On the 5
th
 and the 10
th
 days the amount of 
oxygen consumed for growth drops to 207 mg/L and 206mg/L, respectively, 
suggesting lower amount of COD consumption. However on the 31
st
 day the oxygen 
consumption was 243 mg/L. Moreover, it can be seen that the OUR profile has 
altered in the course of 30 days of chronic exposure to TET. More insight in the 
change of degradation kinetics will be revealed in the activated sludge modeling 
section. The OUR profiles and COD removal trends of T50 SRT 10d chronic reactor 
can be seen in Figure 5.18 and Figure 5.20, respectively. 
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Figure 5.18: Chronic effect of TET on activated sludge system (SRT: 10d, 50 
mg/L). 
E50 SRT 10d chronic reactor was fed with a combination of 720 mgCOD/L of 
peptone-meat extract mixture and 50mg/L of ERY, which in total resulted in 804 
mgCOD/L. The chronic test of ERY 50 mg/L of SRT 10d showed lower oxygen 
consumption of 110 mg/L on the 5
th
 day of exposure. However after 30 days of 
exposure the system consumed almost twice as much oxygen (238 mgO2/L), even 
though still lower than the control system. Chronic exposure of ERY has changed the 
OUR profile and the oxygen consumption decreased. The OUR profiles and COD 
removal trends of E50 SRT 10d chronic reactor can be seen in Figure 5.19 and 
Figure 5.20, respectively. 
 
Figure 5.19: Chronic effect of ERY on activated sludge system (SRT: 10d, 50 
mg/L). 
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The calculated peptone-COD removal efficiencies for acute and chronic tests for 
antibiotic substances may not be the correct approach for investigating the effect of 
antibiotics on the biomass activity. The reason for this is that the amount of oxygen 
consumed decreases with the addition of antibiotics in both acute and chronic 
experiments. However the system reaches the endogenous decay level almost at the 
same time as the control system, which suggests that the system consumes fewer 
amounts of COD, therefore that the antibiotic substances have the property to bind 
with the enzyme-substrate complex causing uncompetitive inhibition. This 
phenomenon will be explained in the following sections, however in this section the 
standard method is used to calculate the peptone-removal efficiencies, assuming that 
the concentration of antibiotic substances are stable throughout the experiment. 
Chronic exposure to SMX had different peptone-meat extract COD removal 
efficiencies on different days; 93% and 87% on 2
nd
 and 4
th
 days, respectively. SMX 
decreased the peptone removal efficiency of the system after 7 days from 91% (SRT 
2d Control) to 68%. In the case of TET, due to its binding properties of TET with 
divalent ions standard COD removal efficiency calculations are not reliable. 
However, the calculated value is 97% on the 2
nd
 day of chronic feeding.  Moreover, 
peptone removal efficiency of the system after 7 days of chronic exposure to TET 
was 89%. The chronic test of ERY 50 mg/L of SRT 2d showed 80% of peptone-meat 
extract mixture COD removal efficiency in the 3
rd
 day of exposure. The effect of 
ERY on peptone-meat extract mixture removal on the 10
th
 day was not very 
dramatic, however the OUR profile has changed and the oxygen consumption 
decreased slightly, whereas the peptone-meat extract removal efficiency dropped 
from 91% (SRT 2d Control) to 88% (day10). The SRT 10d chronic experiments had 
different results on peptone-meat extract COD removal efficiency. The efficiency of 
the SMX system changed from 94% (SRT 10d Control) to 95%, 87% and 93% on 
days 10, 24 and 30, respectively. Moreover when the system was fed with only 
peptone-meat extract mixture the COD removal efficiency was calculated as 92%. 
Chronic TET exposure had higher COD removal efficiencies, 97% and 95% 
efficiency on 5
th
 and 10
th
 days. Finally, the calculated efficiencies for chronic ERY 
exposure were 93%, 100% and 93% on 5
th
, 10
th
 and 30
th
 days. As can be seen from 
the calculation results, the peptone-meat extract COD removal efficiency cannot be 
interpreted with the usual vision, and binding of antibiotics on the substrate-enzyme 
complex should be taken into consideration. (Figure 5.20) 
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Figure 5.20: COD removal trends of chronic feeding reactors (SRT: 10d). 
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As can be seen from Figure 5.21, the biomass concentration in the chronic reactors 
decreased with increasing time of exposure to antibiotics. Additionally, the SRT 2d 
reactors show an imbalanced profile under the effect of antibiotics. 
  
Figure 5.21: Chronic effect of antibiotics on reactor biomasses (Top: SRT 10d, 
Bottom: SRT 2d). 
5.5 Antibiotic Measurements 
The measurements of SMX showed that the substance is kept in the mixed liquor. In 
acute and also in chronic inhibition experiments all the given SMX has been 
measured in the 0.45 µm filtered samples.  
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Figure 5.22Figure 5.22, Figure 5.23 and Figure 5.24 show the effluent SMX 
concentrations of the acute experiments and the chronic reactors (SRT 2 and 10 
days), respectively. As can be seen in the figures all the fed antibiotic compound was 
measured in the effluent. These findings are supported with the knowledge in the 
literature that SMX does not have the property to adsorb onto the sludge, and 
moreover shows that the substance has not been degraded by the activated sludge 
biomass. 
 
Figure 5.22: SMX concentrations in the acute inhibition experiments. 
 
Figure 5.23: Effluent SMX concentrations in the chronic reactor (SRT: 2d). 
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Figure 5.24: Effluent SMX concentrations in the chronic reactor (SRT: 10d). 
Since the main of the study was to determine the effect of antibiotic substance on the 
substrate biodegradation properties of the activated sludge biomass, mainly the 
behavior of the three selected antibiotics were not of interest. However since there is 
information of SMX being removed as nitrogen source given in the literature SMX 
was successfully measured (Drillia et al., 2005). Additionally, in the literature there 
is no information of TET and ERY being biodegraded by activated sludge biomass, 
therefore measuring these substances was not of importance. However, TET and 
ERY were also tried to be measured, and different methods were applied, none of 
which gave positive results.  
5.6 Conceptual Framework on Enzyme Inhibition 
Inhibitory actions in substrate biodegradation are conveniently evaluated using the 
analogy of enzyme-catalyzed reactions. In fact, the same approach was adopted to 
provide conceptual support to the empirical Monod-type expression now commonly 
utilized in defining microbial growth in activated sludge systems. As described in 
detail in the literature (Mulchandani et al., 1989; Orhon and Artan, 1994), the 
enzyme analogy was mostly introduced to differentiate two major types of inhibitory 
effects with retardation effects on microbial growth: In competitive inhibition, the 
inhibitor (I) forms with the enzyme (E) an enzyme-inhibitor complex, [EI] and 
competes with substrate (S) for the same enzymatic site in biomass. This effect is 
kinetically expressed in terms of a higher half saturation coefficient, which can be 
reversed by increasing the substrate concentration.  
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In non-competitive inhibition, the enzyme-inhibitor complex [EI] cannot be reversed 
by the substrate concentration, which becomes unable to prevent the combination of 
the inhibitor with the enzyme. This time the effect is on the maximum specific 
growth rate.  
Recent studies have also indicated that the inhibitory impacts of chemicals should be 
visualized, not only in the utilization of the readily biodegradable substrate for 
microbial growth, but also in the hydrolysis of the slowly biodegradable substrate 
(Insel et al., 2006). The common feature of both types of inhibition is that the 
inhibitory action only affects process kinetics so that the available biodegradable 
substrate is fully utilized. 
In uncompetitive inhibition however, the inhibitor (I) attacks the enzyme substrate 
sites, [ES], and forms an [ESI] complex, which does not undergo further biochemical 
reactions and this way, it blocks a part of the available substrate for biodegradation.  
The significant aspect that differentiates uncompetitive inhibition from the other 
types is that the induced effect is primarily stoichiometric, i.e. the fraction of 
substrate bound by the inhibitor becomes not available for microbial growth as 
indicated by the following mass balance equation: 
  [  ]  [   ]     (5.1) 
The basic stoichiometry and mass balance for available substrate is of capital 
importance for evaluating the impact of inhibitors, mainly because without any 
consideration of substrate blockage, a kinetic interpretation is bound to be distorted 
and misleading. Almost all similar studies reported in the literature overlooked 
substrate blockage as they only relied on measurements of substrate profiles which 
cannot differentiate the bound fraction not utilized by biochemical reactions. The 
introduction of the OUR profiles for inhibitory impact constitutes the basis of the 
original approach in this study in determining substrate binding potential of the 
selected antibiotics by means of uncompetitive inhibition. 
Obtained OUR profiles mostly have the same properties, one of which is that they 
reach the endogenous decay level at the same time as the control experiment, 
indicating that all the external carbon source has been utilized for metabolic 
activities. Additionally after the addition of antibiotic substances the amount of 
consumed oxygen decreases, which means that the system is utilizing less amount of 
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substrate than the control experiment. This situation shows that antibiotic substances 
have substrate binding properties, which leads to uncompetitive inhibition of the 
system.  
In this context, two characteristics of the OUR profile should be considered for the 
evaluation of the results: 
(i) The OUR area above the endogenous respiration level directly gives the amount 
of oxygen consumed, O2, at the expense of all available organic substrate 
(biodegradable COD) utilized by means of the following mass balance expression: 
O2 = CS(1 − YH)    (5.2) 
where CS is the biodegradable COD concentration and YH is the heterotrophic yield 
coefficient (mg cell COD/mg COD). Consequently, with a known/predetermined 
amount of biodegradable substrate, the OUR curve may be used to determine YH 
and/or inert COD components (Orhon and Okutman, 2003). 
(ii) The OUR experiment is started at the endogenous respiration level before the 
addition of substrate onto biomass in the reactor; the experiment ends when the OUR 
drops to the same level again, indicating that all available external substrate has been 
consumed. 
The organic substrate (peptone-meat extract mixture) used in the experiments is by 
nature totally biodegradable; this is one of the main reasons for its selection and 
recommendation as the standard substrate for biodegradation experiments. Because 
the biodegradable COD in the control reactor was completely depleted after the OUR 
profile dropped to the initial endogenous respiration level, COD remaining in the 
control reactor represents the residual soluble microbial products, SP, generated in 
the course of biochemical reactions; (Chudoba et al., 1985; Artan and Orhon, 1989) 
in the proposed decay associated models, SP is conveniently expressed as a fraction 
of the influent biodegradable COD, CS1 in terms of a yield coefficient, YSP: (Orhon et 
al., 1999) 
SP = YSPCS1     (5.3) 
Using the data of the control reactor, a YSP value of 0.06 mg COD/mg COD was 
calculated, since an SP value 36 mg/L was generated at the expense of 600 mg/L of 
peptone mixture COD initially supplied in the reactor. Furthermore, 211 mg/L of 
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oxygen consumed during the experiment corresponded to a yield coefficient, YH, of 
0.60 mg cell COD/mg COD using the simulation results of the control data and the 
basic mass balance expression given above (5.2).  
The significant feature of the impact of antibiotics on peptone mixture 
biodegradation is the reduction of oxygen consumption in the OUR experiments 
despite the fact that the OUR profiles drop down to the level of endogenous 
respiration within the observation period, indicating that all available biodegradable 
COD is utilized. This observation is against basic stoichiometry and cannot be 
explained by the conventional understanding of the inhibitory impact, which would 
retard biodegradation by either reducing the maximum specific growth rate, μH 
and/or increase the half saturation coefficient, KS. Both types of effects are kinetic in 
nature, slowing down the rate of substrate utilization. The observed change in the 
OUR profile inflicted by this type of inhibition would be a longer period to reach the 
endogenous respiration level but the same area under the OUR curve or the same 
level of oxygen consumption. 
Moreover, the decrease in oxygen utilization cannot be explained with the 
inactivation and/or decrease of the biomass in the system either. The result of 
reduced active biomass concentration in the system would cause the system to 
continue substrate degradation at a slower rate, which would prolong the period 
required for the substrate to be depleted. The corresponding OUR curve would 
eventually reach the endogenous decay level, thus keeping the area under the OUR 
curve same as the non-inhibited system, as the amount of substrate utilized remains 
the same. 
Table 5.9 and Table 5.11, Table 5.10 and Table 5.12 show the mass balance between 
oxygen consumption and COD utilization in the SRT 10d and 2d acute and chronic 
inhibition experiments. In this context using the total area under the OUR curve the 
amount of COD corresponding to the amount of oxygen consumed has been 
calculated, and since the given amount of COD is known, the amount of COD bound 
by the antibiotic substance has been calculated. Moreover, using the utilized COD 
and YSP, the soluble metabolic products and amount of bound substrate and 
antibiotic-substrate complex amount has been calculated. 
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From Table 5.9 and Table 5.10 it can be seen that uncompetitive inhibition theory 
can be applied to all acute experimental runs, however the extent of the inhibitory 
impact greatly varied as a function of dosage and type of antibiotics. At 50 mg/L 
dosage, during SRT 10d acute experiments the amount of peptone mixture utilized 
dropped from 600 mg/L in the unaffected control reactor to 515 mg/L with SMX; to 
428 mg/L with TET and to 280 mg/L with ERY, which exerted the strongest effect. 
For sludge age of 2 days the amount of peptone mixture utilized dropped from 760 
mg/L in the control reactor to 665 mg/L with SMX (with 720 mg/L peptone 
addition); to 573 mg/L with TET (with 720 mg/L peptone addition) and to 310 mg/L 
with ERY (with 720 mg/L peptone addition), which again exerted the strongest 
effect. However, this shows that the substrate binding effect of antibiotic differs with 
the sludge history as well. 
At 200 mg/L dosage of SRT 10d acute experiments, the amount of peptone mixture 
utilized dropped from 600 mg/L in the unaffected control reactor to 628 mg/L with 
SMX (with 650 mg/L peptone addition); to 435 mg/L with TET and to 140 mg/L 
with ERY, which again exerted the strongest effect. For sludge age of 2 days the 
amount of peptone mixture utilized dropped from 760 mg/L in the control reactor to 
650 mg/L with SMX (with 720 mg/L peptone addition); to 468 mg/L with TET (with 
720 mg/L peptone addition). However, this shows that the substrate binding effect of 
antibiotic differs with the sludge history as well. 
A parallel decrease could be calculated for the generation of the residual soluble 
metabolic products, SP as shown in Table 5.9 to Table 5.12. Interestingly, the 
remaining soluble COD in the reactor at the completion of the OUR test (endogenous 
respiration level) did not show the same trend for 50 mg/L antibiotic addition (acute 
SRT 10d): for SMX, the total COD associated with the [ESI] complex was calculated 
as 155 mg/L and the remaining COD contained around 97% of the 
antibiotic/substrate complex, the remaining 3% presumably being entrapped/attached 
to the biomass. The strongest biomass entrapment was attributed to TET, which 
yielded the lowest remaining COD level of 52 mg/L including SP (Table 5.9). Also 
for the SRT 2 days acute experiments TET again showed the lowest remaining COD 
level of 75 mg/L inclusive SP (Table 5.10).  
When the antibiotic dosage was increased to 200 mg/L the remaining COD 
concentrations were substantially higher, indicating that not all available antibiotics 
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were bound with substrate and the remaining COD included aside the [ESI] complex, 
the unattached/free antibiotic fraction. Complex formation potential of the selected 
antibiotics maintained the same character so that TET yielded again the lowest level 
of remaining COD, which yielded the lowest remaining COD level of 143 mg/L 
including SP (Table 5.9). Also for the SRT 2 days acute experiments TET again 
showed the lowest remaining COD level of 267 mg/L inclusive SP (Table 5.10).  
From Table 5.11 and Table 5.12 it can be seen that uncompetitive inhibition theory 
can also be applied to chronic exposure experiments. At 50 mg/L chronic dosage, the 
amount of peptone mixture utilized dropped from 600 mg/L in the unaffected control 
reactor to 695 mg/L with SMX after 30 days (with 720 mg/L peptone addition), 608 
mg/L with TET after 31 days (with 720 mg/L peptone addition) and again 30 days of 
exposure to 595 mg/L with ERY (with 720 mg/L peptone addition). For sludge age 
of 2 days the amount of peptone mixture utilized dropped from 760 mg/L in the 
control reactor to 637 mg/L with SMX (with 720 mg/L peptone addition); to 695 
mg/L with TET (with 720 mg/L peptone addition) and to 545 mg/L with ERY (with 
720 mg/L peptone addition), which again exerted the strongest effect.  
Remaining soluble COD in the reactor at the completion of the OUR test 
(endogenous respiration level) during the SRT 10d chronic exposure studies showed 
that for SMX, the total COD associated with the [ESI] complex was calculated as 95 
mg/L and the remaining COD contained around 84% of the antibiotic/substrate 
complex, the remaining 16% presumably being entrapped/attached to the biomass.  
For SRT 2d system after 4 days of SMX exposure the total COD associated with the 
[ESI] complex was calculated as 223 mg/L and the remaining COD contained around 
78% of the antibiotic/substrate complex, the remaining 22% presumably being 
entrapped/attached to the biomass.  For the SRT 2 days chronic experiments the 
strongest biomass entrapment was attributed to TET, which yielded the lowest 
remaining COD level of 89 mg/L including SP (Table 5.12).  
Additionally, in SRT 10d chronic experiments, after 30 days of exposure to the 
antibiotic substance, the systems was stopped to be fed for 20 days, and on the 50
th
 
day systems were fed with the antibiotic substance again. In these cases, the amount 
of peptone mixture utilized dropped from 600 mg/L in the unaffected control reactor 
to 688 mg/L with SMX on the 50
th
 day (with 720 mg/L peptone addition), and again 
to 540 mg/L with ERY (with 720 mg/L peptone addition). Remaining soluble COD 
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in the reactor at the completion of the OUR test (endogenous respiration level) 
during the SRT 10d chronic exposure studies (day 50) showed that for SMX, the 
total COD associated with the [ESI] complex was calculated as 103 mg/L and the 
remaining COD contained around 91% of the antibiotic/substrate complex, the 
remaining 9% presumably being entrapped/attached to the biomass.  For ERY 
however, total COD associated with the [ESI] complex was calculated as 264 mg/L 
and the remaining COD contained around 23% of the antibiotic/substrate complex, 
the remaining 77% presumably being entrapped/attached to the biomass.   
In the light of these information substrate binding properties of antibiotic substances 
were taken into consideration for simulation of the behavior of activated sludge 
biomass of different runs. The mass balances presented in this section were used as 
input data for activated sludge models. 
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Table 5.9: Mass balance between oxygen consumption and COD utilization based on OUR profiles in acute inhibition studies (SRT 10d). 
Run 
Antibiotic 
Concentration 
(mg/L) 
Initial Peptone 
COD 
(mg/L) 
Oxygen 
Consumed 
(mg/L) 
COD 
Utilized 
(mg/L) 
COD 
Bound 
(mg/L) 
Remaining Soluble COD (mg/L) 
Total 
Soluble Metabolic 
Product, SP 
Peptone + 
Antibiotic 
Control - 600 211 600 - 36 36 - 
SMX 50 600 206 515 85 182 31 151 
TET 50 600 171 428 173 52 26 26 
ERY 50 600 112 280 320 109 17 92 
SMX 200 650 251 628 23 343 38 305 
TET 200 600 174 435 165 143 26 117 
ERY 200 600 56 140 460 329 8 321 
Table 5.10: Mass balance between oxygen consumption and COD utilization based on OUR profiles in acute inhibition studies (SRT 2d). 
Run 
Antibiotic 
Concentration 
(mg/L) 
Initial Peptone 
COD 
(mg/L) 
Oxygen 
Consumed 
(mg/L) 
COD 
Utilized 
(mg/L) 
COD 
Bound 
(mg/L) 
Remaining Soluble COD (mg/L) 
Total 
Soluble Metabolic 
Product, SP 
Peptone + 
Antibiotic 
Control - 760 284 760 - 71 71 - 
SMX 50 720 266 665 55 189 62 127 
TET 50 720 229 573 148 75 53 22 
ERY 50 720 124 310 410 379 29 350 
SMX 200 720 260 650 70 326 61 265 
TET 200 720 187 468 253 267 44 223 
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Table 5.11: Mass balance between oxygen consumption and COD utilization based on OUR profiles in chronic inhibition studies (SRT 10d). 
Run 
Antibiotic 
Concentration 
(mg/L) 
Initial  
Peptone COD 
(mg/L) 
Oxygen 
Consumed 
(mg/L) 
COD 
Utilized 
(mg/L) 
COD 
Bound 
(mg/L) 
Remaining Soluble COD (mg/L) 
Total 
Soluble Metabolic 
Product, SP 
Peptone + 
Antibiotic 
Control - 600 211 600 - 36 36 - 
SMX – Day 30 50 720 278 695 25 122 42 80 
SMX – Day 50 50 720 275 688 33 135 41 94 
TET – Day 31 50 720 243 608 113 100 36 64 
ERY – Day 31 50 720 238 595 125 132 36 96 
ERY – Day 50 50 720 216 540 180 93 32 61 
Table 5.12: Mass balance between oxygen consumption and COD utilization based on OUR profiles in chronic inhibition studies (SRT 2d). 
Run 
Antibiotic 
Concentration 
(mg/L) 
Initial Peptone 
COD 
(mg/L) 
Oxygen 
Consumed 
(mg/L) 
COD 
Utilized 
(mg/L) 
COD 
Bound 
(mg/L) 
Remaining Soluble COD (mg/L) 
Total 
Soluble Metabolic 
Product, SP 
Peptone + 
Antibiotic 
Control - 760 284 760 - 71 71 - 
SMX – Day 4 100 720 255 637 83 235 60 175 
TET – Day 2 50 720 278 695 25 89 65 24 
ERY – Day 3 50 720 218 545 175 233 51 182 
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5.7 Modeling of Activated Sludge Systems 
In order to determine the effect of antibiotic compounds on the biodegradation of 
peptone-meat extract mixture various simulations were run using the AQUASIM 
program, which simulates oxygen utilization rate (OUR), chemical oxygen demand 
(COD) and polyhydroxy alkanoates (PHA) data at the same time. To be able to 
establish a baseline for comparison model calibration of control reactors of different 
sludge ages acclimated on peptone-meat extract mixture were completed. Table 5.13 
gives the kinetic information describing the biodegradation of peptone-meat extract 
mixture at SRT 10d and SRT 2d. 
Simulations of both SRT2d and SRT10d control systems showed that sludge history 
plays an important role on the kinetics of substrate removal. SRT 2d system having 
higher growth rate and faster hydrolysis of XS, shows slower hydrolysis of SH than 
that of SRT 10d system. Additionally, the simulations showed that since it is a fast 
growing system, the endogenous decay rate of the SRT 2d system is higher than the 
SRT 10d system. Model calibration of control systems showed that the readily 
biodegradable fraction of peptone mixture is 9.5%, readily hydrolysable COD is 56% 
and hydrolysable COD is 34.5% of the total biodegradable COD given to the system. 
PHA analysis showed that the SRT 10d system has a 10 mgCOD/L PHA pool and 
maximum PHA storage is 32 mgCOD/L. However, previous studies revealed that 
SRT 2d systems do not have significant storage properties (Orhon et al., 2009). 
Therefore SRT 2d systems were not monitored for their storage products.   
COD and OUR profiles and model simulations of both SRT 10d and 2d control 
systems are given in Figure 5.25, Figure 5.26, Figure 5.28 and Figure 5.29. Moreover 
PHA profile of SRT 10d control system is given in Figure 5.27.  
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Table 5.13: Model calibration of peptone-meat extract acclimated control reactors. 
 
 
Model Parameter  Unit 
Control 
– SRT 
10d 
Control 
– SRT 
2d 
Maximum growth rate for XH µ
’
H 1/day 5.2 7.2 
Half saturation constant for growth of XH KS 
mg 
COD/L 
24 30 
Endogenous decay rate for XH and bH 1/day 0.1 0.2 
Heterotrophic half saturation coefficient 
for oxygen 
KOH 
mg O2/L 0.01 0.01 
Maximum hydrolysis rate for SH1 kh 1/day 5.2 4 
Hydrolysis half saturation constant for SH1 KX 
g COD/g 
COD 
0.15 0.15 
Maximum hydrolysis rate for XS1  khx 1/day 0.56 1 
Hydrolysis half saturation constant for XS1 KXX 
g COD/g 
COD 
0.05 0.05 
Maximum storage rate of PHA by XH kSTO 1/day 1.2 0 
Maximum growth rate on PHA for XH µ
’
STO 1/day 0.8 0 
Half saturation constant for storage of 
PHA by XH 
KSTO 
mg 
COD/L 
0.5 0 
Yield coefficient of XH YH 
g COD/g 
COD 
0.6 0.6 
Yield coefficient of PHA YSTO 
g COD/g 
COD 
0.8 0 
Fraction of biomass converted to SP fES - 0.05 0.05 
Fraction of biomass converted to XP fEX - 0.15 0.15 
State variables  Unit   
Total biomass  
mgCOD
/L 
2010 809 
Initial active biomass XH1 
mg 
COD/L 
1450 630 
Activity
 
 % 72 78 
Initial amount of PHA XSTO1 
mg 
COD/L 
10 0 
Initial amount of biodegradable COD CS1 
mg 
COD/L 
600 760 
Initial amount of readily biodegradable 
COD 
SS1 
mg 
COD/L 
57 72 
Initial amount of readily hydrolysable 
COD 
SH1 
mg 
COD/L 
335 424 
Initial amount of hydrolysable COD XS1 
mg 
COD/L 
208 264 
Bound COD 
 mgCOD
/L 
- - 
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Figure 5.25: OUR profile of peptone-meat extract biodegradation and simulation 
(SRT 10d). 
 
Figure 5.26: COD removal profile of peptone-meat extract biodegradation and 
simulation (SRT 10d). 
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Figure 5.27: PHA storage profile of peptone-meat extract biodegradation and 
simulation (SRT 10d). 
 
Figure 5.28: OUR profile of peptone-meat extract biodegradation and simulation 
(SRT 2d). 
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Figure 5.29: COD removal profile of peptone-meat extract biodegradation and 
simulation (SRT 2d).  
During the course of the acute and chronic experimental runs polyhydroxyalkanoates 
(PHA) samples were collected from each set to characterize the bacterial storage 
mechanism in the reactors. Results of PHA measurements showed that primary effect 
of antibiotics on the metabolism of activated sludge biomass is that in the SRT 10d 
system storage mechanism is inhibited completely. Therefore it has been established 
that in acute inhibition experiments the system continued to utilize the PHA pool in 
the sludge, since the sludge was taken from the control reactor. However, in the 
chronic exposure experiments, since the storage mechanism was completely 
inhibited the PHA pools were also non-existent, leading to the inability to storage of 
and grow on PHA molecules.  
Moreover preliminary evaluation of OUR profiles showed that with addition of 
antibiotic substance the system responded with lower oxygen consumption compared 
to the control sample, which coincided with uncompetitive inhibition, of which the 
effect on the OUR profile has been demonstrated before. Additionally, the amount of 
COD bound for each run of experiment was calculated and used in simulation 
studies, which was given in the previous section (Table 5.9 to Table 5.12). 
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5.7.1 Sulfamethoxazole simulations 
5.7.1.1 SRT: 10 d 
Results of simulation studies to determine the kinetic effect of SMX on the 
biodegradation of peptone-meat extract showed the antibiotic inhibits the PHA 
storage of the SRT 10d system (Figure 5.30 to Figure 5.32). Kinetics of acute 
inhibition studies showed that the system, however unable to store PHA was still 
able to grow on already stored PHA. Moreover it was shown that SMX increases the 
half saturation constant of the substrate, therefore making it less available for the 
biomass. The system also demonstrated that with increasing antibiotic concentration 
rate of hydrolysis of SH decreases as well, which is presented by decreased rate and 
increased half saturation constant for SH hydrolysis. Finally, it has been determined 
that the system utilizes not all the COD given, but 85 and 23 mgCOD/L less than 
given amount for SMX50 and SMX200 acute additions, respectively (Table 5.14). 
Additionally, it is very important to note that the endogenous decay level of the 
system increases with the addition of the antibiotic substance. 
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Table 5.14: Effect of SMX on kinetics of peptone-meat extract removal (SRT 10d). 
Model Parameter  Unit 
Control – SRT 
10d 
Acute – 
SMX200 
Acute – 
SMX50 
Chronic – 
SMX Day 30 
Chronic – 
SMX Day 50 
Maximum growth rate for XH µ
’
H 1/day 5.2 5.2 5.2 3 5.2 
Half saturation constant for 
growth of XH 
KS mg COD/L 24 40 40 80 50 
Endogenous decay rate for XH 
and 
bH 1/day 0.1 0.2 0.2 0.27 0.27 
Heterotrophic half saturation 
coefficient for oxygen 
KOH mg O2/L 0.01 0.01 0.01 0.01 0.01 
Maximum hydrolysis rate for SH1 kh 1/day 5.2 4.06 5.2 3.9 3.8 
Hydrolysis half saturation 
constant for SH1 
KX g COD/g COD 0.15 0.21 0.15 0.21 0.15 
Maximum hydrolysis rate for XS1  khx 1/day 0.56 0.56 0.56 0.56 0.56 
Hydrolysis half saturation 
constant for XS1 
KXX g COD/g COD 0.05 0.05 0.05 0.05 0.05 
Maximum storage rate of PHA 
by XH 
kSTO 1/day 1.2 0 0 0 0 
Maximum growth rate on PHA 
for XH 
µ’STO 1/day 0.8 0.8 0.8 0 0 
Half saturation constant for 
storage of PHA by XH 
KSTO mg COD/L 0.5 0.5 0.5 0 0 
Yield coefficient of XH YH g COD/g COD 0.6 0.6 0.6 0.6 0.6 
Yield coefficient of PHA YSTO g COD/g COD 0.8 0.8 0.8 0.8 0.8 
Fraction of biomass converted to 
SP 
fES - 0.05 0.05 0.05 0.05 0.05 
Fraction of biomass converted to 
XP 
fEX - 0.15 0.15 0.15 0.15 0.15 
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Table 5.14 (continued): Effect of SMX on kinetics of peptone-meat extract removal (SRT 10d). 
 
 
 
 
 
 
 
 
 
 
 
 
State variables  Unit 
Control – SRT 
10d 
Acute – 
SMX200 
Acute – 
SMX50 
Chronic – 
SMX Day 30 
Chronic – 
SMX Day 50 
Total biomass  mgCOD/L 2010 2009 1891 1640 1846 
Initial active biomass XH1 mg COD/L 1450 1450 1200 932 1000 
Activity
 
 % 72 72 64 57 54 
Initial amount of PHA XSTO1 mg COD/L 10 20 16 0 0 
Initial amount of biodegradable 
COD 
CS1 mg COD/L 600 650 600 720 720 
Initial amount of readily 
biodegradable COD 
SS1 mg COD/L 57 62 57 68 68 
Initial amount of readily 
hydrolysable COD 
SH1 mg COD/L 335 363 280 402 390 
Initial amount of hydrolysable 
COD 
XS1 mg COD/L 208 202 178 225 229 
Bound COD  mgCOD/L - 23 85 25 33 
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Figure 5.30: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute SMX200 SRT 10d). 
 
Figure 5.31: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute SMX50 SRT 10d). 
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Figure 5.32: COD removal profile of peptone-meat extract biodegradation and 
simulation (Top: Acute SMX200 SRT 10d; Bottom: Acute SMX50 SRT 10d). 
In addition to the acute inhibition studies, simulations of the chronic inhibition data 
revealed that exposed to 50 mg/L SMX for 30 days, the half saturation constant of 
the substrate increases and the maximum growth rate of the microorganisms 
decreases, affecting both substrate degradation and growth (Table 5.14). Moreover, 
the endogenous decay level increases under the effect of constant exposure. Finally, 
consistent with the stoichiometric calculations the model simulation showed that the 
system utilized 25 mgCOD/L less than given amount and it can also be seen that the 
rate of hydrolysis for SH decreased further than the SMX50 acute inhibition and the 
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half saturation constant increased to the level of acute effect of 200 mg/L SMX 
addition. (Figure 5.33 and Figure 5.34) 
 
Figure 5.33: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic SMX50 SRT 10d Day30). 
 
Figure 5.34: COD removal profile of peptone-meat extract biodegradation and 
simulation (Chronic SMX50 SRT 10d Day30). 
After 30 days of exposure the 50 mg/L SMX, the systems was not fed with the 
antibiotic for 20 days, but only fed with peptone-meat extract mixture. On the 50
th
 
day 50 mg/L SMX was added to the system again and it has been observed that the 
system responded with decreased hydrolysis and growth rates and increased half 
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saturation constant (KS). However the effect was not as severe as on the 30
th
 day. 
Moreover the system again utilized 33 mgCOD/L less substrate than given to the 
system. Finally, the endogenous decay rate of the biomass increased to 0.27 d
-1
 for 
both 30
th
 and 50
th
 days, indicating that chronic exposure to SMX besides lowering 
the growth and the hydrolysis rate of SH almost triples the endogenous decay of the 
organisms. However it can also be seen that for both acute and chronic exposures the 
hydrolysis rates of XS remained unaffected (Table 5.14). 
Additionally, the COD removal profiles indicate that the system seems to have a 
faster COD removal. However the simulation suggests otherwise, indicating that the 
COD was bound and removed, but not utilized for growth. (Figure 5.35 and Figure 
5.36) 
 
Figure 5.35: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic SMX50 SRT 10d Day50). 
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Figure 5.36: COD removal profile of peptone-meat extract biodegradation and 
simulation (Chronic SMX50 SRT 10d Day50). 
5.7.1.2 SRT: 2 d 
Results of SRT 2d system simulation studies to determine the kinetic effect of SMX 
on the biodegradation of peptone-meat extract showed acute exposure to the 
antibiotic does not affect the growth kinetic of the system, resulting unchanged 
maximum growth rate and half saturation constant of the biomass. Kinetics of both 
50 mg/L and 200 mg/L SMX acute inhibition studies showed that substance does not 
adversely affect the hydrolysis kinetics of the system as well. Additionally, it has 
been determined that the SRT 2d system utilizes 59 and 70 mgCOD/L less than 
given amount for SMX50 and SMX200 acute additions, respectively. Finally, in 
contrast to SRT 10d system, it has been observed that the endogenous decay level of 
the SRT 2d control system, which due to its fast nature is already double as much as 
the SRT 10d control system, does not increase further under the effect of antibiotic 
substance (Table 5.15). (Figure 5.37, Figure 5.38 and Figure 5.39) 
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Figure 5.37: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute SMX200 SRT 2d). 
 
Figure 5.38: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute SMX50 SRT 2d). 
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Table 5.15: Effect of SMX on kinetics of peptone-meat extract removal (SRT 2d). 
Model Parameter  Unit 
Control – 
SRT 2d 
Acute –  
SMX200 
Acute – 
SMX50 
Chronic – 
SMX100 Day 4 
Maximum growth rate for XH µ
’
H 1/day 7.2 7.2 7.2 1.5 
Half saturation constant for growth of XH KS mg COD/L 30 30 30 25 
Endogenous decay rate for XH and bH 1/day 0.2 0.2 0.2 0.2 
Heterotrophic half saturation coefficient for 
oxygen 
KOH mg O2/L 0.01 0.01 0.01 0.01 
Maximum hydrolysis rate for SH1 kh 1/day 4 4 4 3.1 
Hydrolysis half saturation constant for SH1 KX g COD/g COD 0.15 0.15 0.15 0.15 
Maximum hydrolysis rate for XS1  khx 1/day 1 1.2 1 0.7 
Hydrolysis half saturation constant for XS1 KXX g COD/g COD 0.05 0.05 0.05 0.26 
Maximum storage rate of PHA by XH kSTO 1/day 0 0 0 0 
Maximum growth rate on PHA for XH µ
’
STO 1/day 0 0 0 0 
Half saturation constant for storage of PHA 
by XH 
KSTO mg COD/L 0 0 0 0 
Yield coefficient of XH YH g COD/g COD 0.6 0.6 0.6 0.6 
Yield coefficient of PHA YSTO g COD/g COD 0 0 0 0 
Fraction of biomass converted to SP fES - 0.05 0.05 0.05 0.05 
Fraction of biomass converted to XP fEX - 0.15 0.15 0.15 0.15 
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Table 5.15 (continued): Effect of SMX on kinetics of peptone-meat extract removal (SRT 2d). 
 
 
State variables  Unit 
Control –  
SRT 2d 
Acute – 
SMX200 
Acute – 
SMX50 
Chronic – 
SMX100 Day 4 
Total biomass  mgCOD/L 809 568 567 653 
Initial active biomass XH1 mg COD/L 630 440 400 480 
Activity
 
 % 78 77 71 74 
Initial amount of PHA XSTO1 mg COD/L 0 0 0 0 
Initial amount of biodegradable COD CS1 mg COD/L 760 720 720 720 
Initial amount of readily biodegradable 
COD 
SS1 mg COD/L 72 54 54 40 
Initial amount of readily hydrolysable 
COD 
SH1 mg COD/L 424 402 402 347 
Initial amount of hydrolysable COD XS1 mg COD/L 264 186 205 250 
Bound COD  mgCOD/L - 70 59 83 
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Figure 5.39: COD removal profile of peptone-meat extract biodegradation and 
simulation (Top: Acute SMX200 SRT 2d; Bottom: Acute SMX50 SRT 2d). 
Simulations of the chronic inhibition data revealed that exposed to 100 mg/L SMX 
for 4 days, both the half saturation constant of the substrate and the maximum growth 
rate of the microorganisms decreased, affecting both substrate degradation and 
growth by showing the properties of uncompetitive inhibition (Table 5.15). 
Moreover, it has been seen that hydrolysis rate of SH decreased together with a 
decrease of XS hydrolysis rate, showing that constant exposure to 100 mg/L SMX 
retarded both hydrolysis mechanisms. Finally, consistent with the stoichiometric 
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calculations the model simulation showed that the system utilized 83 mgCOD/L less 
than given amount. (Figure 5.40 and Figure 5.41) 
 
Figure 5.40: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic SMX50 SRT 2d Day4). 
 
Figure 5.41: COD removal profile of peptone-meat extract biodegradation and 
simulation (Chronic SMX50 SRT 2d Day4). 
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5.7.2 Tetracycline simulations 
5.7.2.1 SRT: 10 d 
Results of simulation studies to determine the kinetic effect of TET on the 
biodegradation of peptone-meat extract showed the antibiotic inhibits the PHA 
storage of the SRT 10d system. Kinetics of acute inhibition studies showed that the 
system, however unable to store PHA was still able to grow on already stored PHA. 
Moreover it was shown that TET does not affect the half saturation constant of the 
substrate (KS). The system also demonstrated that with increasing antibiotic 
concentration half saturation constant of SH hydrolysis increases, which adversely 
affects degradation of SH fraction of the substrate. Moreover, hydrolysis of XS was 
shown not to be affected by acute inhibition of TET. Finally, it has been determined 
that the system utilizes not all the COD given, but 173 and 165 mgCOD/L less than 
given amount for TET50 and TET200 acute additions. Additionally, as shown in the 
SMX simulations the antibiotic substance causes the endogenous decay level of the 
system to increase (Table 5.16). (Figure 5.42, Figure 5.43 and Figure 5.44)  
 
Figure 5.42: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute TET200 SRT 10d). 
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Figure 5.43: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute TET50 SRT 10d). 
 
Figure 5.44: COD removal profile of peptone-meat extract biodegradation and 
simulation (Top: Acute TET200 SRT 10d; Bottom: Acute TET50 SRT 10d). 
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Table 5.16: Effect of TET on kinetics of peptone-meat extract removal (SRT 10d). 
 
 
 
 
Model Parameter  Unit 
Control –  
SRT 10d 
Acute – 
TET200 
Acute – 
TET50 
Chronic –  
TET Day 30 
Maximum growth rate for XH µ
’
H 1/day 5.2 5.2 5.2 5 
Half saturation constant for growth of XH KS mg COD/L 24 24 24 33 
Endogenous decay rate for XH and bH 1/day 0.1 0.15 0.15 0.15 
Heterotrophic half saturation coefficient 
for oxygen 
KOH mg O2/L 0.01 0.01 0.01 0.01 
Maximum hydrolysis rate for SH1 kh 1/day 5.2 5.2 5.2 5.2 
Hydrolysis half saturation constant for 
SH1 
KX g COD/g COD 0.15 0.25 0.20 0.15 
Maximum hydrolysis rate for XS1  khx 1/day 0.56 0.56 0.56 0.56 
Hydrolysis half saturation constant for 
XS1 
KXX g COD/g COD 0.05 0.05 0.05 0.05 
Maximum storage rate of PHA by XH kSTO 1/day 1.2 0 0 0 
Maximum growth rate on PHA for XH µ
’
STO 1/day 0.8 0.8 0.8 0 
Half saturation constant for storage of 
PHA by XH 
KSTO mg COD/L 0.5 0.5 0.5 0 
Yield coefficient of XH YH g COD/g COD 0.6 0.6 0.6 0.6 
Yield coefficient of PHA YSTO g COD/g COD 0.8 0.8 0.8 0.8 
Fraction of biomass converted to SP fES - 0.05 0.05 0.05 0.05 
Fraction of biomass converted to XP fEX - 0.15 0.15 0.15 0.15 
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Table 5.16 (continued): Effect of TET on kinetics of peptone-meat extract removal (SRT 10d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
State variables  Unit 
Control –  
SRT 10d 
Acute – 
TET200 
Acute – 
TET50 
Chronic –  
TET Day 30 
Total biomass  mgCOD/L 2010 2010 1980 2370 
Initial active biomass XH1 mg COD/L 1450 1500 1300 1150 
Activity
 
 % 72 75 66 48 
Initial amount of PHA XSTO1 mg COD/L 10 10 10 0 
Initial amount of biodegradable COD CS1 mg COD/L 600 600 600 720 
Initial amount of readily biodegradable 
COD 
SS1 mg COD/L 
57 57 57 68 
Initial amount of readily hydrolysable 
COD 
SH1 mg COD/L 
335 200 240 402 
Initial amount of hydrolysable COD XS1 mg COD/L 208 178 130 138 
Bound COD  mgCOD/L - 165 173 112 
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In addition to the acute inhibition studies, simulations of the chronic inhibition data 
revealed that exposed to 50 mg/L TET for 30 days, the half saturation constant of the 
substrate increases and the maximum growth rate of the microorganisms decreases. 
Moreover, the endogenous decay level increases under the effect of constant 
exposure. However, the endogenous decay rate, in contrast with chronic exposure to 
SMX does not increase further than in acute exposure simulations in the course of 
30 days of exposure to TET. Finally, simulation showed that the system utilized 
112 mgCOD/L less than given amount and it can also be seen that the hydrolysis 
mechanisms of both SH and XS remain unaffected under chronic exposure to TET 
(Table 5.16). (Figure 5.45 and Figure 5.46) 
 
Figure 5.45: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic TET50 SRT 10d Day30). 
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Figure 5.46: COD removal profile of peptone-meat extract biodegradation and 
simulation (Chronic TET50 SRT 10d Day30). 
5.7.2.2 SRT: 2 d 
Results of SRT 2d system simulation studies to determine the kinetic effect of TET 
on the biodegradation of peptone-meat extract showed that acute exposure to the 50 
mg/L and 200 mg/L concentrations of antibiotic has significant effects on the growth 
kinetics of the system, resulting in decreased maximum growth rate and increased 
half saturation constant of the biomass. Kinetics of both acute inhibition studies 
showed that substance significantly increases the half saturation constant and 
decreases the rate of SH hydrolysis, showing that TET additions adversely affected 
the SH hydrolysis mechanism. Moreover it has been observed that the XS hydrolysis 
rate was not significantly affected by acute inhibition of TET. Finally, it has been 
determined that the SRT 2d system utilizes 148 and 253 mgCOD/L less than given 
amount for TET50 and TET200 acute additions (Table 5.17). Additionally, in 
contrast to SRT 10d system, it has been observed that the endogenous decay level of 
the SRT 2d control system, which is due to its fast nature already double as much as 
the SRT 10d control system, does not increase under the effect of antibiotic 
substance. (Figure 5.47, Figure 5.48 and Figure 5.49) 
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Figure 5.47: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute TET200 SRT 2d). 
 
Figure 5.48: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute TET50 SRT 2d). 
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Table 5.17: Effect of TET on kinetics of peptone-meat extract removal (SRT 2d). 
 
 
Model Parameter  Unit 
Control – SRT 
2d 
Acute – 
TET200 
Acute –  
TET50 
Chronic – 
TET50 Day 2 
Maximum growth rate for XH µ
’
H 1/day 7.2 4.6 4.6 6.5 
Half saturation constant for growth of XH KS mg COD/L 30 33 33 30 
Endogenous decay rate for XH and bH 1/day 0.2 0.2 0.2 0.2 
Heterotrophic half saturation coefficient 
for oxygen 
KOH mg O2/L 0.01 0.01 0.01 0.01 
Maximum hydrolysis rate for SH1 kh 1/day 4 0.68 3.37 4.4 
Hydrolysis half saturation constant for 
SH1 
KX g COD/g COD 0.15 0.5 0.45 0.15 
Maximum hydrolysis rate for XS1  khx 1/day 1 1 0.7 1.37 
Hydrolysis half saturation constant for 
XS1 
KXX g COD/g COD 0.05 0.05 0.05 0.05 
Maximum storage rate of PHA by XH kSTO 1/day 0 0 0 0 
Maximum growth rate on PHA for XH µ
’
STO 1/day 0 0 0 0 
Half saturation constant for storage of 
PHA by XH 
KSTO mg COD/L 0 0 0 0 
Yield coefficient of XH YH g COD/g COD 0.60 0.60 0.60 0.60 
Yield coefficient of PHA YSTO g COD/g COD 0 0 0 0 
Fraction of biomass converted to SP fES - 0.05 0.05 0.05 0.05 
Fraction of biomass converted to XP fEX - 0.15 0.15 0.15 0.15 
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Table 5.17 (continued): Effect of TET on kinetics of peptone-meat extract removal (SRT 2d). 
 
 
 
 
State variables  Unit 
Control –  
SRT 2d 
Acute – 
TET200 
Acute –  
TET50 
Chronic – 
TET50 Day 2 
Total biomass  mgCOD/L 809 809 710 405 
Initial active biomass XH1 mg COD/L 630 433 380 315 
Activity
 
 % 78 53 54 78 
Initial amount of PHA XSTO1 mg COD/L 0 0 0 0 
Initial amount of biodegradable COD CS1 mg COD/L 760 720 720 720 
Initial amount of readily biodegradable 
COD 
SS1 mg COD/L 
72 68 68 68 
Initial amount of readily hydrolysable 
COD 
SH1 mg COD/L 
424 149 254 384 
Initial amount of hydrolysable COD XS1 mg COD/L 264 250 250 244 
Bound COD  mgCOD/L - 253 148 24 
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Figure 5.49: COD removal profile of peptone-meat extract biodegradation and 
simulation (Top: Acute TET200 SRT 2d; Bottom: Acute TET50 SRT 2d). 
In addition to the acute inhibition studies, simulations of the chronic inhibition data 
revealed that chronic exposure to 50 mg/L TET for 2 days decreased the maximum 
growth rate of the biomass. However, under the effect of constant exposure the 
endogenous decay level does not increase further compared to control system. 
Simulations showed that the biomass consortia formed under the constant exposure 
to TET was able to degrade both hydrolysable COD fractions with higher rates than 
the control system. Finally, simulation showed that the system utilized 24 mgCOD/L 
less than given amount (Table 5.17). (Figure 5.50 and Figure 5.51) 
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Figure 5.50: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic TET50 SRT 2d Day2). 
 
Figure 5.51: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic TET50 SRT 2d Day2). 
5.7.3 Erythromycin simulations  
5.7.3.1 SRT: 10 d 
Results of simulation studies to determine the kinetic effect of ERY on the 
biodegradation of peptone-meat extract showed the antibiotic inhibits the PHA 
storage of the SRT 10d system (Table 5.18). Kinetics of acute inhibition studies 
0
5
10
15
20
25
30
35
40
45
50
-0,02 0,08 0,18 0,28 0,38 0,48 0,58
O
U
R
 (
m
g/
L.
h
)
Time (d)
OUR Data (T-2-Day2)
Model Simulation of
Heterotrophic Growth
0
100
200
300
400
500
600
700
800
900
-0,02 0,18 0,38 0,58 0,78 0,98
C
O
D
 (
m
g/
L)
Time (d)
COD Data (T-2-Day2)
Model Simulation of C_S
Model Simulation of S_S
Model Simulation of S_H
Model Simulation of X_S
Model Simulation of S_P
120 
 
showed that the system maintained to ability to grow on already stored PHA. 
Moreover it was shown that ERY did not affect the maximum growth rate of the 
system but increased the half saturation constant of the substrate, making it less 
available for the biomass. The system also demonstrated that with increasing 
antibiotic concentration half saturation constant of SH hydrolysis increased. 
Additionally, acute addition of ERY did not affect kinetics of XS hydrolysis. Finally, 
it has been determined that the system utilizes not all the COD given, but 313 and 
443 mgCOD/L less than given amount for ERY50 and ERY200 acute additions. 
Additionally, it has been demonstrated that with the addition of the antibiotic 
substance the endogenous decay level of the system increased from 0.1d
-1
 in the 
SRT10d system to 0.20d
-1
 with 50 mg/L ERY addition and to 0.24d
-1
 with 200 mg/L 
ERY addition. (Figure 5.52, Figure 5.53 and Figure 5.54) 
 
Figure 5.52: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute ERY200 SRT 10d). 
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Figure 5.53: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute ERY50 SRT 10d). 
 
Figure 5.54: COD removal profile of peptone-meat extract biodegradation and 
simulation (Top: Acute ERY200 SRT 10d; Bottom: Acute ERY50 SRT 10d). 
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Table 5.18: Effect of ERY on kinetics of peptone-meat extract removal (SRT 10d). 
Model Parameter  Unit 
Control –  
SRT 10d 
Acute –  
ERY200 
Acute – 
ERY50 
Chronic –  
ERY Day 31 
Chronic – 
ERY Day 50 
Maximum growth rate for XH µ
’
H 1/day 5.2 5.2 5.2 4.2 5.2 
Half saturation constant for growth of 
XH 
KS mg COD/L 24 30 30 30 32 
Endogenous decay rate for XH and bH 1/day 0.1 0.24 0.20 0.23 0.15 
Heterotrophic half saturation 
coefficient for oxygen 
KOH mg O2/L 0.01 0.01 0.01 0.01 0.01 
Maximum hydrolysis rate for SH1 kh 1/day 5.2 5.2 5.2 2.16 2.22 
Hydrolysis half saturation constant for 
SH1 
KX g COD/g COD 0.15 0.28 0.22 0.05 0.15 
Maximum hydrolysis rate for XS1  khx 1/day 0.56 0.56 0.56 0.58 0.56 
Hydrolysis half saturation constant for 
XS1 
KXX g COD/g COD 0.05 0.05 0.02 0.05 0.05 
Maximum storage rate of PHA by XH kSTO 1/day 1.2 0 0 0 0 
Maximum growth rate on PHA for XH µ
’
STO 1/day 0.8 0.8 0.8 0 0 
Half saturation constant for storage of 
PHA by XH 
KSTO mg COD/L 0.5 0.5 0.5 0 0 
Yield coefficient of XH YH g COD/g COD 0.6 0.6 0.6 0.6 0.6 
Yield coefficient of PHA YSTO g COD/g COD 0.8 0.8 0.8 0.8 0.8 
Fraction of biomass converted to SP fES - 0.05 0.05 0.05 0.05 0.05 
Fraction of biomass converted to XP fEX - 0.15 0.15 0.15 0.15 0.15 
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Table 5.18 (continued): Effect of ERY on kinetics of peptone-meat extract removal (SRT 10d). 
 
 
 
 
 
 
State variables  Unit 
Control –  
SRT 10d 
Acute –  
ERY200 
Acute – 
ERY50 
Chronic –  
ERY Day 31 
Chronic – ERY 
Day 50 
Total biomass  mgCOD/L 2010 2037 2010 1666 1633 
Initial active biomass XH1 mg COD/L 1450 1350 1400 1000 1016 
Activity
 
 % 72 66 70 60 62 
Initial amount of PHA XSTO1 mg COD/L 10 10 10 0 0 
Initial amount of 
biodegradable COD 
CS1 mg COD/L 
600 600 600 720 720 
Initial amount of readily 
biodegradable COD 
SS1 mg COD/L 
57 35 23 30 34 
Initial amount of readily 
hydrolysable COD 
SH1 mg COD/L 
335 77 164 353 300 
Initial amount of 
hydrolysable COD 
XS1 mg COD/L 
208 45 100 206 206 
Bound COD  mgCOD/L - 443 313 131 180 
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Simulations of chronic inhibition data revealed that exposed to 50 mg/L ERY for 31 
days, the maximum growth rate of the microorganisms decreased (Table 5.18). 
However the half saturation constant of the substrate remained at 30 mg/L as in acute 
experiments. Moreover, the endogenous decay level increased to 0.23 d
-1
 under the 
effect of constant exposure. Finally, simulation showed that the system utilized 
131mgCOD/L less than given amount and it can also be seen that both the rate and 
the half saturation constant of hydrolysis for SH decreased, which coincides with the 
effect of uncompetitive inhibition. However, hydrolysis mechanism of XS was not 
significantly affected under the effect of ERY50. (Figure 5.55 and Figure 5.56) 
 
Figure 5.55: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic ERY50 SRT 10d Day31). 
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Figure 5.56: COD removal profile of peptone-meat extract biodegradation and 
simulation (Chronic ERY50 SRT 10d Day31). 
After 30 days of exposure to 50 mg/L ERY, the system was not fed with the 
antibiotic for 20 days, but only fed with peptone-meat extract mixture. On the 50
th
 
day 50 mg/L ERY was added to the system again and it has been observed that the 
system responded with a decrease in hydrolysis rate of SH. The maximum growth 
rate increased to the unaffected level, while the half saturation constant of the 
substrate remained increased (Table 5.18). Moreover, it has been observed that the 
XS hydrolysis mechanism remain unaffected. Finally, the endogenous decay rate of 
the biomass increased to 0.15 d
-1
 for the 50
th
 day, indicating that discontinuance of 
20 days in ERY feeding resulted in recovery of the biomass. Moreover the system 
again utilized 180 mgCOD/L less substrate that given to the system. (Figure 5.57 and 
Figure 5.58) 
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Figure 5.57: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic ERY50 SRT 10d Day50). 
 
Figure 5.58: COD removal profile of peptone-meat extract biodegradation and 
simulation (Chronic ERY50 SRT 10d Day50). 
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5.7.3.2 SRT: 2 d 
Results of SRT 2d system simulation studies to determine the kinetic effect of ERY 
on the biodegradation of peptone-meat extract showed acute exposure to the 
antibiotic does not affect the growth kinetics of the system, resulting unchanged 
maximum growth rate and half saturation constant of the biomass (Table 5.19). 
Kinetics of 50 mg/L ERY acute inhibition study showed that substance has a 
negative effect on the hydrolysis of SH fraction of the peptone-meat extract mixture, 
where it decreases the rate of SH hydrolysis substantially. Moreover kinetics of XS 
hydrolysis is also affected by acute 50 mg/L ERY addition, which is seen as a small 
decrease of the hydrolysis rate of XS fraction of the substrate. Finally, it has been 
determined that the SRT 2d system utilizes 420 mgCOD/L less than given amount 
for ERY50 acute additions. Moreover, the endogenous decay level increases 
significantly to 0.4 d
-1
 under the exposure of ERY. (Figure 5.59 and Figure 5.60) 
 
Figure 5.59: OUR simulation of peptone-meat extract biodegradation and simulation 
(Acute ERY50 SRT 2d). 
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Figure 5.60: COD removal profile of peptone-meat extract biodegradation and 
simulation (Acute ERY50 SRT 2d). 
Simulations of the chronic inhibition data revealed that exposed to 50 mg/L ERY for 
3 days, the maximum growth rate of the microorganisms decreased significantly, 
affecting growth of microbial biomass. Moreover, it has been seen that hydrolysis of 
SH was affected by the chronic exposure to ERY, where the half saturation constant 
increased substantially and the hydrolysis rate decreased. Moreover, the endogenous 
decay level increases significantly under chronic exposure to ERY. Moreover as in 
the ERY acute simulations, kinetics of XS hydrolysis was affected by chronic 
exposure to 50 mg/L ERY, which is again seen as a small decrease of the hydrolysis 
rate of XS fraction of the substrate. Finally, consistent with the stoichiometric 
calculations the model simulation showed that the system utilized 175 mgCOD/L 
less than given amount (Table 5.19). (Figure 5.61 and Figure 5.62) 
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Table 5.19: Effect of ERY on kinetics of peptone-meat extract removal (SRT 2d). 
 
 
 
 
 
Model Parameter  Unit 
Control –  
SRT 2d 
Acute –  
ERY50 
Chronic –  
ERY50 Day 3 
Maximum growth rate for XH µ
’
H 1/day 7.2 7.2 2.5 
Half saturation constant for growth of XH KS mg COD/L 30 30 30 
Endogenous decay rate for XH and bH 1/day 0.2 0.4 0.35 
Heterotrophic half saturation coefficient for 
oxygen 
KOH mg O2/L 0.01 0.01 0.01 
Maximum hydrolysis rate for SH1 kh 1/day 4 1.56 3.6 
Hydrolysis half saturation constant for SH1 KX g COD/g COD 0.15 0.15 0.3 
Maximum hydrolysis rate for XS1  khx 1/day 1 0.70 0.84 
Hydrolysis half saturation constant for XS1 KXX g COD/g COD 0.05 0.05 0.05 
Maximum storage rate of PHA by XH kSTO 1/day 0 0 0 
Maximum growth rate on PHA for XH µ
’
STO 1/day 0 0 0 
Half saturation constant for storage of PHA by 
XH 
KSTO mg COD/L 0 0 0 
Yield coefficient of XH YH g COD/g COD 0.6 0.6 0.6 
Yield coefficient of PHA YSTO g COD/g COD 0 0 0 
Fraction of biomass converted to SP fES - 0.05 0.05 0.05 
Fraction of biomass converted to XP fEX - 0.15 0.15 0.15 
130 
 
Table 5.19 (continued): Effect of ERY on kinetics of peptone-meat extract removal (SRT 2d). 
 
 
 
State variables  Unit 
Control –  
SRT 2d 
Acute –  
ERY50 
Chronic –  
ERY50 Day 3 
Total biomass  mgCOD/L 809 809 888 
Initial active biomass XH1 mg COD/L 630 540 600 
Activity
 
 % 78 67 68 
Initial amount of PHA XSTO1 mg COD/L 0 0 0 
Initial amount of biodegradable COD CS1 mg COD/L 760 720 720 
Initial amount of readily biodegradable COD SS1 mg COD/L 72 50 50 
Initial amount of readily hydrolysable COD SH1 mg COD/L 424 105 330 
Initial amount of hydrolysable COD XS1 mg COD/L 264 155 165 
Bound COD  mgCOD/L - 420 175 
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Figure 5.61: OUR simulation of peptone-meat extract biodegradation and simulation 
(Chronic ERY50 SRT 2d Day3). 
 
Figure 5.62: COD removal profile of peptone-meat extract biodegradation and 
simulation (Chronic ERY50 SRT 2d Day3). 
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5.8 Microbial Community Analysis 
5.8.1 Antibiotic resistance analysis 
5.8.1.1 Control of DNA extraction method 
In order to determine the most effective DNA extraction method to be used for 
activated sludge samples 23Ins PCR has been applied to different DNA extraction 
methods applied on samples.  
This reaction is reported to amplify the 270 and/or 380 bp fragment of Domain III of 
23S rRNA. Therefore it was expected to locate 3 bands on the agarose gel. (Yu et al. 
2002; Roller et al. 1992). As can be seen in Figure 5.63, each methods lane contains 
3 bands. Top two bands correspond to 270 ad 380 bp sizes, whereas the lower band 
has the size 100 bp, the size of the fragment to be inserted in the 23S ribosomal RNA 
gene. The non-inserted potion is seen as a third band on the gel.  
Comparing the three DNA extraction methods, it can be seen that Macherey-Nagel 
(MN) DNA extraction Kit gave the best results on activated sludge sample. 
Therefore it has been decided to continue the studies with the MN Kit.  
        1   2        3         4        5  
 
Top Lanes: 1) Marker, 2) Positive Control, 3) MN DNA, 4) Method 2 DNA, 5) Method 3 DNA 
Lower Lanes: 1) Marker, 2) MN (-) Control, 3) Method 2 (-) Control, 4) Method 3 (-) Control 
Figure 5.63: Control of gram-positive bacteria. 
380 
bp 
270 
bp 
100 
bp 
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DNA from all activated sludge samples collected from chronic exposure experiments 
have been extracted using the MN Kit. Obtained DNA was measured by NanoDrop 
spectrometer. Results are given in Table 5.20.  
Table 5.20: Obtained DNA concentrations. 
Sample DNA Concentration [ng/µl] Sludge Amount [mg] 
Control-10 477.1 250 
S10-24 100.9 
25 
S10-30 45.8 
T10-10 80.6 
25 
T10-22 135.8 
T10-30 69.8 
T10-50 21.8 
E10-10 192.1 
25 
E10-31 176 
Control-2 108.6 25 
S2-2 185.4 
25 S2-4 77.5 
S2-7 83.8 
T2-2 37.8 25 
T2-4 18.2 13 
T2-7 Inadequate amount of sludge 
E2-3 4.1 63 (watery) 
E2-10 29.3 57 (watery) 
5.8.1.2 Resistance to sulfonamides 
PCR experiments have been run to determine the presence of sulI and sulII resistance 
genes in the genomic DNA extracted from activated sludge samples taken from SMX 
fed reactors. However the experiments also showed that the system did not contain 
sulIII resistance gene. The results have shown that all the activated sludge samples 
including the control sample contains resistance genes against SMX antibiotic. 
Obtained results are summarized in Figure 5.64 and Table 5.21. 
Table 5.21: Results of qualitative determination of SMX resistance genes. 
Sample sulI sulII sulIII 
Positive Control + + - 
Control-2 + + - 
S2-2 + + - 
S2-4 + + - 
S2-7 + + - 
Control-10 + + - 
S10-24 + + - 
S10-30 + + - 
NTC - - - 
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        1   2   3  4   5   6   7  8   9  10 11 12 13 
 
Top Lanes (sulI) ve Lower Lanes (sulII) 1) Marker, 2) Positive Control, 3) Ɵ10 Control, 4) S10 – 24, 5) S10 – 30, 
6) Ɵ2 Control, 7) S2 – 2, 8) S2 – 4, 9) S2 – 8, 10) Ɵ10 Control (-), 11) Ɵ2 Control (-), 12) S2+S10 Control (-), 13) NTC 
Figure 5.64: Qualitative determination of sulI and sulII genes. 
5.8.1.3 Resistance to tetracyclines 
PCR experiments have been run to determine the presence of tet A, B, C, D, E, G, K, 
L, M, O and otrB resistance genes in the genomic DNA extracted from activated 
sludge samples taken from TET fed reactors. The results showed that both systems 
did not contain any tet B, D, K, L and otrB resistance genes. Both control samples 
were positive for tetA and tetG. Moreover, tetA and tetG genes were present in all 
samples taken from chronic reactors. However, in the cases of tet C, M and O, they 
were only found in SRT 10d control reactor. Moreover SRT 2d control sample did 
not contain any tetC, tetE and tetM. Even though the system developed tetC and tetE 
resistances in time, the amount of genes present in the control system (SRT2d) was 
under detection limits. However SRT 2d chronic reactor did not contain any tetM 
resistance gene. The results are given in Table 5.22 and gel photos of qualitative 
determination of tet resistance genes are given in Figure 5.65 to Figure 5.70.  
Additionally, after 30 days of chronic exposure to TET, feeding of antibiotic was 
stopped for 20 days and on the 50
th
 day system was fed with TET again, which was 
also analyzed for its resistance profile. The results revieled that the resistance profile 
did not change during intermittent feeding of TET to the reactor. 
 
 
Sul 1 
Sul 2 
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Table 5.22: Results of qualitative determination of TET resistance genes. 
Sample A B C D E G  K L otrB M O 
Positive Control + + - + - - + + + + - 
Control-2 + - - - - + - - - - - 
T2-2 + - + - + + - - - - + 
T2-4 + - + - + + - - - - + 
Control-10 + - + - - + - - - + + 
T10-10 + - + - + + - - - + + 
T10-22 + - + - - + - - - + + 
T10-30 + - + - - + - - - + + 
T10-50 + - + - - + - - - + + 
NTC - - - - - - - - - - - 
    
  1   2    3   4   5   6   7   8   9  10 11  12     
 
Lanes: 1: Marker, 2: Posivite Control, 3: Control (SRT 2d), 4: Chronic Feeding – Day 2 (SRT 2d), 5: Chronic Feeding – Day 4 
(SRT 2d), 6: Control (SRT 10d), 7: Chronic Feeding – Day 10 (SRT 10d), 8: Chronic Feeding – Day 22 (SRT 10d), 9: Chronic 
Feeding – Day 30 (SRT 10d), 10: Chronic Feeding – Negative Control (SRT 2d), 11: Chronic Feeding – Negative Control (SRT 
10d), 12:  NTC 
Figure 5.65: Qualitative determination of tetA gene. 
   1       2         3   4    5    6   7    8    9   10  11 
 
Lanes: 1: Marker, 2: Control (SRT 2d), 3: Chronic Feeding – Day 2 (SRT 2d), 4: Chronic Feeding – Day 4 (SRT 2d), 5: 
Control (SRT 10d), 6: Chronic Feeding – Day 10 (SRT 10d), 7: Chronic Feeding – Day 22 (SRT 10d), 8: Chronic Feeding – 
Day 30 (SRT 10d), 9: Chronic Feeding – Negative Control (SRT 2d), 10: Chronic Feeding – Negative Control (SRT 10d), 11:  
NTC 
Figure 5.66: Qualitative determination of tetC gene. 
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   1    2   3    4    5   6    7   8   9 
 
Lanes: 1: Marker, 2: Control (SRT 2d), 3: Chronic Feeding – Day 2 (SRT 2d), 4: Chronic Feeding – Day 4 (SRT 2d), 5: 
Control (SRT 10d), 6: Chronic Feeding – Day 10 (SRT 10d), 7: Chronic Feeding – Day 22 (SRT 10d), 8: Chronic Feeding – 
Day 30 (SRT 10d), 9:  NTC 
Figure 5.67: Qualitative determination of tetE gene. 
    1    2    3   4    5   6    7   8    9 
 
Lanes: 1: Marker, 2: Control (SRT 2d), 3: Chronic Feeding – Day 2 (SRT 2d), 4: Chronic Feeding – Day 4 (SRT 2d), 5: 
Control (SRT 10d), 6: Chronic Feeding – Day 10 (SRT 10d), 7: Chronic Feeding – Day 22 (SRT 10d), 8: Chronic Feeding – 
Day 30 (SRT 10d), 9:  NTC  
Figure 5.68: Qualitative determination of tetG gene. 
 
      1   2   3   4    5   6    7   8    9  10  
 
Lanes: 1: Marker, 2: Psitive Control , 3: Control (SRT 2d), 4: Chronic Feeding – Day 2 (SRT 2d), 5: Chronic Feeding – Day 4 
(SRT 2d), 6: Control (SRT 10d), 7: Chronic Feeding – Day 10 (SRT 10d), 8: Chronic Feeding – Day 22 (SRT 10d), 9: Chronic 
Feeding – Day 30 (SRT 10d), 10:  NTC 
Figure 5.69: Qualitative determination of tetM gene. 
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   1    2   3    4   5   6    7    8   9  10  
 
Lanes: 1: Marker, 2: Control (SRT 2d), 3: Chronic Feeding – Day 2 (SRT 2d), 4: Chronic Feeding – Day 4 (SRT 2d), 5: 
Control (SRT 10d), 6: Chronic Feeding – Day 10 (SRT 10d), 7: Chronic Feeding – Day 22 (SRT 10d), 8: Chronic Feeding – 
Day 30 (SRT 10d), 9:  NTC 
Figure 5.70: Qualitative determination of tetO gene. 
5.8.1.4 Resistance to macrolides 
PCR experiments have been run to determine the presence of erm A, B, C and msrA 
resistance genes in the genomic DNA extracted from activated sludge samples taken 
from ERY fed reactors. The results showed that none of the activated sludge samples 
including the control sample contained rRNA-methlylase type resistance genes 
against ERY antibiotic. During 3 sludge ages of time, in which the system has been 
exposed to the antibiotic substance resistance in the form of RNA methylase did not 
occur. Initial studies on mphA gene did not give positive results on the occurrence of 
mphA in the control samples. However, since its occurrence is found in the chronic 
samples, the experiment has been repeated for control samples, where C-2 was still 
negative for mphA, applying two different concentrations of C-10 sample DNA (1ng 
and 10ng) resulted in positive results. This result showed that the control sample (C-
10) is also positive for mphA, and applying higher concentration of DNA showed 
that the amount of mphA in the control sample was under detection limits.  
Therefore, it can be said that the system harbours enzyme inactivating phosphorylase 
gene mphA. The results are given in Table 5.23 and gel photos of qualitative 
determination of erm A, B, C, msrA and mphA genes are given in Figure 5.71 to 
Figure 5.76.  
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Table 5.23: Results of qualitative determination of ERY resistance genes. 
Sample ermA ermB ermC msrA 
16S 
Internal 
Control 
mphA 
Positive Control + + + + + - 
Control-2 - - - - + - 
E2-3 - - - - + + 
E2-10 - - - - + + 
Control-10 - - - - + + 
E10-10 - - - - + + 
E10-31 - - - - + + 
NTC - - - - + - 
 
             1     2    3    4     5     6     7    8     9   10  11   12   13 
 
Lanes: 1: Marker, 2: Positive Control, 3: Chronic Feeding – Day 3 (SRT 2d), 4: Chronic Feeding – Day 10 (SRT 2d), 5: Chronic Feeding – Day 
10 (SRT 10d), 6: Chronic Feeding – Day 31 (SRT 10d), 7: Control (SRT 2d), 8: Control (SRT 10d), 9: Chronic Feeding – Negative Control (SRT 
2d), 10: Chronic Feeding – Negative Control (SRT 10d), 11: Control – Negative Control (SRT 2d), 12: Control  – Negative Control (SRT 10d), 
13: NTC 
Figure 5.71: Qualitative determination of ermA gene. 
  1     2    3    4    5    6    7     8    9   10  11  12   13 
 
Lanes: 1: Marker, 2: Positive Control, 3: Chronic Feeding – Day 3 (SRT 2d), 4: Chronic Feeding – Day 10 (SRT 2d), 5: Chronic Feeding – Day 
10 (SRT 10d), 6: Chronic Feeding – Day 31 (SRT 10d), 7: Control (SRT 2d), 8: Control (SRT 10d),  9: Chronic Feeding – Negative Control (SRT 
2d), 10: Chronic Feeding – Negative Control (SRT 10d), ), 11: Control – Negative Control (SRT 2d), 12: Control  – Negative Control (SRT 10d), 
13: NTC 
Figure 5.72: Qualitative determination of ermB gene. 
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        1     2    3     4     5    6    7     8     9   10   11  12  13 
 
Lanes: 1: Marker, 2: Positive Control, 3: Chronic Feeding – Day 3 (SRT 2d), 4: Chronic Feeding – Day 10 (SRT 2d), 5: Chronic Feeding – Day 
10 (SRT 10d), 6: Chronic Feeding – Day 31 (SRT 10d), 7: Control (SRT 2d), 8: Control (SRT 10d), 9: Chronic Feeding – Negative Control (SRT 
2d), 10: Chronic Feeding – Negative Control (SRT 10d), ), 11: Control – Negative Control (SRT 2d), 12: Control  – Negative Control (SRT 10d), 
13: NTC 
Figure 5.73: Qualitative determination of ermC gene. 
1    2     3    4     5   6     7     8    9   10   11   12   13 
 
Lanes: 1: Marker, 2: Positive Control, 3: Chronic Feeding – Day 3 (SRT 2d), 4: Chronic Feeding – Day 10 (SRT 2d), 5: Chronic Feeding – Day 
10 (SRT 10d), 6: Chronic Feeding – Day 31 (SRT 10d), 7: Control (SRT 2d), 8: Control (SRT 10d),  9: Chronic Feeding – Negative Control (SRT 
2d), 10: Chronic Feeding – Negative Control (SRT 10d), ), 11: Control – Negative Control (SRT 2d), 12: Control  – Negative Control (SRT 10d), 
13: NTC 
Figure 5.74: Qualitative determination of msrA gene. 
               1     2     3      4     5      6    7     8     
 
Lanes: 1: Marker, 2: Control (SRT 2d), 3: Chronic Feeding – Day 3 (SRT 2d), 4: Chronic Feeding – Day 10 (SRT 2d), 5: 
Control (SRT 10d), 6: Chronic Feeding – Day 10 (SRT 10d), 7: Chronic Feeding – Day 31 (SRT 10d), 8: NTC 
Figure 5.75: Qualitative determination of mphA gene. 
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          1          2             3         4 
 
Lanes: 1: Marker, 2: Control (SRT 10d) 10ng , 3:  Control (SRT 10d) 1ng  (SRT 10d), 4: NTC 
Figure 5.76: Determination of mphA gene in the control SRT 10d system (repeat). 
5.8.2 454-pyrosequencing 
Pyrosequencing was performed in order to determine the effect of antibiotic 
substances on the microbial biomass composition of activated sludge samples. Total 
number of 119955 sequences was obtained. Sequences were cleaned-up and grouped 
amongst each other. Each sample resulted with different amount of sequences, which 
are given in Table 5.24. 
Table 5.24: Number of sequences in each sample after clean-up. 
Sample Name 
Sample Name 
Abbreviation 
Number of Sequences 
Control SRT10d C-10 2977 
SMX SRT10d Day 24 S-10-24 3118 
SMX SRT10d Day 30 S-10-30 2752 
TET SRT10d Day 10 T-10-10 1098 
TET SRT10d Day 30 T-10-30 1695 
ERY SRT10d Day 10 E-10-10 3865 
ERY SRT10d Day 31 E-10-31 1239 
Control SRT2d C-2 1759 
SMX SRT2d Day 2 S-2-2 728 
SMX SRT2d Day 4 S-2-4 4882 
SMX SRT2d Day 7 S-2-7 3616 
TET SRT2d Day 2 T-2-2 6552 
TET SRT2d Day 4 T-2-4 3555 
ERY SRT2d Day 3 E-2-3 4257 
ERY SRT2d Day 10 E-2-10 1744 
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5.8.2.1 Community structure of control samples 
Sludge Age 10d System 
Based on the classification of sequence reads by RDP classifier, the SRT 10day 
control system consists of five phyla namely Actinobacteria (59%), Proteobacteria 
(24%), Bacteroidetes (15%), TM7(1%) and an unclassified phylum (1%) (Figure 
5.77). For the downstream analysis sequences were grouped in species (3%) and 
phyla (20%) level OTUs.  
Most abundant species level OTU in SRT 10d control sample were related to family 
Intrasporangiaceae (Actinobacteria) and Chitinophagaceae (Bacteriodetes) with 
45% and 10% abundances respectively.  
Sludge Age 2d System 
Bacterial community in SRT 2d system was distributed in five phyla; Proteobacteria 
(57%), Actinobacteria (22%), Deinococcus-Thermus (18%) and Bacteroidetes (3%) 
phyla. Most abundant OTUs in the SRT 2d control sample was bacteria belonging to 
Paracoccus genus of class Alphaproteobacteria (47%), Deinococcus genus of 
phylum Deinococcus-Thermus (18%), Arthrobacter genus of phylum Actinobacteria 
(10%) and an unclassified bacterium belonging to phylum Actinobacteria (9%) 
(Figure 5.77).  
Differences observed between SRT 10d and SRT 2d control samples enlighten the 
effect of sludge age on the bacterial community structure. Both systems differ only in 
sludge age, while the feeding substrate and inoculum are same. Sludge age is 
considered to be a selection criterion for slow growing bacteria that can easily 
survive in a slow growing system like SRT 10d, where after every 10 days the 
bacterial community regenerates itself through sludge waste. However, the system 
with sludge age of 2d regenerates itself after every 2 days; in such system only 
rapidly growing bacteria can survive because of high regeneration pressure.  
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Figure 5.77: Distribution of phyla in control samples. 
Analysis of microbial communities indicates that in the SRT 2d system, 
Proteobacteria are dominant; while in the SRT 10d system Actinobacteria is the 
dominant group. Actinobacteria are known to be slow growing bacteria (Rosetti et al, 
2005, Seviour et al, 2008), and are fit to survive in a fast growing system but not to 
dominate the community. Additionally, it has been stated that filamentous members 
like Haliscomenobacter hydrossis of Bacteroidetes phylum were identified in 
activated sludge (Wagner et al., 1994, Kampfer, 1995, Eikelboom, 2002, Jenkins et 
al., 2004, Kragelund et al., 2008). Since it is known that filamentous bacteria grow 
slower than flock forming bacteria in non-substrate limiting conditions as it is in all 
the reactors (Seviour and Blackall, 1998, Jonsson, 2005), this may be a reason that 
members of phyla Bacteroidetes and Actinobacteria have a significantly lower 
abundance in the SRT 2d system.  
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5.8.2.2 Effect of sulfamethoxazole on the community structure 
Sludge age 10 d system 
At the phylum level constant exposure to SMX did not show a shift in community 
structure. However after 24 days of exposure the abundance of Actinobacteria 
phylum in C-10 sample changed from 59% to 64% and after 30 days of exposure 
their abundance was 59%. Phylum Proteobacteria had 19% abundance in C-10 
sample, whereas after 24 days their abundance remained 19% and after 30 days 
increased to 26%. Moreover, abundance of Bacteroidetes phylum changed from 15% 
in C-10 to 8% and 9% after 24 and 30 days, respectively. Additionally, TM7 phylum 
having the abundance of 1% in C-10 sample increased to 4% after 24 days. On the 
30th day TM7 phylum had the abundance of 3%. Figure 5.79 shows the change in 
distribution of phyla with increasing time of exposure to SMX.  
RDP library comparison showed that phylum Bacteriodetes significantly decreased 
throughout the treatment. Moreover, compared to C-10 sample on day 24 
Actinobacteria increased and Proteobacteria decreased significantly. However day 
30 did not show any significant changes in Actinobacteria and Proteobacteria phyla 
compared to C-10 sample (Figure 5.78).  
 
Figure 5.78: Significant changes in dominant phyla in the SMX reactor (*Bars with 
same letters are not significantly different). 
 
59%
24%
15%
64%
19%
8%
59%
26%
9%
Actinobacteria Proteobacteria Bacteroidetes
C-10 S-10-24 S-10-30
a
a
b
a
b
a
a
b b
144 
 
 
Figure 5.79: Bacterial community structures at phylum level for exposure to SMX. 
Rarefaction curves generated to determine the change in richness during SMX 
treatment showed that compared to untreated samples (C-10), 24 days treatment of 
SMX resulted in lower richness at phyla (20%). Rarefaction curves at species (3%) 
level showed that the richness of the S-10-24 sample is higher than the C-10 sample. 
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However after 30
th
 day treatment richness was almost similar to C-10 sample at 
species level (3%) and slightly higher at phyla level (20%) (Figure 5.80).  
 
Figure 5.80: Rarefaction curves for SMX samples at 3% and 20% distances. 
Both ACE and Chao1 estimators of richness suggest that the richness of the 
population changes with time. The information obtained from estimators suggests 
that richness increases by the 24
th
 day of exposure; however decreases slightly by the 
30
th
 day compared to the control sample (Table 5.25). Evenness calculated from 
Shannon’s index of diversity shows that all three samples exhibited dominant 
community structures at all levels. Further analysis also revealed that the dominance 
shifted with the effect of SMX (SRT10d) treatment.  
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Table 5.25: Statistical indicators for SMX feeding (SRT 10d). 
 
3% 20% 
C-10 S-10-24 S-10-30 C-10 S-10-24 S-10-30 
Number of OTUs 288 338 289 42 35 41 
Singleton 168 206 169 14 14 13 
Chao1 estimate of  
OTUs richness 
647.7 807.2 619.1 55.0 65.3 52.1 
ACE estimate of  
OTU richness 
1019.5 1278.6 1058.1 66.9 78.2 56.4 
Shannon index of  
diversity (H) 
3.0 3.6 3.6 1.6 1.5 1.6 
Evenness 0.53 0.62 0.63 0.41 0.41 0.43 
Good's estimator of  
coverage (%) 
41.67 39.05 41.52 66.67 60.00 68.29 
According to the information given in the Venn diagrams, at species level C-10 
contains 288 species, S-10-24 contains 338 species level OTUs and S-10-30 contains 
289 species level OTUs. However groups C-10 and S-10-24 exclusively share 34 
species level OTUs, but 154 and 159 species level OTUs belong to each of these 
groups alone, respectively. Moreover C-10 and S-10-24 exclusively share 20 and 63 
species level OTUs with S-10-30, whereas S-10-30 has 124 unshared species level 
OTUs. Additionally, 82 species level OTUs are shared by all groups (total shared 
richness). Finally total richness of all groups together is calculated as 636 species 
level OTUs (Figure 5.81). 
 
Figure 5.81: Venn diagram of SMX samples at 0.03 distance. 
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At phylum level however, C-10 contains 42 phylum level OTUs, S-10-24 contains 
35 phylum level OTUs and S-10-30 contains 41 phylum level OTUs. However 
groups C-10 and S-10-24 exclusively share 3 phylum level OTUs, but 10 phylum 
level OTUs and 3 phylum level OTUs belong to each of these groups alone, 
respectively. Moreover C-10 and S-10-24 exclusively share 9 and 11 phylum level 
OTUs with S-10-30, whereas S-10-30 has 3 unshared phylum level OTUs. 
Additionally, 18 phylum level OTUs are shared by all three groups (total shared 
richness). Finally total richness of all groups together is calculated as 57 
(Figure 5.82). 
 
Figure 5.82: Venn diagram of SMX samples at 0.20 distance. 
Results of statistical analysis revealed the significantly affected OTUs under chronic 
SMX inhibited conditions at SRT 10d. It can be seen that OTU#6 (member of 
unclassified genus of class Actinobacteria) and OTU#10 (member of unclassified 
Chitinophagaceae) were most abundant species in the control sample C-10 (45% and 
10%).  However, after 24 days of SMX treatment OTU#10 disappeared and did not 
reappear throughout the whole treatment (p<0.05, q>0.05), and OTU#6 decreased 
from 45% to 28%, after 30 days it decreased until 9%. Moreover, later in the 
treatment with SMX the microbial population shows further changes, that is bacteria 
that are very low abundant in the control sample increase significantly. Species of 
genus Arthrobacter OTU#2 becomes gradually abundant resulting in 24% at 30
th
 day 
of treatment (Table 5.26). 
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Table 5.26: Significant changes in the activated sludge population under SMX effect 
(SRT10d) (species level OTUs are named by numbers). 
Phylum 
Nearest  
Classified  
Neighbour 
OTU  
Number 
C-10  
(%) 
S-10-24  
(%) 
S-10-30  
(%) 
Actinobacteria Arthrobacter 2 0 2 24 
Actinobacteria Unclassified  
Intrasporangiaceae 
6 45 28 9 
Bacteroidetes Unclassified  
Chitinophagaceae 
10 10 0 0 
Sludge age 2 d system 
At the phylum level constant exposure to SMX (SRT 2d) shows a significant shift in 
community structure. After 2 days of exposure the percentages of present phyla 
change from 57%, 22%, 18% and 3% in the C-2 reactor to 17%, 65%, 14% and 4% 
for Proteobacteria, Actinobacteria, Deinococcus-Thermus and Bacteroidetes phyla, 
respectively, where dominance shifts from Proteobacteria to Deinococcus-Thermus 
phylum. Results obtained at the 4
th
 day show that the Bacteroidetes phylum 
disappears.  Moreover, at the end of treatment the community structure on phylum 
level was Proteobacteria (7%), Actinobacteria (35%) and Deinococcus-Thermus 
(58%). These results showed that Actinobacteria although fit to survive under 
constant exposure of SMX, are not capable of sustaining dominance in a fast 
growing system, which is also confirmed by the structural differences between SRT 
10d and SRT 2d control reactors. Figure 5.83 shows the change in distribution of 
phyla with increasing time of exposure to SMX (SRT 2d). Results revealed that 
members of phylum Bacteroidetes disappeared, Proteobacteria decreased 
significantly and Deinococcus-Thermus became dominant. 
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Figure 5.83: Bacterial community structures at phylum level for SMX (SRT2d) 
exposure.  
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RDP library comparison showed that phyla Proteobacteria and Bacteriodetes 
decreased significantly in time, whereas phylum Deinococcus-Thermus increased 
significantly. However, phylum Actinobacteria, showed first significant increase 
followed by significant decrease, resulting still significantly higher than that of C-2 
sample on the 7
th
 day of treatment (Figure 5.84). 
 
Figure 5.84: Significant changes in dominant phyla in the system (SMX SRT2d) 
(*Bars with same letters are not significantly different). 
On the 2
nd
 day of exposure information obtained from rarefaction curves showed that 
at both levels the richness of the systems is either equal or higher than that of C-2 
sample, but always higher than S-2-4 and S-2-7 samples. Rarefaction curve at 
species (3%) level shows that the richness of S-2-4 and S-2-7 samples are lower than 
C-2 sample, also that S-2-4 has higher richness than S-2-7. However on the phyla 
(20%) level S-2-7 exerts increased richness (Figure 5.85).  
Both non-parametric richness estimators, ACE and Chao1 suggest that the richness 
of the population changes with time. ACE estimator suggests that on species (3%) 
level the system shows first a decrease in richness followed by a constant increase. 
However, on the phyla level it slightly increases with time (Table 5.27). Information 
obtained from evenness calculated from Shannon’s diversity index shows that all 
four samples exhibited dominant community structures at both levels. Further 
analysis also revealed that the dominance shifted with the effect of SMX (SRT2d) 
treatment. 
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Figure 5.85: Rarefaction curves for SMX (SRT2d) samples at 3% and 20% 
distances. 
Table 5.27: Statistical indicators for SMX feeding (SRT 2d). 
 
3% 20% 
C-2 S-2-2 S-2-4 S-2-7 C-2 S-2-2 S-2-4 S-2-7 
Number of OTUs 69 46 105 82 13 13 15 15 
Singleton 36 27 43 44 3 3 4 5 
Chao1 estimate of  
OTUs richness 
139 222 143 168 14 16 17 18 
ACE estimate of  
OTU richness 
196 176 201 294 15 15 18 19 
Shannon index of  
diversity (H) 
1.9 2.1 2.2 2 1.2 1.3 1.2 0.96 
Evenness 0.45 0.56 0.47 0.37 0.45 0.49 0.43 0.35 
Good's estimator of  
coverage (%) 
47.83 41.30 59.05 46.34 76.92 76.92 73.33 66.67 
According to the information presented in Figure 5.86, at species level C-2 contains 
70 species level OTUs, S-2-2 contains 46 species level OTUs, S-2-4 contains 105 
species level OTUs, and S-2-7 contains 82 species level OTUs. However groups C-2 
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and S-2-2 exclusively share 2 species level OTUs, but 14 and 32 species level OTUs 
belong to each of these groups alone, respectively. Moreover C-2 and S-2-2 both 
exclusively share 4 species level OTUs with S-2-4, whereas S-2-4 has 48 unshared 
species level OTUs. S-2-7 has 33 unshared species level OTUs, but shares 3, 2 and 
17 species level OTUs exclusively with C-2, S-2-2 and S-2-4, respectively. C-2, S-2-
2 and S-2-7 don’t have common species level OTUs. However C-2, S-2-2 and S-2-4 
have 5 species level OTUs in common, whereas C-2, S-2-4 and S-2-7 have 8 species 
level OTUs in common. S-2-2, S-2-4 and S-2-7 share 4 species level OTUs. 
Additionally, 15 species level OTUs are shared by all four groups (total shared 
richness). Finally total richness of all groups together is calculated as 191 species 
level OTUs. 
 
Figure 5.86: Venn diagram of SMX (SRT2d) samples at 0.03 distance. 
At phylum level however, C-2 contains 12 phyla, S-2-2 contains 13 phylum level 
OTUs, S-2-4 contains 15 phylum level OTUs and S-2-7, 15 phylum level OTUs. 
However group C-2 does not share phylum level OTUs with S-2-2 and S-2-4. 
However three groups have 2 phyla in common and S-2-2 exclusively shares 1 
phylum with S-2-4. C-2, S-2-2 and S-2-4 have 2, 1 and 3 unshared phylum level 
OTUs, respectively.  S-2-7 has 3 unshared OTUs, but shares 1 phylum level OTU 
exclusively with each of the C-2, S-2-2 and S-2-4 groups. C-2, S-2-2 and S-2-7 don’t 
have common phylum level OTUs. However C-2, S-2-2 and S-2-7 have 1 phylum 
level OTU in common, likewise S-2-2, S-2-4 and S-2-7 also have 1 phylum level 
OTU in common. Additionally, 6 phylum level OTUs are common in all four groups 
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(total shared richness). Finally total richness of all groups together is calculated as 24 
phylum level OTUs (Figure 5.87). 
 
Figure 5.87: Venn diagram of SMX (SRT2d) samples at 0.20 distance. 
Results of statistical analysis revealed the significantly affected OTUs under chronic 
inhibited conditions (Table 5.28). It can be seen that OTU#3 (Paracoccus sp; 47%), 
OTU#1 (Deinococcus sp; 18%) and OTU#4 (Arthrobacter sp; 10%) were most 
abundant in the control sample. However, after 2 days of SMX (SRT2d) treatment, 
OTU#3 decreased significantly, whereas OTU#4 increased up to 39%. Although the 
abundance of OTU#4 decreased after the 4
th
 day of exposure, the statistical analysis 
suggests that this decrease was insignificant (q>0.05). After 7
th
 day of exposure, 
OTU#1 (Deinococcus sp) increased significantly and became the most abundant 
specie in this system. 
Table 5.28: Significant changes in the activated sludge population (SMX SRT2d) 
(species level OTUs are named by numbers). 
Phylum 
Nearest Classified 
Neighbour 
OTU 
Number 
C-2 
(%) 
S-2-2 
(%) 
S-2-4 
(%) 
S-2-7 
(%) 
Deinococcus-
Thermus 
Deinococcus 1 18 14 14 58 
Proteobacteria Paracoccus 3 47 2 6 4 
Actinobacteria Arthrobacter 4 10 39 36 14 
Literature indicates that the dominant bacteria in both SMX systems were resistant to 
the antibiotic. It has been demonstrated that the genes coding for sulfonamide 
resistance, especially the sul1 gene, are located on mobile genetic elements, like 
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plasmids, transposons and integrons, which are responsible for dissemination of the 
resistance markers.  One of the three known resistance genes to SMX, sul1, is known 
to be coded on the class1 integron (Liebert et al., 1999, Carattoli, 2001, Byrne-Bailey 
et al., 2009, Baran et al, 2011). Moreover, Arthrobacter sp., previously detected in 
activated sludge systems (Li et al., 2010), found abundantly in both SMX inhibited 
reactors, was shown to be positive for all three sul genes (Hoa et al., 2008). 
Additionally, Deinococcus sp, also previously isolated from activated sludge by Im 
et al. (2008), has become one of the most abundant species in SRT 2d system. It has 
also been determined that aerobic bacterium Deinococcus maricopensis DSM21211 
(Accession Nr: CP002454) possesses a gene coding for multidrug resistance protein 
of the major facilitator superfamily (MFS), which either accumulate nutrients by a 
cation-substrate symport mechanism or efflux substances like antibiotics (Ward et 
al., 2001). OTUs closely related to these members were also detected in studied 
SMX system.  
In the SRT 2d system, most of the OTUs from phyla Proteobacteria decreased, such 
as most abundant OTU#3 (Paracoccus sp) in control sample, which was not detected 
after 2 days, leading to the overgrowth of Actinobacteria. However Deinococcus sp 
became dominant after 7 days and outcompeted Actinobacteria.  
The information gathered in the literature on the resistance of dominant species in the 
SMX reactors is also coinciding with the data obtained from the resistance gene 
studies conducted on the reactors. Resistance gene studies revealed that the SMX 
systems possess both sulfonamide resistance genes sul1 and sul2, however does not 
contain sul3. 
5.8.2.3 Effect of tetracycline on the community structure 
Sludge age 10 d system 
At the phylum level constant exposure to TET (SRT10d) shows a shift in community 
structure with time. After 10 days of exposure the percentages of present phyla 
change from 59%, 24% and 15% in the C-10 reactor to 19%, 76%, 4% for 
Actinobacteria, Proteobacteria, and Bacteroidetes phyla, respectively, whereas 
phylum TM7 disappeared completely. At the end of the treatment (30
th
 day) the 
distribution in phyla became Actinobacteria (55%), Proteobacteria (39%) and 
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Bacteroidetes (6%). Figure 5.88 shows the change in distribution of phyla with 
increasing time of exposure to TET (SRT10d).  
 
Figure 5.88: Distribution of phyla in TET (SRT10d) system. 
RDP library comparison showed the significant changes in the phylum level among 
the group. The comparison revealed that Actinobacteria, significantly decreased by 
10
th
 day, later increasing gradually and reaching 55% abundance at end of treatment 
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by the 30
th
 day. Proteobacteria showed significant increase at the end of treatment, 
whereas phylum Bacteroidetes significantly decreased throughout the treatment 
(Figure 5.89).  
 
Figure 5.89: Significant changes in dominant phyla in the system (TET SRT10d) 
(*Bars with same letters are not significantly different). 
Rarefaction curves showed that on the 10
th
 and 30
th
 days of exposure the richness 
was lower than the C-10 sample on all levels.  At species (3%) level lowest richness 
is observed in the T-10-30 sample. Additionally, on phyla (20%) level T-10-10 
sample showed higher richness than that of T-10-30, however lower than C-10 
sample. This information suggests that the richness in the activated sludge 
community decreases under the influence of TET antibiotic (Figure 5.90).  
Both ACE and Chao1 estimators of richness suggest that the richness of the 
population decreases with time (Table 5.29). Information obtained from evenness 
shows that all four samples exhibited dominant community structures at all levels. 
Further analysis also revealed that the dominance shifted with the effect of TET 
(SRT10d) treatment. 
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Figure 5.90: Rarefaction curves for TET (SRT10d) samples at 3% and 20% 
distances.  
Table 5.29: Statistical indicators for TET feeding (SRT 10d). 
 
3% 20% 
C-10 T-10-10 T-10-30 C-10 T-10-10 T-10-30 
Number of OTUs 288 104 113 42 18 12 
Singleton 168 67 69 14 8 3 
Chao1 estimate of  
OTUs richness 
647.7 350 260 55.0 32 15 
ACE estimate of  
OTU richness 
1019.5 657 642 66.9 60 21 
Shannon index of  
diversity (H) 
3.0 2.9 2.3 1.6 1.6 1.25 
Evenness 0.53 0.61 0.49 0.41 0.54 0.50 
Good's estimator of  
coverage (%) 
41.67 35.58 38.94 66.67 55.56 75.00 
According to the information presented in Figure 5.91, at species level C-10 contains 
288 species level OTUs, T-10-10 contains 104 species level OTUs and T-10-30 
contains 113 species level OTUs. However groups C-10 and T-10-10 exclusively 
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share 20 species level OTUs, but 238 and 44 species level OTUs belong to each of 
these groups alone, respectively. Moreover C-10 exclusively shares 14 species level 
OTUs with T-10-30. T-10-30 has 59 species level OTUs unique for itself. 
Additionally, 20 species level OTUs are shared by all groups (total shared richness). 
Finally total richness of all four groups together is calculated as 415 species level 
OTUs. 
 
Figure 5.91: Venn diagram of TET (SRT10d) samples at 0.03 distance.  
At phylum level however, C-10 contains 42 phylum level OTUs, T-10-10 contains 
18 phylum level OTUs and T-10-30 contains 12 phylum level OTUs. However 
groups C-10 and T-10-10 share 4 phylum level OTUs, but 28 and 4 phylum level 
OTUs belong to each of these groups alone, respectively. Moreover C-10 shares 2 
phylum level OTU exclusively with T-10-30. T-10-30 has no phylum level OTUs 
unique for itself. Moreover T-10-10 and T-10-30 exclusively share 3 phylum level 
OTUs. Additionally, 7 phylum level OTUs are shared by all four groups (total shared 
richness). Finally total richness of all four groups together is calculated as 48 (Figure 
5.92). 
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Figure 5.92: Venn diagram of TET (SRT10d) samples at 0.20 distance.  
Results of statistical analysis revealed the significantly affected OTUs under chronic 
inhibited conditions (Table 5.30). It can be seen that OTU#6 (unclassified 
Actinobacteria sp; 45%) and OTU#45 (unclassified Sphingobacteria sp of 
Bacteriodetes; 10%) were most abundant species in the control sample (C-10). 
However, after 10 days of TET (SRT10d) treatment OTU#6 decreased significantly 
to 4%, whereas OTU#10 disappeared completely (p<0.05, q>0.05). However 
OTU#160 (Acidovorax sp), and OTU#336 (Stenotrophomas sp) increase 
significantly and become most abundant species in the system by the 10
th
 day of 
exposure. By the 30
th
 day it can be seen that OTU#55 of Arthrobacter sp increased 
gradually in time and became one of the most abundant species in the system 
together with OTU#24 of Diaphorobacter sp of Betaproteobacteria class.  
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Table 5.30: Significant changes in the activated sludge population (TET SRT10d) 
(species level OTUs are named by numbers). 
Phylum 
Nearest  
Classified  
Neighbour 
OTU 
Number 
C-10 
(%) 
T-10-10 
(%) 
T-10-30 
(%) 
Actinobacteria Unclassified  
Intrasporangiaceae 
6 45 4 1 
Bacteroidetes Unclassified  
Chitinophagaceae 
10 10 0 0 
Proteobacteria Diaphorobacter 24 0 2 21 
Actinobacteria Arthrobacter 55 1 6 44 
Proteobacteria Acidovorax 160 0 18 2 
Proteobacteria Stenotrophomonas 336 0 24 1 
Sludge age 2 d system 
At the phylum level constant exposure to TET (SRT 2d) shows a significant shift in 
community structure. After 2 days of exposure the percentages of present phyla 
change from 57%, 22%, 18% and 3% in the C-2 reactor to 40%, 53%, 3% and 4% 
for Proteobacteria, Actinobacteria, Deinococcus-Thermus and Bacteroidetes phyla, 
respectively, where dominance shifts from Proteobacteria to Actinobacteria phylum. 
Results obtained at the 4
th
 day show that the Deinococcus-Thermus phylum 
disappears. Moreover, at the end of treatment the community structure on phyla level 
becomes Proteobacteria (60%), Actinobacteria (34%) and Bacteroidetes (5%). 
These results show that Actinobacteria although fit to survive under constant 
exposure of TET, are not capable of sustaining dominance in a fast growing system. 
Figure 5.93 shows the change in distribution of phyla with increasing time of 
exposure to TET (SRT 2d). Results revealed that the members of phylum 
Deinococcus-Thermus disappeared, Proteobacteria and Actinobacteria increased 
significantly. 
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Figure 5.93: Bacterial community structures at phylum level for TET (SRT2d) 
exposure. 
RDP library comparison showed that phylum Deinococcus-Thermus decreased 
significantly in time, whereas phylum Actinobacteria showed fluctuating dominance, 
which resulted in increased abundance compared to the C-2 sample on the 4
th
 day of 
treatment. However, due to competence with Actinobacteria phylum, 
Proetobacteria, showed first significant decrease followed by significant increase, 
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resulting in insignificant increase in abundance compared to the C-2 sample on the 
4
th
 day of treatment with TET (SRT2d) (Figure 5.94).  
 
Figure 5.94: Significant changes in dominant phyla in the system (TET SRT2d) 
(*Bars with same letters are not significantly different). 
Rarefaction curves showed that on the 2
nd
 and 4
th
 days of exposure the richness is 
lower than the C-2 sample on both species (3%) and phylum (20%) levels.  
Additionally, the figures always show a decreasing trend in richness of the systems at 
both levels under the influence of TET antibiotic (Figure 5.95). Both non-parametric 
richness estimators ACE and Chao1 estimators of richness suggest that the richness 
of the population changes with time. The information suggests that on both levels 
richness fluctuates. It increases on the 2
nd
 day and decreases again on the 4
th
 day. 
However on both levels the system reaches higher richness after 4
th
 day of exposure 
compared to the C-2 sample. The fluctuation in richness might be attributed to the 
increase and decrease in the abundance of Actinobacteria species in the system 
(Table 5.31). Information obtained from evenness calculated from Shannon’s index 
of diversity shows that all four samples exhibited dominant community structures at 
all levels. Further analysis also revealed that the dominance shifted with the effect of 
TET (SRT2d) treatment.  
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Figure 5.95: Rarefaction curves for TET(SRT2d) samples at 3% and 20% distances. 
Table 5.31: Statistical indicators for TET feeding (SRT 2d). 
 
3% 20% 
C-2 T-2-2 T-2-4 C-2 T-2-2 T-2-4 
Number of OTUs 70 95 67 12 16 11 
Singleton 36 49 35 2 5 2 
Chao1 estimate of OTUs richness 133.0 185.5 166.2 12.3 19.3 11.5 
ACE estimate of OTU richness 187.9 291.3 228.7 13.2 22.6 16.5 
Shannon index of diversity (H) 1.9 1.9 2.0 1.1 1.2 1.5 
Evenness 0.45 0.41 0.48 0.46 0.42 0.63 
Good's estimator of coverage (%) 48.57 48.42 47.76 83.33 68.75 81.82 
Venn diagrams in show that at species level C-2 contains 70 species level OTUs, T-
2-2 contains 95 species level OTUs and T-2-4 contains 67 species level OTUs. 
However groups C-2 and T-2-2 exclusively share 9 species level OTUs, but 45 and 
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48 species level OTUs belong to each of these groups alone, respectively. Moreover 
C-2 and T-2-2 share 3 and 25 species level OTUs exclusively with T-2-4, 
respectively, whereas T-2-4 has 26 unshared species level OTUs. Additionally, 13 
species level OTUs are common in all three groups (total shared richness). Finally 
total richness of all groups together is calculated as 169 species level OTUs. (Figure 
5.96) 
 
Figure 5.96: Venn diagram of TET (SRT2d) samples at 0.03 distance. 
At phylum level however, C-2 contains 12 phylum level OTUs, T-2-2 contains 16 
phylum level OTUs and T-2-4 contains 11 phylum level OTUs. However group C-2 
exclusively shares 1 phylum level OTU with T-2-2 and 2 phylum level OTUs with 
T-2-4. T-2-2 and T-2-4 exclusively have 4 phylum level OTUs in common. C-2 and 
T-2-2 have 4 and 6 unshared phylum level OTUs, respectively, whereas T-2-4 does 
not have unshared phylum level OTUs. Additionally, 5 phylum level OTUs are 
common in all three groups (total shared richness). Finally total richness of all 
groups together is calculated as 22 phylum level OTUs (Figure 5.97). 
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Figure 5.97: Venn diagram of TET (SRT2d) samples at 0.20 distance. 
Results of statistical analysis revealed the significantly affected OTUs under chronic 
inhibited conditions (Table 5.32). It can be seen that OTU#3 (Paracoccus sp; 47%), 
OTU#1 (Deinococcus sp; 18%) and OTU#4 (Arthrobacter sp; 10%) were most 
abundant species in the control sample (C-2). However, after 4 days of TET (SRT2d) 
treatment OTU#3 disappeared, whereas OTU#4 increased up to 30%. Abundances of 
OTUs 88 (Comamonas sp) and 135 (Stenotrophomonas sp), non-abundant species in 
C-2 sample increased drastically and reached abundances of 21%, 12% and 20% by 
the 4
th
 day of exposure, respectively.  
Table 5.32: Significant changes in the activated sludge population (TET SRT2d). 
Phylum 
Nearest Classified 
Neighbour 
OTU 
Number 
C-2 
(%) 
T-2-2 
(%) 
T-2-4 
(%) 
Deinococcus-
Thermus 
Deinococcus 1 18 4 0 
Proteobacteria Paracoccus 3 47 0 0 
Actinobacteria Arthrobacter 4 10 37 30 
Proteobacteria Comamonas 88 0 32 21 
Proteobacteria Stenotrophomonas 135 0 2 20 
Constant exposure to TET significantly affected the bacterial community structures 
of both activated sludge biomasses. However in general it can be seen that in the 
SRT 10d system Proteobacteria are outcompeted by the members of Actinobacteria 
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phylum, even though possessing resistance properties to TET. However, as is in the 
control systems Actinobacteria are outcompeted by Proteobacteria in the SRT2d 
system even under the influence of TET. It can be seen that in both systems 
Arthrobacter sp and Stenotrophomonas sp are present in significant percentages. 
Information in the literature suggests that species of both genera are resistant to 
tetracycline. Arthrobacter sp and Stenotrophomonas sp are shown to possess tetK, 
tetL and tetW and tetA, tetB, tetC, tetD, tetH, tetK, tetL, tetJ, tetM, tetO, tetS, tetT, 
tetW, tet33 and tet(AP) resistance genes, respectively (Li et al., 2010). This 
information indicates that both Arthrobacter sp and Stenotrophomonas sp are 
possessing genes encoding both efflux and ribosomal protection protein genes. 
Other genus found in TET inhibited SRT 2d system was Comamonas sp that was 
also shown to possess tetracycline resistance genes. Previously isolated from 
activated sludge systems (Boon et al., 2000) Comamonas testosteroni was shown to 
habour genes encoding both efflux (tetL) and ribosomal protection proteins (tetO) (Li 
et al., 2010). 
Acidovorax sp, known to harbor transpoases and previously detected in activated 
sludge systems (Parsley et al., 2010), is being outcompeted by Actinobacteria species 
in the TET SRT10d reactor. However it is also known to possess resistance genes. 
Acidovorax sp strain MUL2G8 was shown to possess a gene encoding a TetR family 
transcriptional repressor (Ramos et al., 2005). Additionally, Diaphorobacter sp were 
observed in the TET SRT10d system, which was formerly isolated from activated 
sludge systems (Khan and Hiraishi, 2002). Diaphorobacter sp strain TPSY 
(Accession Nr: B9MG39), also known as Acidovorax ebreus (strain TPSY), was also 
shown to have a transcriptional regulator of TetR family. Tet repressor (TetR) 
protein controls the expression of the tetracycline resistance genes (Levy, 1984; 
1988; Hinrichs et al., 1994; Kisker et al., 1995; Yamaguchi et al., 1990a; 1990b; 
Saenger et al., 2000; Ramos et al., 2005). This regulation takes place in the 
transcription level and is induced by [Mg-TET]
+
 complex. Due to higher affinity of 
[Mg-TET]
+
 complex to TetR, the complex binds with TetR, which was bound to the 
operators preventing the expression of resistance proteins, thereby initiating 
resistance expression in the cell, and TET is removed before the inhibition of protein 
synthesis begins (Hillen et al., 1983; Takhashi et al, 1986; Hinrichs et al., 1994).  
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These findings also coincide with the information gained from qualitative evaluation 
of antibiotic resistance genes in the TET reactor. The microbial population in both 
TET reactors was shown to possess tetA, tetC, tetG and tetO genes. However, tetE 
gene was only detected in the SRT2d reactor, whereas tetM only in SRT10d reactor. 
5.8.2.4 Effect of erythromycin on the community structure 
Sludge age 10 d system 
10 days of exposure to ERY showed significant effect on the community structure. 
The abundances of present phyla change from 59%, 24%, 15% and 1% in the C-10 
reactor to 13%, 61%, 24% and 2% for Actinobacteria, Proteobacteria, Bacteroidetes 
and TM7 phyla, respectively. Figure 5.99 shows the change in distribution of 
different phyla with increasing time of exposure to ERY. Results revealed that the 
amount of members of phylum Actinobacteria decrease drastically. However, on the 
other hand amount of bacteria in phylum Proteobacteria increases substantially.  
RDP library showed that Actinobacteria, Proteobacteria and Bacteroidetes phyla are 
significant (Figure 5.98). Drastic changes in the phylum level provided the 
information that the effect of ERY on the activated sludge biomass can even be seen 
on the 20% distance. Therefore changes in the genus and species levels were taken 
into consideration. 
 
Figure 5.98: Significant changes in dominant phyla in the system 
(*Bars with same letters are not significantly different). 
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Figure 5.99: Bacterial community structures at phylum level (ERY SRT10d). 
The information obtained from rarefaction curves on phylum (20%) level show that 
both inhibited samples have substantially lower richness compared to control sample 
(Figure 5.100). Rarefaction curves at species level show that the richness of the C-10 
sample is higher than the ERY inhibited samples (E-10-10 and E-10-31). However it 
shows that E-10-31 has higher richness than that of E-10-10 at these distances.  
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Figure 5.100: Rarefaction curves for ERY(SRT 10d) at 3% and 20% distances. 
Both ACE and Chao1 estimators of richness suggest that the richness of the 
population decreases with time, therefore E-10-10 is estimated to have higher 
richness than E-10-31 at all distances (Table 5.33). Information obtained from 
evenness calculated from Shannon’s index of diversity shows that all three samples 
exhibited dominant community structures at all levels. Further analysis also revealed 
that the dominance shifted with the effect of ERY treatment. 
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Table 5.33: Statistical indicators for ERY feeding (SRT 10d). 
 
3% 20% 
C-10 E-10-10 E-10-31 C-10 E-10-10 E-10-31 
Number of OTUs 288 200 130 42 21 16 
Singleton 168 117 79 14 5 4 
Chao1 estimate of  
OTUs richness 
647.7 451.3 410.1 55.0 23.0 19.0 
ACE estimate of  
OTU richness 
1019.5 806.5 509.1 66.9 24.9 18.9 
Shannon index of  
diversity (H) 
3.0 2.8 3.1 1.6 1.4 1.6 
Evenness 0.53 0.53 0.65 0.41 0.46 0.58 
Good's estimator of  
coverage (%) 
41.67 41.50 39.23 66.67 76.19 75.00 
Venn diagrams shown in Figure 5.101 reveal that at species level C-10 contains 288 
species level OTUs, E-10-10 contains 200 species level OTUs and E-10-31 contains 
130 species level OTUs. However groups C-10 and E-10-10 exclusively share 29 
species level OTUs, but 222 and 105 species level OTUs belong to each of these 
groups alone, respectively. Moreover C-10 and E-10-10 share 6 and 35 species level 
OTUs exclusively with E-10-31, whereas E-10-31 has 58 unshared species level 
OTUs. Additionally, 31 species level OTUs are shared by all three groups (total 
shared richness). Finally total richness of all groups together is calculated as 486 
species level OTUs. 
 
Figure 5.101: Venn diagram of ERY (SRT 10d) treatment samples at 0.03 distance. 
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At phylum level however, C-10 contains 42 species, E-10-10 contains 21 phyla level 
OTUs and E-10-31 contains 16 phyla level OTUs. However groups C-10 and E-10-
10 exclusively share 8 phyla level OTUs, but 23 and 1 phyla level OTUs belong to 
each of these groups alone, respectively. Moreover C-10 and E-10-10 share 2 and 3 
phyla level OTUs exclusively with E-10-31, whereas E-10-31 has 2 unshared phyla 
level OTUs. Additionally, 9 phyla level OTUs are shared by all groups (total shared 
richness). Finally total richness of all groups together is calculated as 48 OTUs 
(Figure 5.102). 
 
Figure 5.102: Venn diagram of ERY (SRT10d) treatment samples at 0.20 distance. 
Results of statistical analysis revealed the significantly affected OTUs under chronic 
inhibited conditions. It can be seen that OTU#6 (unclassified Intrasporangiaceae; 
45%) and OTU#10 (unclassified Chitinophagaceae; 10%) were most abundant 
species in the control sample (C-10). However, after 10 days of ERY treatment these 
species disappeared and did not reappear throughout the whole treatment. Moreover, 
later in the treatment with ERY the microbial population shows further changes, that 
is bacteria that are very low abundant in the control sample increase significantly. 
OTUs of genera Comamonas (30%) and Acidovorax (16%) become significantly 
abundant in the system after 10 days. Additionally, these species continue to be 
present in the system dominantly until the end of the treatment after 31 days (Table 
5.34). 
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Table 5.34: Significant changes in the activated sludge population (ERY SRT10d). 
Phylum 
Nearest Classified  
Neighbour 
OTU 
Number 
C-10 
(%) 
E-10-10 
(%) 
E-10-31 
(%) 
Actinobacteria 
Unclassified  
Intrasporangiaceae 
6 45 1 0 
Bacteroidetes 
Unclassified  
Chitinophagaceae 
10 10 0 0 
Proteobacteria Acidovorax 157 0 16 17 
Proteobacteria Comamonas 293 0 30 19 
Sludge age 2 d system 
At the phylum level constant exposure to ERY (SRT 2d) shows a significant shift in 
community structure. Figure 5.103 shows the change in distribution of phyla with 
increasing time of exposure to ERY (SRT 2d).  
After 3 days of exposure the percentages of present phyla change from 57%, 22%, 
18% and 3% in the C-2 reactor to 33%, 48%, 0% and 17% for Proteobacteria, 
Actinobacteria, Deinococcus-Thermus and Bacteroidetes phyla, respectively, where 
dominance shifts from Proteobacteria to Actinobacteria phylum. Results obtained at 
the 3
rd
 day show that the Deinococcus-Thermus phylum disappears.  Moreover, at the 
end of treatment the community structure on phyla level becomes Proteobacteria 
(49%), Actinobacteria (18%), TM7 (23%) and Bacteroidetes (9%), where abundance 
of TM7 increased drastically. These results show that Actinobacteria and 
Bacteroidetes although fit to survive under constant exposure of ERY, are not 
capable of sustaining dominance in a fast growing system, which is also confirmed 
by the structural differences between SRT 10d and SRT 2d control reactors. Results 
revealed that the members of phylum Deinococcus-Thermus disappeared and 
members of phylum TM7 increased significantly. 
 
173 
 
 
Figure 5.103: Bacterial community structures at phylum level (ERY SRT2d). 
RDP library comparison on the phylum level showed that phylum Deinococcus-
Thermus disappeared, whereas phylum Actinobacteria showed fluctuating 
dominance, which resulted in decreased abundance compared to the C-2 sample on 
the 10
th
 day of treatment. However, due to competence with Actinobacteria phylum, 
Proetobacteria, showed first significant decrease followed by significant increase, 
resulting in increase in abundance compared to the C-2 sample on the 10
th
 day of 
treatment with ERY. Additionally, phylum Bacteroidetes also showed a fluctuating 
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abundance profile ending with significant increase in abundance and phylum TM7 
increased in abundance and became one of the most abundant phyla in the system 
after 10 days of ERY treatment (SRT2d)  (Figure 5.104).  
 
Figure 5.104: Significant changes in dominant phyla in the system (*Bars with same 
letters are not significantly different). 
Rarefaction curves at species (3%) level show that on the 3
rd
 and 10
th
 days of 
exposures richness was higher than C-2 sample. However on the phyla (20%) level 
C-2 sample shows higher richness than both ERY inhibited samples (Figure 5.105). 
Moreover, both ACE and Chao1 estimators of richness suggest that the richness of 
the population changes with time. The information suggests that on all levels 
richness fluctuates. It increases on the 3
rd
 day and decreases again on the 10
th
 day. 
The fluctuation in richness might be attributed to the increase followed by a decrease 
in the abundance of Actinobacteria and Bacteriodetes species in the system (Table 
5.35). Information obtained from evenness calculated from Shannon’s index of 
diversity shows that all four samples exhibited dominant community structures at all 
levels. Further analysis also revealed that the dominance shifted with the effect of 
ERY (SRT2d) treatment.  
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Figure 5.105: Rarefaction curves at 3% and 20% distances (ERY SRT2d). 
Table 5.35: Statistical indicators for ERY feeding (SRT 2d). 
 3% 20% 
C-2 E-2-3 E-2-10 C-2 E-2-3 E-2-10 
Number of OTUs 70 140 77 12 11 9 
Singleton 36 80 40 2 2 0 
Chao1 estimate of OTUs richness 133.0 298.0 163.7 12.3 12.0 9.0 
ACE estimate of OTU richness 187.9 538.5 152.7 13.2 18.7 9.0 
Shannon index of diversity (H) 1.9 2.4 2.6 1.1 1.5 1.7 
Evenness 0.45 0.48 0.59 0.46 0.64 0.77 
Good's estimator of coverage (%) 48.57 42.86 48.05 83.33 81.82 100.00 
According to the information on shared species level OTUs (Figure 5.106), at species 
level C-2 contains 70 species level OTUs, E-2-3 contains 140 species level OTUs 
and E-2-10 contains 77 species level OTUs. However groups C-2 and E-2-3 
exclusively share 7 species level OTUs, but 52 and 91 species level OTUs belong to 
each of these groups alone, respectively. Moreover C-2 and E-2-3 share 1 and 32 
species level OTUs exclusively with E-2-10, respectively, whereas E-2-10 has 34 
unshared species level OTUs. Additionally, 10 species level OTUs are shared by all 
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three groups (total shared richness). Finally total richness of all groups together is 
calculated as 227. 
 
Figure 5.106: Venn diagram of ERY treatment samples at 0.03 distance (SRT2d). 
At phylum level however, C-2 contains 12 phylum level OTUs, E-2-3 contains 11 
phylum level OTUs and E-2-10 contains 9 phylum level OTUs. However group C-2 
does not have any common phylum level OTUs with E-2-3 and E-2-10. E-2-3 and E-
2-10 exclusively share 2 phylum level OTUs. C-2 and E-2-3 have 5 and 2 unshared 
phylum level OTUs, respectively, whereas E-2-10 has no unshared phylum level 
OTUs. Additionally, 7 phylum level OTUs are common in all three groups (total 
shared richness). Finally total richness of all groups together is calculated as 16 
phylum level OTUs (Figure 5.107). 
177 
 
 
Figure 5.107: Venn diagram of ERY treatment samples at 0.20 distance (SRT2d). 
Results of statistical analysis revealed the significantly affected OTUs under chronic 
inhibited conditions. It can be seen that OTU#3 (Paracoccus sp; 47%), OTU#1 
(Deinococcus sp; 18%) and OTU#4 (Arthrobacter sp; 10%) were most abundant 
species in the control sample (C-2). However, after 3 days of ERY (SRT2d) 
treatment OTUs #1 and #3 disappeared, whereas OTU#4 increased up to 34%. 
However OTU#4 could not sustain its abundance due to the fast nature of the SRT 2d 
system and its abundance decreased to 5% by the 10
th
 day of exposure. Additionally, 
on the 3
rd
 day OTU#76 (Comamonas sp; 20%) showed increased abundance. 
Moreover OTU#83 (unclassified member of TM7 phylum) reached 23% abundance 
on the 10
th
 day of exposure, relatively (Table 5.36).  
Table 5.36: Significant changes in the activated sludge population (ERY SRT2d). 
Phylum 
Nearest Classified 
Neighbour 
OTU 
Number 
C-2 
(%) 
E-2-3 
(%) 
E-2-10 
(%) 
Deinococcus-
Thermus 
Deinococcus 1 18 0 0 
Proteobacteria Paracoccus 3 47 0 0 
Actinobacteria Arthrobacter 4 10 34 5 
Proteobacteria Comamonas 76 0 20 20 
TM7 Unclassified TM7 83 0 0 23 
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At the phylum level it can be seen that on the first days of exposure to ERY 
Proteobacteria sp were dominated by the phylum Actinobacteria, which then due to 
their low growth rates became less abundant in the system.  
Literature indicated that the bacteria surviving under constant exposure to 
erythromycin are resistant to the antibiotic substance. Comamonas sp., one of the 
most abundant Proteobacterial genera in the system after 10 and 31 days of exposure 
in the SRT10d and also after 3 and 10 days of exposure in the SRT2d system, have 
been studied and Xiong et al. (2011) showed that Comamonas testosteroni S44 has a 
macrolide specific efflux-protein (mac(A) – Accession Nr: D8D8L7) and an 
erythromycin resistance ATP-binding protein (msr(A) – Accession Nr: D8D8F4).  
Second most abundant bacterial genera in the SRT 10d system after treatment were 
shown to be Acidovorax sp. Among this bacterial genus Acidovorax avenae, also 
known to harbor transposase (Parsley et al., 2010), has been shown to be resistant to 
erythromycin by Oliveira et al. (2007).  
Moreover, as was explained by Roberts (2008), most of the macrolide resistance 
genes are linked with other genes on portable elements found in bacteria. Among 
these linkage of tetO and mef(A) and linkage of ere(A) and mph(A) with class 1 
integron has been shown (Roberts, 2008). Arthrobacter spp, detected in the SRT 2d 
system, was also shown to harbor integrons, showing that members of this genus 
may be resistant to erythromycin through ere(A) or mph(A) gene linked to the class 1 
integron they possess. Arthrobacter sp however became less abundant due to their 
slower nature in the SRT2d system. Additionally, no information was available on 
the resistance of bacteria belonging to TM7 phylum to erythromycin, which was 23% 
abundant at the end of the treatment in the SRT2d system.  
Finally, sudden disappearance of Deinococcus-Thermus phylum under the pressure 
of ERY can be explained by the sensitivity of Deinococcus sp to antibiotics with 
protein synthesis inhibition properties, like erythromycin (Hawiger and Jeljaszewicz, 
1967; Slade and Radman, 2011). 
Resistance gene analysis has been done on both systems. erm(A), erm(B), erm(C), 
msr(A) and mph(A) genes were amplified in ERY samples. However only positive 
results were obtained from mph(A) gene. Sequence similarity search has been done 
using the msr(A) primer used for PCR amplifications and no hits were obtained, 
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indicating primers used were not specific enough to detect erythromycin resistant 
Comamonas sp, detected in both ERY inhibited systems, habouring msr(A) gene. 
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6. CONCLUSIONS AND FUTURE RECOMMENDATIONS 
Main aim of this study was to determine the effects of antibiotics on the 
biodegradation characteristics of activated sludge systems. For this purpose three 
model antibiotic substances; sulfamethoxazole, tetracycline and erythromycin, were 
selected and acute and chronic effects on an activated sludge system acclimated on 
synthetic domestic wastewater were investigated. Model simulations were completed 
and microbial population dynamics were investigated. Detailed response profile of 
activated sludge biomass to antibiotic substances has been established. 
Most important result obtained from this study was that the antibiotic substances 
have the property to bind the substrate. These substances have the capability to 
inhibit the substrate biodegradation pathway at any point of the pathway and cause 
the system to survive on less amount of substrate. Kinetic evaluation of the data 
obtained provided unique information on the effects of antibiotics on the substrate 
degradation properties of activated sludge biomass under acute and chronic pressure 
of antibiotics. The study revealed that antibiotic substances mainly increase the half 
saturation constant of the substrate (KS), making it less available to biomass, and 
inhibit hydrolysis of either SH or XS. Moreover, it has been demonstrated that acute 
and chronic additions of antibiotics increase endogenous decay (bH) levels of the 
microbial biomass significantly. 
Moreover, information obtained from resistance and pyrosequencing studies showed 
that the community structure changes under chronic exposure to antibiotics, where 
only resistant bacteria can survive. Pyrosequencing studies showed serious 
population shifts in all three microbial communities. Additionally, the study 
enlightened the effect of sludge age on the bacterial community structure both with 
and without the effect of antibiotics. Results obtained showed that Actinobacteria as 
slow growing organisms do not have the capacity to dominate a fast growing system 
with the sludge age of 2days, instead Proteobacteria dominate the system. However 
in sludge age 10 day system, where Actinobacteria are not washed out, they were 
182 
 
shown to be dominant. However under the effect of erythromycin at sludge age 10 
day system the dominance shifts from Actinobacteria to Proteobacteria, due to 
resistant strains present in the system, where Comamonas sp OTU#293 becomes the 
most abundant organism. At sludge age 2 day system an unclassified organism of 
candidate phylum TM7 (OTU#83) becomes dominant, where without the pressure of 
erythromycin phylum Proteobacteria was dominant. However in both tetracycline 
systems the dominant phylum does not shift, since in 10day system Actinobacteria 
and in 2 day system Proteobacteria continue to dominate. On the other hand in the 2 
day tetracycline system phylum Deinococcus-Thermus disappeares, whereas OTU#1, 
a member of Deinococcus-Thermus phylum becomes one of the most abundant 
species in the sulfamethoxazole 2 day system. In sulfamethoxazole 2 day system 
Proteobacteria decreases drastically, where Deinococcus-Thermus phylum increases 
substantially. However, in the 10 day sulfamethoxazole system Bacteroidetes 
decrease drastically. In both systems together with both tetracycline systems 
Arthrobacter spp were dominant that are OTU#2, OTU#55 and OTU#4 in 
sulfamethoxazole 10 day, tetracycline 10 day and 2 day systems, respectively. 
Finally, it is recommended that future studies on antibiotics should include 
determination of ways to remove antibiotics via biological treatment systems. For 
instance, bacteria able to degrade antibiotic substances can be detected by stable 
isotope probing and characterized. Moreover model simulation studies on the 
removal antibiotics might enlighten very important questions in this field. 
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